MrHuattt的个人主页 - 老虎社区

MrHuattt

暂无个人介绍

IP属地：未知

434关注

26粉丝

0主题

0勋章

2021-10-19

$SUNTEC REAL ESTATE INV TRUST(T82U.SI)$ bought around sep. Will i be entitled to receive the dividend end of this month?

2022-01-22

H

Why I Sold These 3 High-Growth Tech Stocks

2021-12-25

U

3 Best Buffett Stocks to Buy for the Long Haul

2021-10-26

H

Tesla shares rose 5% in morning trading after reaching one trillion dollar market cap.

2021-12-05

H

DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'

2021-12-12

I

To the moon! Cryptocurrency was the most popular Reddit topic this year

2021-11-06

H

抱歉，原内容已删除

2021-10-29

H

Roblox is a better metaverse play than Facebook - Tao Value

2021-10-25

H

抱歉，原内容已删除

2021-12-13

H

Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion

2021-11-30

I

Apple Stock: Here's Your Chance To Buy

2021-11-25

H

Will Palantir Be a Trillion-Dollar Stock by 2040?

2021-11-12

I

抱歉，原内容已删除

2021-10-18

$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$ have the feeling going to flyyyyyy soon

2021-10-09

H

US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week

2021-12-24

H

Is Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates

2021-12-20

H

Biden electric vehicle push hits setback in U.S Senate

2021-12-19

H

Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade

2021-12-06

H

3 Hot Metaverse Stocks to Buy Before 2021 Is Over

2021-11-19

J

Moderna jumped over 8% while Pfizer and BioNTech SE rose around 2% in morning trading

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4089116574465250,"uuid":"4089116574465250","gmtCreate":1626072873276,"gmtModify":1626072873276,"name":"MrHuattt","pinyin":"mrhuattt","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":26,"headSize":434,"tweetSize":194,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.12","exceedPercentage":"93.23%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.13","exceedPercentage":"80.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":631237073,"gmtCreate":1644755381388,"gmtModify":1644755381694,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/631237073","repostId":"2210409526","repostType":4,"repost":{"id":"2210409526","pubTimestamp":1644633920,"share":"https://www.laohu8.com/m/news/2210409526?lang=&edition=full","pubTime":"2022-02-12 10:45","market":"us","language":"en","title":"China Approves Use of Pfizer's COVID Drug Paxlovid","url":"https://stock-news.laohu8.com/highlight/detail?id=2210409526","media":"Reuters","summary":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditi","content":"<html><head></head><body><p>BEIJING, Feb 12 (Reuters) - China&#39;s medical products regulator said on Saturday it has given conditional approval for Pfizer&#39;s COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.</p><p>The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.</p><p>It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment. </p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Approves Use of Pfizer's COVID Drug Paxlovid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Approves Use of Pfizer's COVID Drug Paxlovid\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-12 10:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BK4007":"制药","BK4124":"机动车零配件与设备","PFE":"辉瑞","BK4534":"瑞士信贷持仓"},"source_url":"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2210409526","content_text":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633573358,"gmtCreate":1644245319180,"gmtModify":1644245319475,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633573358","repostId":"1186876974","repostType":4,"repost":{"id":"1186876974","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1644245081,"share":"https://www.laohu8.com/m/news/1186876974?lang=&edition=full","pubTime":"2022-02-07 22:44","market":"us","language":"en","title":"EV Stocks Rose in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1186876974","media":"Tiger Newspress","summary":"EV stocks rose in morning trading, with Tesla, Rivian, NIO, Xpeng, Fisker and Arrival rising from 2 ","content":"<html><head></head><body><p>EV stocks rose in morning trading, with Tesla, Rivian, NIO, Xpeng, Fisker and Arrival rising from 2 to 4%.<img src=\"https://static.tigerbbs.com/7a9d27c437985a03bc85e29abf014cd3\" tg-width=\"382\" tg-height=\"517\" referrerpolicy=\"no-referrer\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Rose in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Rose in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-07 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>EV stocks rose in morning trading, with Tesla, Rivian, NIO, Xpeng, Fisker and Arrival rising from 2 to 4%.<img src=\"https://static.tigerbbs.com/7a9d27c437985a03bc85e29abf014cd3\" tg-width=\"382\" tg-height=\"517\" referrerpolicy=\"no-referrer\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来","RIVN":"Rivian Automotive, Inc.","TSLA":"特斯拉"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186876974","content_text":"EV stocks rose in morning trading, with Tesla, Rivian, NIO, Xpeng, Fisker and Arrival rising from 2 to 4%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633234522,"gmtCreate":1644109049758,"gmtModify":1644109050033,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"//<a href=\"https://laohu8.com/U/4089116574465250\">@MrHuattt</a>: Hhhh","listText":"//<a href=\"https://laohu8.com/U/4089116574465250\">@MrHuattt</a>: Hhhh","text":"//@MrHuattt: Hhhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633234522","repostId":"1130580421","repostType":4,"repost":{"id":"1130580421","pubTimestamp":1644040812,"share":"https://www.laohu8.com/m/news/1130580421?lang=&edition=full","pubTime":"2022-02-05 14:00","market":"us","language":"en","title":"2022 Could be a Success or a Lost Opportunity for Novavax","url":"https://stock-news.laohu8.com/highlight/detail?id=1130580421","media":"InvestorPlace","summary":"Novavax can either generate a boost of sales or lose an opportunity in the industry of vaccines against coronavirus","content":"<html><head></head><body><p><b>Novavax, Inc</b>. (NASDAQ:<b><u>NVAX</u></b><u>)</u> has had a tough year with losses of approximately 68%. It has already declined about 37% year-to-date, as well. However, as of Feb. 3, 2022, the stock has a 5-day return of nearly 25%. This increased volatility in the stock price is primarily news-driven.</p><p>Novavax is trying to become active in the global industry of vaccines against the coronavirus to put an end to the pandemic so all of us can return to normal conditions at which social distancing will be a distant memory, along with wearing face masks.</p><p><b>Novavax Business News</b></p><p>The latest business news is that Novavax got conditional authorization in the U.K for its protein-based Covid-19 vaccine called Nuvaxovid. It is reported that “the U.K. has already ordered up to 60 million doses of Novavax’s vaccine.”</p><p>The company announced that it filed for authorization in the U.S. market in late Jan. 2022. Novavax has been granted provisional registration for its vaccine in Australia. Additionally, in South Korea, the Ministry of Food and Drug Safety has approved the firm’s vaccine. At the same time the “European Commission (EC) has granted Novavax conditional marketing authorization (CMA) for Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.”</p><p>Novavax also submitted for emergency use authorization of its vaccine in South Africa.</p><p>A lot of this news is a catalyst for NVAX stock. The greatest impact on the stock probably would be U.S. market approval for Nuvaxovid. Investors waiting for further positive news are already building a bull case for Novavax.</p><p><b>Bullish Scenario for NVAX Stock</b></p><p>Novavax’s vaccine is the fifth vaccine approved by the E.U. Protein vaccines like Nuvaxovid can do a lot for the global vaccination campaign. This is because they work differently from the vaccines currently available in the E.U., which are based on either mRNA technology, such as Pfizer and Moderna, or viral vector technology, such as AstraZeneca and Johnson &amp; Johnson.</p><p>If unvaccinated people are not biased against vaccination to protect from Covid-19, they could soon be vaccinated with protein vaccines such as Nuvaxovid. Such protein vaccines have been used for decades to protect against polio, tetanus, hepatitis B, and the flu. They also offer very good protection against coronavirus and cause even fewer side effects than vaccines that are already approved.</p><p>Also, these vaccines are important. Richer countries are so preoccupied with booster vaccinations and closing vaccination gaps that they may forget that in poor countries very few people have been vaccinated.</p><p>Protein-based vaccines could also make a significant contribution to the market. They are relatively inexpensive to produce and can be transported and stored at 2° to 8° C much more easily than mRNA vaccines, which need to be frozen.</p><p>Novavax will first supply its vaccine in poorer countries like Africa. The Novavax vaccine is a combination vaccine that is said to protect against the coronavirus and the flu at the same time. According to Novavax, initially,100 million doses of the vaccine could be produced per month. They later expect to be able to produce 150 million doses of the vaccine per month.</p><p>Europe being supplied with Nuvaxovid is certainly big news for Novavax. The U.S. Food and Drug Administration (FDA) may become biased and send the green light for the biotechnology company to boost its sales, especially if its price is cheaper than other vaccines.</p><p><b>Bearish Case for NVAX Stock</b></p><p>Third quarter (Q3) 2021 financial results showed a year-over-year increase of 14% for revenue to $179 million and a 38% increase of total expenses to $486 million. Loss from operations widened to $307 million compared to a loss of $194 million in Q3 2020. Net loss also widened to $322 million compared to a net loss of $197 million in Q3 2020.</p><p>The firm has poor financial strength as the debt-to-equity (D/E) ratio of 0.70 is considered high for a money-losing business that has been burning cash over the past five consecutive years.</p><p>Another negative sign for NVAX stock is that shareholders have been substantially diluted in the past year, with total shares outstanding growing by 137.4%.</p><p><b>Novavax: At an Inflection Point Now</b></p><p>The company has positive news that sparks enthusiasm. The broader fundamental analysis, however, is not supportive of the company. Widening losses and burning cash must be addressed fast and radically for a stock price rebound to occur and last.</p><p>I remain bearish on NVAX stock, waiting for sales updates as the key catalyst.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2022 Could be a Success or a Lost Opportunity for Novavax</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2022 Could be a Success or a Lost Opportunity for Novavax\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-05 14:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/02/2022-could-be-a-success-or-a-lost-opportunity-for-novavax/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax, Inc. (NASDAQ:NVAX) has had a tough year with losses of approximately 68%. It has already declined about 37% year-to-date, as well. However, as of Feb. 3, 2022, the stock has a 5-day return of...</p>\n\n<a href=\"https://investorplace.com/2022/02/2022-could-be-a-success-or-a-lost-opportunity-for-novavax/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2022/02/2022-could-be-a-success-or-a-lost-opportunity-for-novavax/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130580421","content_text":"Novavax, Inc. (NASDAQ:NVAX) has had a tough year with losses of approximately 68%. It has already declined about 37% year-to-date, as well. However, as of Feb. 3, 2022, the stock has a 5-day return of nearly 25%. This increased volatility in the stock price is primarily news-driven.Novavax is trying to become active in the global industry of vaccines against the coronavirus to put an end to the pandemic so all of us can return to normal conditions at which social distancing will be a distant memory, along with wearing face masks.Novavax Business NewsThe latest business news is that Novavax got conditional authorization in the U.K for its protein-based Covid-19 vaccine called Nuvaxovid. It is reported that “the U.K. has already ordered up to 60 million doses of Novavax’s vaccine.”The company announced that it filed for authorization in the U.S. market in late Jan. 2022. Novavax has been granted provisional registration for its vaccine in Australia. Additionally, in South Korea, the Ministry of Food and Drug Safety has approved the firm’s vaccine. At the same time the “European Commission (EC) has granted Novavax conditional marketing authorization (CMA) for Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.”Novavax also submitted for emergency use authorization of its vaccine in South Africa.A lot of this news is a catalyst for NVAX stock. The greatest impact on the stock probably would be U.S. market approval for Nuvaxovid. Investors waiting for further positive news are already building a bull case for Novavax.Bullish Scenario for NVAX StockNovavax’s vaccine is the fifth vaccine approved by the E.U. Protein vaccines like Nuvaxovid can do a lot for the global vaccination campaign. This is because they work differently from the vaccines currently available in the E.U., which are based on either mRNA technology, such as Pfizer and Moderna, or viral vector technology, such as AstraZeneca and Johnson & Johnson.If unvaccinated people are not biased against vaccination to protect from Covid-19, they could soon be vaccinated with protein vaccines such as Nuvaxovid. Such protein vaccines have been used for decades to protect against polio, tetanus, hepatitis B, and the flu. They also offer very good protection against coronavirus and cause even fewer side effects than vaccines that are already approved.Also, these vaccines are important. Richer countries are so preoccupied with booster vaccinations and closing vaccination gaps that they may forget that in poor countries very few people have been vaccinated.Protein-based vaccines could also make a significant contribution to the market. They are relatively inexpensive to produce and can be transported and stored at 2° to 8° C much more easily than mRNA vaccines, which need to be frozen.Novavax will first supply its vaccine in poorer countries like Africa. The Novavax vaccine is a combination vaccine that is said to protect against the coronavirus and the flu at the same time. According to Novavax, initially,100 million doses of the vaccine could be produced per month. They later expect to be able to produce 150 million doses of the vaccine per month.Europe being supplied with Nuvaxovid is certainly big news for Novavax. The U.S. Food and Drug Administration (FDA) may become biased and send the green light for the biotechnology company to boost its sales, especially if its price is cheaper than other vaccines.Bearish Case for NVAX StockThird quarter (Q3) 2021 financial results showed a year-over-year increase of 14% for revenue to $179 million and a 38% increase of total expenses to $486 million. Loss from operations widened to $307 million compared to a loss of $194 million in Q3 2020. Net loss also widened to $322 million compared to a net loss of $197 million in Q3 2020.The firm has poor financial strength as the debt-to-equity (D/E) ratio of 0.70 is considered high for a money-losing business that has been burning cash over the past five consecutive years.Another negative sign for NVAX stock is that shareholders have been substantially diluted in the past year, with total shares outstanding growing by 137.4%.Novavax: At an Inflection Point NowThe company has positive news that sparks enthusiasm. The broader fundamental analysis, however, is not supportive of the company. Widening losses and burning cash must be addressed fast and radically for a stock price rebound to occur and last.I remain bearish on NVAX stock, waiting for sales updates as the key catalyst.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633234699,"gmtCreate":1644108910459,"gmtModify":1644108910743,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633234699","repostId":"1130580421","repostType":4,"repost":{"id":"1130580421","pubTimestamp":1644040812,"share":"https://www.laohu8.com/m/news/1130580421?lang=&edition=full","pubTime":"2022-02-05 14:00","market":"us","language":"en","title":"2022 Could be a Success or a Lost Opportunity for Novavax","url":"https://stock-news.laohu8.com/highlight/detail?id=1130580421","media":"InvestorPlace","summary":"Novavax can either generate a boost of sales or lose an opportunity in the industry of vaccines against coronavirus","content":"<html><head></head><body><p><b>Novavax, Inc</b>. (NASDAQ:<b><u>NVAX</u></b><u>)</u> has had a tough year with losses of approximately 68%. It has already declined about 37% year-to-date, as well. However, as of Feb. 3, 2022, the stock has a 5-day return of nearly 25%. This increased volatility in the stock price is primarily news-driven.</p><p>Novavax is trying to become active in the global industry of vaccines against the coronavirus to put an end to the pandemic so all of us can return to normal conditions at which social distancing will be a distant memory, along with wearing face masks.</p><p><b>Novavax Business News</b></p><p>The latest business news is that Novavax got conditional authorization in the U.K for its protein-based Covid-19 vaccine called Nuvaxovid. It is reported that “the U.K. has already ordered up to 60 million doses of Novavax’s vaccine.”</p><p>The company announced that it filed for authorization in the U.S. market in late Jan. 2022. Novavax has been granted provisional registration for its vaccine in Australia. Additionally, in South Korea, the Ministry of Food and Drug Safety has approved the firm’s vaccine. At the same time the “European Commission (EC) has granted Novavax conditional marketing authorization (CMA) for Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.”</p><p>Novavax also submitted for emergency use authorization of its vaccine in South Africa.</p><p>A lot of this news is a catalyst for NVAX stock. The greatest impact on the stock probably would be U.S. market approval for Nuvaxovid. Investors waiting for further positive news are already building a bull case for Novavax.</p><p><b>Bullish Scenario for NVAX Stock</b></p><p>Novavax’s vaccine is the fifth vaccine approved by the E.U. Protein vaccines like Nuvaxovid can do a lot for the global vaccination campaign. This is because they work differently from the vaccines currently available in the E.U., which are based on either mRNA technology, such as Pfizer and Moderna, or viral vector technology, such as AstraZeneca and Johnson &amp; Johnson.</p><p>If unvaccinated people are not biased against vaccination to protect from Covid-19, they could soon be vaccinated with protein vaccines such as Nuvaxovid. Such protein vaccines have been used for decades to protect against polio, tetanus, hepatitis B, and the flu. They also offer very good protection against coronavirus and cause even fewer side effects than vaccines that are already approved.</p><p>Also, these vaccines are important. Richer countries are so preoccupied with booster vaccinations and closing vaccination gaps that they may forget that in poor countries very few people have been vaccinated.</p><p>Protein-based vaccines could also make a significant contribution to the market. They are relatively inexpensive to produce and can be transported and stored at 2° to 8° C much more easily than mRNA vaccines, which need to be frozen.</p><p>Novavax will first supply its vaccine in poorer countries like Africa. The Novavax vaccine is a combination vaccine that is said to protect against the coronavirus and the flu at the same time. According to Novavax, initially,100 million doses of the vaccine could be produced per month. They later expect to be able to produce 150 million doses of the vaccine per month.</p><p>Europe being supplied with Nuvaxovid is certainly big news for Novavax. The U.S. Food and Drug Administration (FDA) may become biased and send the green light for the biotechnology company to boost its sales, especially if its price is cheaper than other vaccines.</p><p><b>Bearish Case for NVAX Stock</b></p><p>Third quarter (Q3) 2021 financial results showed a year-over-year increase of 14% for revenue to $179 million and a 38% increase of total expenses to $486 million. Loss from operations widened to $307 million compared to a loss of $194 million in Q3 2020. Net loss also widened to $322 million compared to a net loss of $197 million in Q3 2020.</p><p>The firm has poor financial strength as the debt-to-equity (D/E) ratio of 0.70 is considered high for a money-losing business that has been burning cash over the past five consecutive years.</p><p>Another negative sign for NVAX stock is that shareholders have been substantially diluted in the past year, with total shares outstanding growing by 137.4%.</p><p><b>Novavax: At an Inflection Point Now</b></p><p>The company has positive news that sparks enthusiasm. The broader fundamental analysis, however, is not supportive of the company. Widening losses and burning cash must be addressed fast and radically for a stock price rebound to occur and last.</p><p>I remain bearish on NVAX stock, waiting for sales updates as the key catalyst.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2022 Could be a Success or a Lost Opportunity for Novavax</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2022 Could be a Success or a Lost Opportunity for Novavax\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-05 14:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/02/2022-could-be-a-success-or-a-lost-opportunity-for-novavax/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax, Inc. (NASDAQ:NVAX) has had a tough year with losses of approximately 68%. It has already declined about 37% year-to-date, as well. However, as of Feb. 3, 2022, the stock has a 5-day return of...</p>\n\n<a href=\"https://investorplace.com/2022/02/2022-could-be-a-success-or-a-lost-opportunity-for-novavax/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2022/02/2022-could-be-a-success-or-a-lost-opportunity-for-novavax/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130580421","content_text":"Novavax, Inc. (NASDAQ:NVAX) has had a tough year with losses of approximately 68%. It has already declined about 37% year-to-date, as well. However, as of Feb. 3, 2022, the stock has a 5-day return of nearly 25%. This increased volatility in the stock price is primarily news-driven.Novavax is trying to become active in the global industry of vaccines against the coronavirus to put an end to the pandemic so all of us can return to normal conditions at which social distancing will be a distant memory, along with wearing face masks.Novavax Business NewsThe latest business news is that Novavax got conditional authorization in the U.K for its protein-based Covid-19 vaccine called Nuvaxovid. It is reported that “the U.K. has already ordered up to 60 million doses of Novavax’s vaccine.”The company announced that it filed for authorization in the U.S. market in late Jan. 2022. Novavax has been granted provisional registration for its vaccine in Australia. Additionally, in South Korea, the Ministry of Food and Drug Safety has approved the firm’s vaccine. At the same time the “European Commission (EC) has granted Novavax conditional marketing authorization (CMA) for Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.”Novavax also submitted for emergency use authorization of its vaccine in South Africa.A lot of this news is a catalyst for NVAX stock. The greatest impact on the stock probably would be U.S. market approval for Nuvaxovid. Investors waiting for further positive news are already building a bull case for Novavax.Bullish Scenario for NVAX StockNovavax’s vaccine is the fifth vaccine approved by the E.U. Protein vaccines like Nuvaxovid can do a lot for the global vaccination campaign. This is because they work differently from the vaccines currently available in the E.U., which are based on either mRNA technology, such as Pfizer and Moderna, or viral vector technology, such as AstraZeneca and Johnson & Johnson.If unvaccinated people are not biased against vaccination to protect from Covid-19, they could soon be vaccinated with protein vaccines such as Nuvaxovid. Such protein vaccines have been used for decades to protect against polio, tetanus, hepatitis B, and the flu. They also offer very good protection against coronavirus and cause even fewer side effects than vaccines that are already approved.Also, these vaccines are important. Richer countries are so preoccupied with booster vaccinations and closing vaccination gaps that they may forget that in poor countries very few people have been vaccinated.Protein-based vaccines could also make a significant contribution to the market. They are relatively inexpensive to produce and can be transported and stored at 2° to 8° C much more easily than mRNA vaccines, which need to be frozen.Novavax will first supply its vaccine in poorer countries like Africa. The Novavax vaccine is a combination vaccine that is said to protect against the coronavirus and the flu at the same time. According to Novavax, initially,100 million doses of the vaccine could be produced per month. They later expect to be able to produce 150 million doses of the vaccine per month.Europe being supplied with Nuvaxovid is certainly big news for Novavax. The U.S. Food and Drug Administration (FDA) may become biased and send the green light for the biotechnology company to boost its sales, especially if its price is cheaper than other vaccines.Bearish Case for NVAX StockThird quarter (Q3) 2021 financial results showed a year-over-year increase of 14% for revenue to $179 million and a 38% increase of total expenses to $486 million. Loss from operations widened to $307 million compared to a loss of $194 million in Q3 2020. Net loss also widened to $322 million compared to a net loss of $197 million in Q3 2020.The firm has poor financial strength as the debt-to-equity (D/E) ratio of 0.70 is considered high for a money-losing business that has been burning cash over the past five consecutive years.Another negative sign for NVAX stock is that shareholders have been substantially diluted in the past year, with total shares outstanding growing by 137.4%.Novavax: At an Inflection Point NowThe company has positive news that sparks enthusiasm. The broader fundamental analysis, however, is not supportive of the company. Widening losses and burning cash must be addressed fast and radically for a stock price rebound to occur and last.I remain bearish on NVAX stock, waiting for sales updates as the key catalyst.","news_type":1},"isVote":1,"tweetType":1,"viewCount":573,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633294665,"gmtCreate":1644078199963,"gmtModify":1644078200275,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"h","listText":"h","text":"h","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633294665","repostId":"1196927717","repostType":4,"repost":{"id":"1196927717","pubTimestamp":1644033090,"share":"https://www.laohu8.com/m/news/1196927717?lang=&edition=full","pubTime":"2022-02-05 11:51","market":"us","language":"en","title":"Palantir: Red Flag Or Opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=1196927717","media":"Seeking Alpha","summary":"SummaryPalantir has only 203 total customers as of Q3 2021, while just 20 of those customers account","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>Palantir has only 203 total customers as of Q3 2021, while just 20 of those customers account for 58% of total revenue.</li><li>Revenue growth in Palantir’s core client cohort slowed to 20% annualized through the first three quarters of 2021 compared to 2020.</li><li>During 2021, Palantir fundamentally transformed its go-to-market strategy. The company is now using its cash to aggressively invest in other companies (Investees) who agree to purchase Palantir’s software.</li><li>Management continues to guide for 30% sales growth through mid-decade. However, Palantir’s 3-phase business model hints at sales trending lower excluding its Investee sales.</li><li>Palantir offers extraordinary long-term growth potential which should place it on the watchlist of all growth investors. The investment case rests on the fulcrum between opportunity and red flags.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dd7a77abaec0ea0aa58eebb9ce4b9606\" tg-width=\"1536\" tg-height=\"1187\" width=\"100%\" height=\"auto\"/><span>agawa288/iStock via Getty Images</span></p><p>I am assigning Palantir (NYSE:PLTR) a neutral risk/reward rating as the long-term growth opportunity is counterbalanced by near-term red flags. The long-term opportunity lies in becoming a foundational enterprise operating system capable of integrating structured and unstructured data for real-time intelligence. However, a number of notable red flags warrant caution. The primary red flags include slowing sales, an unusual go-to-market shift, rapidly decelerating profitability, and an elevated valuation which offers limited margin for error.</p><p><b>Risk/Reward Rating: Neutral</b></p><p>Palantir has an unusual business model compared to its peers in the enterprise software sector in regard to how it acquires and grows its customer base. The company categorizes its customers according to three phases of development or cohorts: (1) Acquire, (2) Expand, and (3) Scale. While they are generic terms that are applicable to all businesses, they are unique in the case of Palantir due to how the company approaches its customers.</p><p><b>Customer Detail</b></p><p>Palantir defines a customer in the Acquire cohort as one that has generated less than $100,000 of revenue as of year-end while being unprofitable to Palantir. The Expand cohort is characterized by a customer that generated more than $100,000 of sales yet remained unprofitable. Finally, the Scale cohort is defined as a customer that has generated more than $100,000 of revenue while being a profitable relationship for Palantir during the year.</p><p>The following tables were compiled from Palantir’s Q3 2021 10-Q filed with the SEC. The first table displays Palantir’s 2020 sales from each of the client cohorts which were categorized at the end of 2020 (2020 Revenue). In the 2021 Annualized column, you will find the sales of each of these 2020 customer cohorts through Q3 2021 annualized. In the second set of tables, I have compiled key details regarding Palantir’s largest customers over the past twelve months, as well as critical details pertaining to customers that are new to Palantir in 2021 which are not yet assigned to a cohort. Cohort categorization occurs at the end of each year.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0e38ee31a1d6e826d2d02216e39ac570\" tg-width=\"640\" tg-height=\"151\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b4dc61112528e104ef0d3a8dc80f89d1\" tg-width=\"581\" tg-height=\"481\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>For ease of comparison, I have color-coded the information that is related. One of the dominant realities for Palantir is its concentrated customer base, which is highlighted in blue. Palantir has only 203 customers, with the top 20 accounting for 58% of sales.</p><p>By definition, Palantir’s largest customers are in the Scale cohort. Through the first three quarters of 2021, the Scale cohort (categorized as such at the end of 2020) is growing at an annualized rate of 20%. Given that this group accounts for 86% of Palantir’s revenue, it will be challenging to move the sales growth needle materially above 20% without explosive growth from the other two cohorts or a material acceleration from the Scale cohort. It should be noted that management is guiding to 30% annual sales growth through mid-decade.</p><p>The 2020 year-end Acquire and Expand cohorts are highlighted in yellow in the upper table. New customers in 2021 will not be assigned to a cohort until the year-end Palantir report. I have highlighted the pertinent 2021 new customer data in yellow for easy comparison to the 2020 Acquire and Expand customer cohorts. I view the 2021 new customer sales performance excluding sales to Investees to be a sustainable core growth rate. The Investee customer acquisition strategy is extraordinarily unusual and carries an exceedingly high capital risk which introduces reputational and, therefore, brand risk.</p><p>Please note that Investee here refers to customers that Palantir has purchased the stock of in return for the Investee using Palantir’s software. Meaning, the revenue from Investees is a reciprocation of Palantir investing in the shares of these customers. In this respect, these are not arm’s-length transactions. I believe the new client numbers excluding sales to Investees is an important data point for ascertaining a purely market-based new customer growth rate.</p><p>Similar to the Scale cohort growth rate annualizing at 20% in 2021, the new customer sales growth rate is annualizing at 22% through Q3 2021 compared to the $20.6 million of sales from the Acquire and Expand cohorts of 2020. While this is not a perfect comparison for sales growth from new customers, it is a fair estimation. As a result, Palantir appears to be trending toward an underlying sales growth rate closer to 20% than the company’s 30% sales growth guidance through mid-decade.</p><p><b>Investees</b></p><p>It is important to step back and review Palantir’s investments in Investees as this is an extraordinarily unusual go-to-market strategy for customer acquisition. The above numbers, which suggest revenue growth is trending toward 20%, place Palantir’s use of its balance sheet cash to fund new customers in a new light. The following tables were compiled from Palantir’s Q3 2021 10-Q. The first table lists companies that Palantir has funded as of the end of Q3 2021. The second table displays Palantir’s investment commitments to new companies that are not yet funded.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4dda111182479c1fbaddc642369e4bd3\" tg-width=\"640\" tg-height=\"264\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>I have conducted a cursory review of each of the above companies. The common theme is that they are all early-stage companies in the most popular growth sectors. These sectors include EVs, robotics, flying electric vehicles, satellite services and drug discovery. None of the Investees appears to offer enough appreciation potential in its own right to move the needle materially for Palantir’s valuation. Palantir’s ownership stake ranges from 0.4% to 1.6%.</p><p>It remains unclear how much of each company’s funding can be spent on Palantir’s software. Furthermore, it is not clear if the $19 million of revenue through Q3 2021 from these companies is sustainable.</p><p>I have highlighted in blue Palantir’s total investment of $150 million in the seven companies. The yellow highlighted cell represents the current valuation of the investments. Palantir is now down approximately $64 million on these seven companies alone. This highlights an extreme risk for this method of customer acquisition as the capital losses to date dwarf the revenue generated. There are other private company investments not listed above, however, Palantir does not break out the details. They are included in other assets on Palantir’s balance sheet which amounted to $116 million as of Q3 2021.</p><p>The following table displays Palantir’s commitments to invest in new companies as of Q3 2021. I have highlighted in yellow the two companies that Palantir funded subsequent to the end of Q3 2021.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e06664e25242d0bacb6f2a64a7a80228\" tg-width=\"640\" tg-height=\"526\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>I have highlighted in blue the total funding commitment for new investments as of Q3 2021. This is $252 million on top of the $150 million completed prior to the end of Q3. While I have not looked into these particular companies, they appear similar to the first seven investments reviewed above. Meaning, they appear to carry extreme capital risk with upside potential that is likely to be minimal when compared to the valuation upside inherent in Palantir’s software business. It should be noted that recent valuations were extreme and continue to contract rapidly. As a result, the timing risk for capital loss is also heightened by making the investments at the top of the VC/IPO cycle.</p><p><b>Financial Performance</b></p><p>Turning to Palantir’s recent performance, I have chosen to view sales growth excluding the Investees as this is the most likely sustainable growth trajectory. The following table was compiled from Palantir’s Q3 2021 10-Q filed with the SEC. I made an adjustment by removing Investee revenue to arrive at a net revenue figure.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b09c2f2aada9cb30c8b720be23d096e2\" tg-width=\"640\" tg-height=\"156\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>I have highlighted in yellow the 29% revenue growth in Q3 2021 after removing the Investee revenue. Investees added 6.5% to growth in Q3. Year-to-date, the Investee revenue accounted for 1.7% revenue growth. The 29% growth rate is already decelerating beneath the company’s 30% growth guidance through mid-decade. Keep in mind that the Investee revenue stream will grow with additional funding of Palantir’s investment commitments. Regardless, growth is decelerating rapidly at 29% in Q3 compared to 41% year-to-date excluding these non-arm’s-length sales.</p><p><b>Geographic &amp; Segment Sales</b></p><p>The sales slowdown is being led by France, which contracted 22% through the first three quarters of 2021 (highlighted in orange below). It should be noted that Palantir has had a material relationship with Airbus and the airline industry. This could be a negative read through for an important client and industry. While the US remained the best performer in Q3 2021, growth is slowing rapidly as is evidenced by the blue highlighted cells below. The table was compiled from Palantir’s Q3 2021 10-Q filed with the SEC.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b19bc17658ff1b951eec789ec95deddd\" tg-width=\"640\" tg-height=\"314\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>In addition to France, the rest of the world is also slowing rapidly, from 45% through the first nine months of the year to 20% in Q3 2021. Please note that these are reported sales without any adjustments. The following table was compiled from the same SEC filing and highlights that the large sales slowdown in Q3 occurred in the Government segment. Please keep in mind that the Investee revenue is included in the figures below and added approximately 6.5% to the Q3 growth rate in the Commercial segment.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9a553cc3913c2af281262da7b15bdc3c\" tg-width=\"640\" tg-height=\"278\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>In summary, the Commercial segment is growing revenue rather steadily, approximately 29% excluding the Investee revenue. However, the Government segment is decelerating rapidly, from 57% through the first nine months of 2021 to 34% in Q3.</p><p><b>Gross Profit &amp; KPI</b></p><p>Palantir’s unusual customer acquisition strategy predates the shift to Investees. The company’s sales and marketing expenses appear to be quite similar to the cost of goods sold for other companies. This is the case because Palantir offers prospective customers free pilot programs as opposed to requiring payment upfront for use of its software. Sales and marketing personnel execute the pilot programs and coordinate solution development in order to generate sales. The following quote from the Q3 2021 10-Q summarizes the situation:</p><blockquote>Sales and marketing costs primarily include salaries, stock-based compensation expense, and benefits for our sales force and personnel involved in executing on pilots and customer growth activities...</blockquote><p>As a result, I view the sales and marketing expense in the case of Palantir to be a cost of goods sold and reduction to gross margin. While this categorization does not affect the bottom line, it does serve to place the reported 78% gross margin in context.</p><p>I believe this perspective on sales and marketing expense is helpful in thinking about Palantir’s business model in relation to other companies and relative valuations that rely on gross profit margins. The following table was compiled from Palantir’s Q3 2021 10-Q and displays the reported cost of revenue and sales and marketing expense adjusted by removing the related stock-based compensation expense from each line item.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/55c5e5fcea6102ca9d0542c130ee1d15\" tg-width=\"640\" tg-height=\"501\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>Notice that the adjusted gross profit growth has slowed considerably to 25% in Q3 (highlighted in blue in the lower portion of the table) compared to 59% through the first nine months of 2021 (highlighted in yellow). The cost of sales is rising rapidly in Q3 2021 compared to the first nine months of the year.</p><p>Palantir utilizes one KPI or Key Performance Indicator to judge performance and inform decision-making, which is referred to as Contribution Margin. It is similar to my adjusted gross margin figure above as can be seen in the following table compiled from Palantir’s Q3 2021 10-Q.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7cc4e966e16c27ea17f99ccb08a18957\" tg-width=\"640\" tg-height=\"281\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>Notice that the contribution row is remarkably similar to my adjusted gross profit row in the previous table. Additionally, the growth rate deceleration is similar, as can be seen in the highlighted cells. While 37% is materially different from my estimate of 25% growth, the step change lower from 64% is of similar amplitude.</p><p><b>Operating Income</b></p><p>Turning to operating income, I have adjusted the reported figures once again by removing stock option-related expenses as well as one-off expenses pertaining to the direct listing IPO in 2020. The overriding message is once again one of rapid deceleration. The following table was compiled from the same SEC filing and displays operating expenses excluding sales and marketing expenses, as well as my adjusted operating income estimate.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5f344c289a598ec7824067b39c04f09\" tg-width=\"640\" tg-height=\"479\" width=\"100%\" height=\"auto\"/><span>Source: Created by Brian Kapp, stoxdox</span></p><p>In the lower section of the table, notice the incredible deceleration in adjusted operating income to 40% growth in Q3 of 2021 compared to 266% growth through the first nine months of the year. General and administrative expenses accelerated rapidly in Q3 2021, while Palantir materially reduced research and development investment to just 5% growth in Q3.</p><p>The research and development investment slowdown could be a negative read through for sales growth as R&amp;D is an integral part of the sales process. Research and development expenses should track the sales cycle through the three customer phases: Acquire, Expand, and Scale. As customer needs are identified by sales and marketing, research and development expenses should respond to increased future sales potential. This does not appear to be happening at the moment.</p><p>As of Q3 2021, Palantir is annualizing at an adjusted operating income run rate of approximately $300 to $320 million, or about $.16 per share. This is a before-tax operating income figure. The primary takeaway from the operating income front is that profitability is slowing rapidly. This provides additional color for the unusual Investee customer acquisition strategy being deployed.</p><p><b>Consensus Growth Estimates</b></p><p>If Palantir is producing at a $320 million adjusted annual operating income run rate and it was taxed at a normalized 25% rate, the current earnings power would be in the $240 million range or $.12 per diluted share. With this information and the growth deceleration outlined above, we can begin to put consensus earnings estimates into context. The following table was compiled from Seeking Alpha and displays consensus earnings and revenue estimates through 2023.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/022fd2d18964776a3e20294c7917548f\" tg-width=\"640\" tg-height=\"241\" width=\"100%\" height=\"auto\"/><span>Source: Seeking Alpha. Created by Brian Kapp, stoxdox</span></p><p>I have highlighted the 2022 consensus estimates for earnings and sales growth. Notice that the 39% consensus earnings growth estimate for 2022 is in line with the 40% operating income growth posted in Q3 of 2021. Additionally, the sales growth estimate of 30% is just above the 29% adjusted sales growth in Q3 2021 excluding sales to Investees.</p><p>The 39% earnings growth expected for 2022 appears to be at material risk of being too high given the rapid slowdown in operating income to 40% in Q3 2021 compared to 266% through the first nine months of the year. This trajectory would likely place earnings growth for 2022 well below 39%.</p><p>The 30% sales growth estimate for 2022 looks to be achievable given Palantir’s aggressive investment strategy in regard to Investees who then purchase Palantir software. I believe the market will tend to discount Investee sales as I have. Excluding these sales, the revenue growth trajectory appears to be trending closer to 20% than 30% for 2022, which opens the door to further growth disappointment.</p><p>Looking to consensus estimates for 2023, the expected growth rates are remarkably similar to 2022. This straight-line growth forecast through 2023 adds to the risk that consensus estimates could be too high over the coming years. The current trajectory points to growth materially below that expected for 2022 and 2023.</p><p><b>Valuation</b></p><p>Palantir is trading at 87x the consensus earnings estimate for 2021 and 62x that for 2022. Please keep in mind that these are non-GAAP (generally accepted accounting principles) earnings estimates. On a GAAP basis, Palantir continues to produce at a loss. The reported loss in Q3 2021 was $92 million and was $352 million through the first nine months of 2021.</p><p>Using the non-GAAP earnings estimates, 87x current year earnings and 62x forward earnings are extreme valuations from a historical market perspective. That said, they are within the realm of possibility for a growth stock in recent years. When viewed against Palantir’s rapidly slowing sales and operating income growth rates, as well as the heightened risk that consensus estimates may be too high, the current valuation multiples on consensus estimates offer little margin for error.</p><p>On the sales front, Palantir is valued at 17x the consensus 2021 revenue estimate and 13x that for 2022. These are extreme price-to-sales multiples for a large-cap company from a historical perspective. My estimate of core sales growth trending toward 20% excluding Investee revenue suggests that these valuation multiples on sales also offer little margin for error.</p><p>The valuation risks are further elevated when combined with the rapidly slowing operating income growth. Furthermore, as can be seen in my adjusted gross margin figure growing at 25% as of Q3 2021, the Palantir business model may not be supportive of a historically extreme price-to-sales valuation.</p><p><b>Technicals</b></p><p>While the fundamental backdrop points toward little margin for error and subdued excess return potential, the technical setup suggests more meaningful upside return potential. The following 3-year weekly chart offers a bird’s eye view of the potential technical return spectrum. I have highlighted the key resistance levels with orange horizontal lines and the primary support level with a green line.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e9aaa4f2a36fa507e420c9353d0cd91c\" tg-width=\"640\" tg-height=\"372\" width=\"100%\" height=\"auto\"/><span>Palantir 3-year weekly chart. (Created by Brian Kapp using a chart from Barchart.com)</span></p><p>The return potential to the nearest resistance levels of $19 and $22 is 43% and 65%, respectively. On the downside, the nearest support lies at the IPO price range near $10. The downside return potential to this level is -25%. It should be noted that Palantir’s short trading history of 16 months limits the usefulness of technical analysis. Additionally, with no trading history beneath the IPO price, it is unclear where support will be found if the $10 level is breached to the downside.</p><p>To estimate downside potential beneath $10, I apply an earnings multiple of 40x the 2022 non-GAAP consensus earnings estimate. This valuation is twice that of the current market averages and would place Palantir shares at $8. This represents -40% downside risk from current levels.</p><p>If the 39% consensus earnings estimate for 2022 is too high, further downside from $8 is in the realm of possibility. To estimate the downside risk potential if estimates are too high, I apply the same 40x non-GAAP earnings to my estimate of Palantir’s current annual run rate for fully-taxed, non-GAAP profitability. If earnings growth comes in at 25% for 2022 (my estimate of adjusted gross profit growth as of Q3 2021) on top of my estimate of $.12 for the current annual run rate of adjusted earnings after tax, the shares could trade down to $6. This would represent downside risk of -55%.</p><p>The following daily chart provides a closer look at the technical backdrop.</p><p><img src=\"https://static.tigerbbs.com/fa32fdab79f60368696ab122ff81b60a\" tg-width=\"640\" tg-height=\"372\" width=\"100%\" height=\"auto\"/></p><p>The technical picture suggests heavy resistance between $19 and $22. Given the unrelenting downtrend over the past three months, a near-term bounce is likely. That said, the upside technical potential combined with the downside fundamental potential leaves the shares with a balanced potential return spectrum of 65% to -55% over the near term.</p><p><b>Summary</b></p><p>All told, Palantir should be placed on the watchlist for high-risk growth investors. The long-term opportunity lies in becoming a foundational enterprise operating system capable of integrating structured and unstructured data for real-time intelligence. However, with notable red flags in the mix, caution is in order. The primary red flags include slowing sales, an unusual go-to-market shift, rapidly decelerating profitability, and an elevated valuation which offers limited margin for error. The resulting symmetry between risk and reward results in a neutral rating.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir: Red Flag Or Opportunity?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir: Red Flag Or Opportunity?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-05 11:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4484295-palantir-red-flag-or-opportunity><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryPalantir has only 203 total customers as of Q3 2021, while just 20 of those customers account for 58% of total revenue.Revenue growth in Palantir’s core client cohort slowed to 20% annualized ...</p>\n\n<a href=\"https://seekingalpha.com/article/4484295-palantir-red-flag-or-opportunity\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4484295-palantir-red-flag-or-opportunity","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196927717","content_text":"SummaryPalantir has only 203 total customers as of Q3 2021, while just 20 of those customers account for 58% of total revenue.Revenue growth in Palantir’s core client cohort slowed to 20% annualized through the first three quarters of 2021 compared to 2020.During 2021, Palantir fundamentally transformed its go-to-market strategy. The company is now using its cash to aggressively invest in other companies (Investees) who agree to purchase Palantir’s software.Management continues to guide for 30% sales growth through mid-decade. However, Palantir’s 3-phase business model hints at sales trending lower excluding its Investee sales.Palantir offers extraordinary long-term growth potential which should place it on the watchlist of all growth investors. The investment case rests on the fulcrum between opportunity and red flags.agawa288/iStock via Getty ImagesI am assigning Palantir (NYSE:PLTR) a neutral risk/reward rating as the long-term growth opportunity is counterbalanced by near-term red flags. The long-term opportunity lies in becoming a foundational enterprise operating system capable of integrating structured and unstructured data for real-time intelligence. However, a number of notable red flags warrant caution. The primary red flags include slowing sales, an unusual go-to-market shift, rapidly decelerating profitability, and an elevated valuation which offers limited margin for error.Risk/Reward Rating: NeutralPalantir has an unusual business model compared to its peers in the enterprise software sector in regard to how it acquires and grows its customer base. The company categorizes its customers according to three phases of development or cohorts: (1) Acquire, (2) Expand, and (3) Scale. While they are generic terms that are applicable to all businesses, they are unique in the case of Palantir due to how the company approaches its customers.Customer DetailPalantir defines a customer in the Acquire cohort as one that has generated less than $100,000 of revenue as of year-end while being unprofitable to Palantir. The Expand cohort is characterized by a customer that generated more than $100,000 of sales yet remained unprofitable. Finally, the Scale cohort is defined as a customer that has generated more than $100,000 of revenue while being a profitable relationship for Palantir during the year.The following tables were compiled from Palantir’s Q3 2021 10-Q filed with the SEC. The first table displays Palantir’s 2020 sales from each of the client cohorts which were categorized at the end of 2020 (2020 Revenue). In the 2021 Annualized column, you will find the sales of each of these 2020 customer cohorts through Q3 2021 annualized. In the second set of tables, I have compiled key details regarding Palantir’s largest customers over the past twelve months, as well as critical details pertaining to customers that are new to Palantir in 2021 which are not yet assigned to a cohort. Cohort categorization occurs at the end of each year.Source: Created by Brian Kapp, stoxdoxSource: Created by Brian Kapp, stoxdoxFor ease of comparison, I have color-coded the information that is related. One of the dominant realities for Palantir is its concentrated customer base, which is highlighted in blue. Palantir has only 203 customers, with the top 20 accounting for 58% of sales.By definition, Palantir’s largest customers are in the Scale cohort. Through the first three quarters of 2021, the Scale cohort (categorized as such at the end of 2020) is growing at an annualized rate of 20%. Given that this group accounts for 86% of Palantir’s revenue, it will be challenging to move the sales growth needle materially above 20% without explosive growth from the other two cohorts or a material acceleration from the Scale cohort. It should be noted that management is guiding to 30% annual sales growth through mid-decade.The 2020 year-end Acquire and Expand cohorts are highlighted in yellow in the upper table. New customers in 2021 will not be assigned to a cohort until the year-end Palantir report. I have highlighted the pertinent 2021 new customer data in yellow for easy comparison to the 2020 Acquire and Expand customer cohorts. I view the 2021 new customer sales performance excluding sales to Investees to be a sustainable core growth rate. The Investee customer acquisition strategy is extraordinarily unusual and carries an exceedingly high capital risk which introduces reputational and, therefore, brand risk.Please note that Investee here refers to customers that Palantir has purchased the stock of in return for the Investee using Palantir’s software. Meaning, the revenue from Investees is a reciprocation of Palantir investing in the shares of these customers. In this respect, these are not arm’s-length transactions. I believe the new client numbers excluding sales to Investees is an important data point for ascertaining a purely market-based new customer growth rate.Similar to the Scale cohort growth rate annualizing at 20% in 2021, the new customer sales growth rate is annualizing at 22% through Q3 2021 compared to the $20.6 million of sales from the Acquire and Expand cohorts of 2020. While this is not a perfect comparison for sales growth from new customers, it is a fair estimation. As a result, Palantir appears to be trending toward an underlying sales growth rate closer to 20% than the company’s 30% sales growth guidance through mid-decade.InvesteesIt is important to step back and review Palantir’s investments in Investees as this is an extraordinarily unusual go-to-market strategy for customer acquisition. The above numbers, which suggest revenue growth is trending toward 20%, place Palantir’s use of its balance sheet cash to fund new customers in a new light. The following tables were compiled from Palantir’s Q3 2021 10-Q. The first table lists companies that Palantir has funded as of the end of Q3 2021. The second table displays Palantir’s investment commitments to new companies that are not yet funded.Source: Created by Brian Kapp, stoxdoxI have conducted a cursory review of each of the above companies. The common theme is that they are all early-stage companies in the most popular growth sectors. These sectors include EVs, robotics, flying electric vehicles, satellite services and drug discovery. None of the Investees appears to offer enough appreciation potential in its own right to move the needle materially for Palantir’s valuation. Palantir’s ownership stake ranges from 0.4% to 1.6%.It remains unclear how much of each company’s funding can be spent on Palantir’s software. Furthermore, it is not clear if the $19 million of revenue through Q3 2021 from these companies is sustainable.I have highlighted in blue Palantir’s total investment of $150 million in the seven companies. The yellow highlighted cell represents the current valuation of the investments. Palantir is now down approximately $64 million on these seven companies alone. This highlights an extreme risk for this method of customer acquisition as the capital losses to date dwarf the revenue generated. There are other private company investments not listed above, however, Palantir does not break out the details. They are included in other assets on Palantir’s balance sheet which amounted to $116 million as of Q3 2021.The following table displays Palantir’s commitments to invest in new companies as of Q3 2021. I have highlighted in yellow the two companies that Palantir funded subsequent to the end of Q3 2021.Source: Created by Brian Kapp, stoxdoxI have highlighted in blue the total funding commitment for new investments as of Q3 2021. This is $252 million on top of the $150 million completed prior to the end of Q3. While I have not looked into these particular companies, they appear similar to the first seven investments reviewed above. Meaning, they appear to carry extreme capital risk with upside potential that is likely to be minimal when compared to the valuation upside inherent in Palantir’s software business. It should be noted that recent valuations were extreme and continue to contract rapidly. As a result, the timing risk for capital loss is also heightened by making the investments at the top of the VC/IPO cycle.Financial PerformanceTurning to Palantir’s recent performance, I have chosen to view sales growth excluding the Investees as this is the most likely sustainable growth trajectory. The following table was compiled from Palantir’s Q3 2021 10-Q filed with the SEC. I made an adjustment by removing Investee revenue to arrive at a net revenue figure.Source: Created by Brian Kapp, stoxdoxI have highlighted in yellow the 29% revenue growth in Q3 2021 after removing the Investee revenue. Investees added 6.5% to growth in Q3. Year-to-date, the Investee revenue accounted for 1.7% revenue growth. The 29% growth rate is already decelerating beneath the company’s 30% growth guidance through mid-decade. Keep in mind that the Investee revenue stream will grow with additional funding of Palantir’s investment commitments. Regardless, growth is decelerating rapidly at 29% in Q3 compared to 41% year-to-date excluding these non-arm’s-length sales.Geographic & Segment SalesThe sales slowdown is being led by France, which contracted 22% through the first three quarters of 2021 (highlighted in orange below). It should be noted that Palantir has had a material relationship with Airbus and the airline industry. This could be a negative read through for an important client and industry. While the US remained the best performer in Q3 2021, growth is slowing rapidly as is evidenced by the blue highlighted cells below. The table was compiled from Palantir’s Q3 2021 10-Q filed with the SEC.Source: Created by Brian Kapp, stoxdoxIn addition to France, the rest of the world is also slowing rapidly, from 45% through the first nine months of the year to 20% in Q3 2021. Please note that these are reported sales without any adjustments. The following table was compiled from the same SEC filing and highlights that the large sales slowdown in Q3 occurred in the Government segment. Please keep in mind that the Investee revenue is included in the figures below and added approximately 6.5% to the Q3 growth rate in the Commercial segment.Source: Created by Brian Kapp, stoxdoxIn summary, the Commercial segment is growing revenue rather steadily, approximately 29% excluding the Investee revenue. However, the Government segment is decelerating rapidly, from 57% through the first nine months of 2021 to 34% in Q3.Gross Profit & KPIPalantir’s unusual customer acquisition strategy predates the shift to Investees. The company’s sales and marketing expenses appear to be quite similar to the cost of goods sold for other companies. This is the case because Palantir offers prospective customers free pilot programs as opposed to requiring payment upfront for use of its software. Sales and marketing personnel execute the pilot programs and coordinate solution development in order to generate sales. The following quote from the Q3 2021 10-Q summarizes the situation:Sales and marketing costs primarily include salaries, stock-based compensation expense, and benefits for our sales force and personnel involved in executing on pilots and customer growth activities...As a result, I view the sales and marketing expense in the case of Palantir to be a cost of goods sold and reduction to gross margin. While this categorization does not affect the bottom line, it does serve to place the reported 78% gross margin in context.I believe this perspective on sales and marketing expense is helpful in thinking about Palantir’s business model in relation to other companies and relative valuations that rely on gross profit margins. The following table was compiled from Palantir’s Q3 2021 10-Q and displays the reported cost of revenue and sales and marketing expense adjusted by removing the related stock-based compensation expense from each line item.Source: Created by Brian Kapp, stoxdoxNotice that the adjusted gross profit growth has slowed considerably to 25% in Q3 (highlighted in blue in the lower portion of the table) compared to 59% through the first nine months of 2021 (highlighted in yellow). The cost of sales is rising rapidly in Q3 2021 compared to the first nine months of the year.Palantir utilizes one KPI or Key Performance Indicator to judge performance and inform decision-making, which is referred to as Contribution Margin. It is similar to my adjusted gross margin figure above as can be seen in the following table compiled from Palantir’s Q3 2021 10-Q.Source: Created by Brian Kapp, stoxdoxNotice that the contribution row is remarkably similar to my adjusted gross profit row in the previous table. Additionally, the growth rate deceleration is similar, as can be seen in the highlighted cells. While 37% is materially different from my estimate of 25% growth, the step change lower from 64% is of similar amplitude.Operating IncomeTurning to operating income, I have adjusted the reported figures once again by removing stock option-related expenses as well as one-off expenses pertaining to the direct listing IPO in 2020. The overriding message is once again one of rapid deceleration. The following table was compiled from the same SEC filing and displays operating expenses excluding sales and marketing expenses, as well as my adjusted operating income estimate.Source: Created by Brian Kapp, stoxdoxIn the lower section of the table, notice the incredible deceleration in adjusted operating income to 40% growth in Q3 of 2021 compared to 266% growth through the first nine months of the year. General and administrative expenses accelerated rapidly in Q3 2021, while Palantir materially reduced research and development investment to just 5% growth in Q3.The research and development investment slowdown could be a negative read through for sales growth as R&D is an integral part of the sales process. Research and development expenses should track the sales cycle through the three customer phases: Acquire, Expand, and Scale. As customer needs are identified by sales and marketing, research and development expenses should respond to increased future sales potential. This does not appear to be happening at the moment.As of Q3 2021, Palantir is annualizing at an adjusted operating income run rate of approximately $300 to $320 million, or about $.16 per share. This is a before-tax operating income figure. The primary takeaway from the operating income front is that profitability is slowing rapidly. This provides additional color for the unusual Investee customer acquisition strategy being deployed.Consensus Growth EstimatesIf Palantir is producing at a $320 million adjusted annual operating income run rate and it was taxed at a normalized 25% rate, the current earnings power would be in the $240 million range or $.12 per diluted share. With this information and the growth deceleration outlined above, we can begin to put consensus earnings estimates into context. The following table was compiled from Seeking Alpha and displays consensus earnings and revenue estimates through 2023.Source: Seeking Alpha. Created by Brian Kapp, stoxdoxI have highlighted the 2022 consensus estimates for earnings and sales growth. Notice that the 39% consensus earnings growth estimate for 2022 is in line with the 40% operating income growth posted in Q3 of 2021. Additionally, the sales growth estimate of 30% is just above the 29% adjusted sales growth in Q3 2021 excluding sales to Investees.The 39% earnings growth expected for 2022 appears to be at material risk of being too high given the rapid slowdown in operating income to 40% in Q3 2021 compared to 266% through the first nine months of the year. This trajectory would likely place earnings growth for 2022 well below 39%.The 30% sales growth estimate for 2022 looks to be achievable given Palantir’s aggressive investment strategy in regard to Investees who then purchase Palantir software. I believe the market will tend to discount Investee sales as I have. Excluding these sales, the revenue growth trajectory appears to be trending closer to 20% than 30% for 2022, which opens the door to further growth disappointment.Looking to consensus estimates for 2023, the expected growth rates are remarkably similar to 2022. This straight-line growth forecast through 2023 adds to the risk that consensus estimates could be too high over the coming years. The current trajectory points to growth materially below that expected for 2022 and 2023.ValuationPalantir is trading at 87x the consensus earnings estimate for 2021 and 62x that for 2022. Please keep in mind that these are non-GAAP (generally accepted accounting principles) earnings estimates. On a GAAP basis, Palantir continues to produce at a loss. The reported loss in Q3 2021 was $92 million and was $352 million through the first nine months of 2021.Using the non-GAAP earnings estimates, 87x current year earnings and 62x forward earnings are extreme valuations from a historical market perspective. That said, they are within the realm of possibility for a growth stock in recent years. When viewed against Palantir’s rapidly slowing sales and operating income growth rates, as well as the heightened risk that consensus estimates may be too high, the current valuation multiples on consensus estimates offer little margin for error.On the sales front, Palantir is valued at 17x the consensus 2021 revenue estimate and 13x that for 2022. These are extreme price-to-sales multiples for a large-cap company from a historical perspective. My estimate of core sales growth trending toward 20% excluding Investee revenue suggests that these valuation multiples on sales also offer little margin for error.The valuation risks are further elevated when combined with the rapidly slowing operating income growth. Furthermore, as can be seen in my adjusted gross margin figure growing at 25% as of Q3 2021, the Palantir business model may not be supportive of a historically extreme price-to-sales valuation.TechnicalsWhile the fundamental backdrop points toward little margin for error and subdued excess return potential, the technical setup suggests more meaningful upside return potential. The following 3-year weekly chart offers a bird’s eye view of the potential technical return spectrum. I have highlighted the key resistance levels with orange horizontal lines and the primary support level with a green line.Palantir 3-year weekly chart. (Created by Brian Kapp using a chart from Barchart.com)The return potential to the nearest resistance levels of $19 and $22 is 43% and 65%, respectively. On the downside, the nearest support lies at the IPO price range near $10. The downside return potential to this level is -25%. It should be noted that Palantir’s short trading history of 16 months limits the usefulness of technical analysis. Additionally, with no trading history beneath the IPO price, it is unclear where support will be found if the $10 level is breached to the downside.To estimate downside potential beneath $10, I apply an earnings multiple of 40x the 2022 non-GAAP consensus earnings estimate. This valuation is twice that of the current market averages and would place Palantir shares at $8. This represents -40% downside risk from current levels.If the 39% consensus earnings estimate for 2022 is too high, further downside from $8 is in the realm of possibility. To estimate the downside risk potential if estimates are too high, I apply the same 40x non-GAAP earnings to my estimate of Palantir’s current annual run rate for fully-taxed, non-GAAP profitability. If earnings growth comes in at 25% for 2022 (my estimate of adjusted gross profit growth as of Q3 2021) on top of my estimate of $.12 for the current annual run rate of adjusted earnings after tax, the shares could trade down to $6. This would represent downside risk of -55%.The following daily chart provides a closer look at the technical backdrop.The technical picture suggests heavy resistance between $19 and $22. Given the unrelenting downtrend over the past three months, a near-term bounce is likely. That said, the upside technical potential combined with the downside fundamental potential leaves the shares with a balanced potential return spectrum of 65% to -55% over the near term.SummaryAll told, Palantir should be placed on the watchlist for high-risk growth investors. The long-term opportunity lies in becoming a foundational enterprise operating system capable of integrating structured and unstructured data for real-time intelligence. However, with notable red flags in the mix, caution is in order. The primary red flags include slowing sales, an unusual go-to-market shift, rapidly decelerating profitability, and an elevated valuation which offers limited margin for error. The resulting symmetry between risk and reward results in a neutral rating.","news_type":1},"isVote":1,"tweetType":1,"viewCount":722,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633805306,"gmtCreate":1643900650735,"gmtModify":1643900650997,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633805306","repostId":"1133602233","repostType":4,"repost":{"id":"1133602233","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643899881,"share":"https://www.laohu8.com/m/news/1133602233?lang=&edition=full","pubTime":"2022-02-03 22:51","market":"us","language":"en","title":"Lightning Emotors Soared over 13% in Morning Trading as It Will Provide General Motors with Fully Electric Medium-Duty Trucks","url":"https://stock-news.laohu8.com/highlight/detail?id=1133602233","media":"Tiger Newspress","summary":"Lightning Emotors soared over 13% in morning trading as it will provide general motors with fully el","content":"<html><head></head><body><p>Lightning Emotors soared over 13% in morning trading as it will provide general motors with fully electric medium-duty trucks.</p><p><img src=\"https://static.tigerbbs.com/6c8308413348a815893f350b0d2c7fca\" tg-width=\"773\" tg-height=\"563\" referrerpolicy=\"no-referrer\"/></p><p>The company announced it has reached an agreement with General Motors to be the first GM Specialty Vehicle Manufacturer to provide fully electric Class 3 through Class 6 commercial vehicles.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lightning Emotors Soared over 13% in Morning Trading as It Will Provide General Motors with Fully Electric Medium-Duty Trucks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLightning Emotors Soared over 13% in Morning Trading as It Will Provide General Motors with Fully Electric Medium-Duty Trucks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-03 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Lightning Emotors soared over 13% in morning trading as it will provide general motors with fully electric medium-duty trucks.</p><p><img src=\"https://static.tigerbbs.com/6c8308413348a815893f350b0d2c7fca\" tg-width=\"773\" tg-height=\"563\" referrerpolicy=\"no-referrer\"/></p><p>The company announced it has reached an agreement with General Motors to be the first GM Specialty Vehicle Manufacturer to provide fully electric Class 3 through Class 6 commercial vehicles.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZEV":"Lightning eMotors, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133602233","content_text":"Lightning Emotors soared over 13% in morning trading as it will provide general motors with fully electric medium-duty trucks.The company announced it has reached an agreement with General Motors to be the first GM Specialty Vehicle Manufacturer to provide fully electric Class 3 through Class 6 commercial vehicles.","news_type":1},"isVote":1,"tweetType":1,"viewCount":732,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633103513,"gmtCreate":1643814937749,"gmtModify":1643814938018,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633103513","repostId":"1143415910","repostType":4,"repost":{"id":"1143415910","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643812844,"share":"https://www.laohu8.com/m/news/1143415910?lang=&edition=full","pubTime":"2022-02-02 22:40","market":"us","language":"en","title":"EV Stocks Dropped in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1143415910","media":"Tiger Newspress","summary":"Tesla, Nio, XPeng, and Li Auto fell between 1% and 3% in morning trading.nio","content":"<html><head></head><body><p>Tesla, Nio, XPeng, and Li Auto fell between 1% and 3% in morning trading.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eee2a7d57e8975380425d690fa964aaa\" tg-width=\"711\" tg-height=\"607\" referrerpolicy=\"no-referrer\"/><span>nio</span></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Dropped in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Dropped in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-02 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Tesla, Nio, XPeng, and Li Auto fell between 1% and 3% in morning trading.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eee2a7d57e8975380425d690fa964aaa\" tg-width=\"711\" tg-height=\"607\" referrerpolicy=\"no-referrer\"/><span>nio</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","XPEV":"小鹏汽车","NIO":"蔚来"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143415910","content_text":"Tesla, Nio, XPeng, and Li Auto fell between 1% and 3% in morning trading.nio","news_type":1},"isVote":1,"tweetType":1,"viewCount":664,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633923723,"gmtCreate":1643690469605,"gmtModify":1643690469933,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/U/4089116574465250\">@MrHuattt</a>: Gh","listText":"<a href=\"https://laohu8.com/U/4089116574465250\">@MrHuattt</a>: Gh","text":"@MrHuattt: Gh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633923723","repostId":"2207822223","repostType":4,"repost":{"id":"2207822223","pubTimestamp":1643674787,"share":"https://www.laohu8.com/m/news/2207822223?lang=&edition=full","pubTime":"2022-02-01 08:19","market":"us","language":"en","title":"Worried About This Crypto Crash? Avoid Crypto Miners","url":"https://stock-news.laohu8.com/highlight/detail?id=2207822223","media":"Motley Fool","summary":"Leveraged exposure to crypto sounds good on the way up, but not so great right now.","content":"<html><head></head><body><p>The question of whether to buy <b>Bitcoin </b>(CRYPTO:BTC) or Bitcoin miners such as <b>Marathon Digital </b>(NASDAQ:MARA), <b>Bit Digital </b>(NASDAQ:BTBT), or <b>CleanSpark </b>(NASDAQ:CLSK) is a good <a href=\"https://laohu8.com/S/AONE.U\">one</a>. Fool.com contributors Chris MacDonald and Jon Quast discussed the pros and cons of taking this approach on this <b>Jan. 19 </b>episode of &#34;The Crypto Show&#34; on <i>Backstage Pass</i>.</p><p><b>Jon Quast:</b> We&#39;ll go ahead and start talking about that here. This was an article that came out on Saturday, very, very interesting on Bitcoin mining stocks. Specifically, here, I believe he is looking at Marathon Digital symbol, MARA and he is also looking at well, let me just flip ahead Bit Digital, symbol, BTBT, and CleanSpark CLSK. CleanSpark is not just a Bitcoin miner. They do have these other products that are basically designed to make power systems more efficient. Especially, I believe it&#39;s off-grid power systems help them be more efficient and they said well, we can apply this and mine Bitcoin more efficiently.</p><p>But, Anders, very interesting, the look that he had of these companies and their stocks and their beta their relative volatility to the market, finding that, as you pointed out, they&#39;re much more volatile than Bitcoin itself.</p><p><b>Chris MacDonald:</b> We touched on Bitcoin miners, I know in previous shows, in terms of their leverage exposure to the underlying prices of cryptocurrencies like Bitcoin. These top miners are Bitcoin miners. Generally speaking, when the price of Bitcoin goes up because these miners have high fixed costs and their costs are locked in dollars when the price of Bitcoin goes up, their debt, which is denominated in dollars, goes down relative to Bitcoin and their revenue, which is denominated in Bitcoin, goes up. Their balance sheet looks a heck of a lot better when Bitcoins on an uptrend.</p><p>Based on which direction Bitcoin is moving, these miners can often move in an amplified way. If you are looking at this slide here, so it&#39;s interesting when we look at Marathon with a beta of four that means essentially if the market goes up by 1%, Marathon could go up by 4% on average and vice versa.</p><p><b>Bitcoin</b> like I said, with the beta of zero, you don&#39;t know which direction it&#39;s necessarily going to go. It&#39;s kind of agnostic to the markets, which is more of what we would expect. It is a lower correlation asset. Some of these other cryptocurrencies do have higher betas.</p><p>That goes back to our previous discussion, but looking at the Bitcoin miners, you get that leveraged exposure to crypto prices. In good times, that&#39;s great. In times of a little bit more uncertainty like right now, these top miners are seeing drops.</p><p>But that being said, you look at Marathon Digital with its three-year return, they&#39;re over 2000%. That is pretty incredible and I think relative to the other ones like Bit Digital, we&#39;re going to touch on a little bit later. Relative to a lot of the other crypto miners it&#39;s got a lot better fundamentals. This would be my top crypto miner to look at it just based on its geographic location in the U.S. and its balance sheet right now.</p><p>There are differences among crypto miners. It is a higher beta one, which is interesting. If the market continues to decline, will Marathon dip harder? That remains to be seen. It has run pretty incredibly over the past three years. This is a sector to watch right now, I think.</p><p><b>Quast:</b> Yes, definitely. Beta doesn&#39;t predict where the price is going to go is a historical indicator. This has been what has historically trended so far. If history continues to repeat itself, it&#39;s what you would expect. The market falls, you&#39;d expect Marathon to fall harder.</p><p>What&#39;s interesting is, if you read the article, Anders, he points out that most of the months with these companies, with these stocks, they are not small moves. It was a 20% or more move up or down, like eight out of 12 months last year. There was a lot of months that it was up by 20% or more, but there was also several months where it was down 20% or more, really big swings.</p><p>For me personally, these bitcoin miners just haven&#39;t been attractive investments to me even though they have several of these. I don&#39;t believe Bit Digital, but definitely, Marathon beating the market by a wide margin over the past three years.</p><p>The reason I don&#39;t really like them is because you have the risk of Bitcoin in the first place and then you bring in a company that is the miner then you add in execution risks on top of it. I don&#39;t really see the point of that. I&#39;m invested in Bitcoin personally and that&#39;s enough risk for me.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Worried About This Crypto Crash? Avoid Crypto Miners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWorried About This Crypto Crash? Avoid Crypto Miners\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 08:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/31/worried-about-this-crypto-crash-avoid-crypto-miner/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The question of whether to buy Bitcoin (CRYPTO:BTC) or Bitcoin miners such as Marathon Digital (NASDAQ:MARA), Bit Digital (NASDAQ:BTBT), or CleanSpark (NASDAQ:CLSK) is a good one. Fool.com ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/31/worried-about-this-crypto-crash-avoid-crypto-miner/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MARA":"Marathon Digital Holdings Inc","BTBT":"Bit Digital, Inc.","CLSK":"CleanSpark, Inc.","BK4023":"应用软件"},"source_url":"https://www.fool.com/investing/2022/01/31/worried-about-this-crypto-crash-avoid-crypto-miner/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2207822223","content_text":"The question of whether to buy Bitcoin (CRYPTO:BTC) or Bitcoin miners such as Marathon Digital (NASDAQ:MARA), Bit Digital (NASDAQ:BTBT), or CleanSpark (NASDAQ:CLSK) is a good one. Fool.com contributors Chris MacDonald and Jon Quast discussed the pros and cons of taking this approach on this Jan. 19 episode of \"The Crypto Show\" on Backstage Pass.Jon Quast: We'll go ahead and start talking about that here. This was an article that came out on Saturday, very, very interesting on Bitcoin mining stocks. Specifically, here, I believe he is looking at Marathon Digital symbol, MARA and he is also looking at well, let me just flip ahead Bit Digital, symbol, BTBT, and CleanSpark CLSK. CleanSpark is not just a Bitcoin miner. They do have these other products that are basically designed to make power systems more efficient. Especially, I believe it's off-grid power systems help them be more efficient and they said well, we can apply this and mine Bitcoin more efficiently.But, Anders, very interesting, the look that he had of these companies and their stocks and their beta their relative volatility to the market, finding that, as you pointed out, they're much more volatile than Bitcoin itself.Chris MacDonald: We touched on Bitcoin miners, I know in previous shows, in terms of their leverage exposure to the underlying prices of cryptocurrencies like Bitcoin. These top miners are Bitcoin miners. Generally speaking, when the price of Bitcoin goes up because these miners have high fixed costs and their costs are locked in dollars when the price of Bitcoin goes up, their debt, which is denominated in dollars, goes down relative to Bitcoin and their revenue, which is denominated in Bitcoin, goes up. Their balance sheet looks a heck of a lot better when Bitcoins on an uptrend.Based on which direction Bitcoin is moving, these miners can often move in an amplified way. If you are looking at this slide here, so it's interesting when we look at Marathon with a beta of four that means essentially if the market goes up by 1%, Marathon could go up by 4% on average and vice versa.Bitcoin like I said, with the beta of zero, you don't know which direction it's necessarily going to go. It's kind of agnostic to the markets, which is more of what we would expect. It is a lower correlation asset. Some of these other cryptocurrencies do have higher betas.That goes back to our previous discussion, but looking at the Bitcoin miners, you get that leveraged exposure to crypto prices. In good times, that's great. In times of a little bit more uncertainty like right now, these top miners are seeing drops.But that being said, you look at Marathon Digital with its three-year return, they're over 2000%. That is pretty incredible and I think relative to the other ones like Bit Digital, we're going to touch on a little bit later. Relative to a lot of the other crypto miners it's got a lot better fundamentals. This would be my top crypto miner to look at it just based on its geographic location in the U.S. and its balance sheet right now.There are differences among crypto miners. It is a higher beta one, which is interesting. If the market continues to decline, will Marathon dip harder? That remains to be seen. It has run pretty incredibly over the past three years. This is a sector to watch right now, I think.Quast: Yes, definitely. Beta doesn't predict where the price is going to go is a historical indicator. This has been what has historically trended so far. If history continues to repeat itself, it's what you would expect. The market falls, you'd expect Marathon to fall harder.What's interesting is, if you read the article, Anders, he points out that most of the months with these companies, with these stocks, they are not small moves. It was a 20% or more move up or down, like eight out of 12 months last year. There was a lot of months that it was up by 20% or more, but there was also several months where it was down 20% or more, really big swings.For me personally, these bitcoin miners just haven't been attractive investments to me even though they have several of these. I don't believe Bit Digital, but definitely, Marathon beating the market by a wide margin over the past three years.The reason I don't really like them is because you have the risk of Bitcoin in the first place and then you bring in a company that is the miner then you add in execution risks on top of it. I don't really see the point of that. I'm invested in Bitcoin personally and that's enough risk for me.","news_type":1},"isVote":1,"tweetType":1,"viewCount":713,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633923456,"gmtCreate":1643690452483,"gmtModify":1643690452754,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"G","listText":"G","text":"G","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633923456","repostId":"2207822223","repostType":4,"repost":{"id":"2207822223","pubTimestamp":1643674787,"share":"https://www.laohu8.com/m/news/2207822223?lang=&edition=full","pubTime":"2022-02-01 08:19","market":"us","language":"en","title":"Worried About This Crypto Crash? Avoid Crypto Miners","url":"https://stock-news.laohu8.com/highlight/detail?id=2207822223","media":"Motley Fool","summary":"Leveraged exposure to crypto sounds good on the way up, but not so great right now.","content":"<html><head></head><body><p>The question of whether to buy <b>Bitcoin </b>(CRYPTO:BTC) or Bitcoin miners such as <b>Marathon Digital </b>(NASDAQ:MARA), <b>Bit Digital </b>(NASDAQ:BTBT), or <b>CleanSpark </b>(NASDAQ:CLSK) is a good <a href=\"https://laohu8.com/S/AONE.U\">one</a>. Fool.com contributors Chris MacDonald and Jon Quast discussed the pros and cons of taking this approach on this <b>Jan. 19 </b>episode of &#34;The Crypto Show&#34; on <i>Backstage Pass</i>.</p><p><b>Jon Quast:</b> We&#39;ll go ahead and start talking about that here. This was an article that came out on Saturday, very, very interesting on Bitcoin mining stocks. Specifically, here, I believe he is looking at Marathon Digital symbol, MARA and he is also looking at well, let me just flip ahead Bit Digital, symbol, BTBT, and CleanSpark CLSK. CleanSpark is not just a Bitcoin miner. They do have these other products that are basically designed to make power systems more efficient. Especially, I believe it&#39;s off-grid power systems help them be more efficient and they said well, we can apply this and mine Bitcoin more efficiently.</p><p>But, Anders, very interesting, the look that he had of these companies and their stocks and their beta their relative volatility to the market, finding that, as you pointed out, they&#39;re much more volatile than Bitcoin itself.</p><p><b>Chris MacDonald:</b> We touched on Bitcoin miners, I know in previous shows, in terms of their leverage exposure to the underlying prices of cryptocurrencies like Bitcoin. These top miners are Bitcoin miners. Generally speaking, when the price of Bitcoin goes up because these miners have high fixed costs and their costs are locked in dollars when the price of Bitcoin goes up, their debt, which is denominated in dollars, goes down relative to Bitcoin and their revenue, which is denominated in Bitcoin, goes up. Their balance sheet looks a heck of a lot better when Bitcoins on an uptrend.</p><p>Based on which direction Bitcoin is moving, these miners can often move in an amplified way. If you are looking at this slide here, so it&#39;s interesting when we look at Marathon with a beta of four that means essentially if the market goes up by 1%, Marathon could go up by 4% on average and vice versa.</p><p><b>Bitcoin</b> like I said, with the beta of zero, you don&#39;t know which direction it&#39;s necessarily going to go. It&#39;s kind of agnostic to the markets, which is more of what we would expect. It is a lower correlation asset. Some of these other cryptocurrencies do have higher betas.</p><p>That goes back to our previous discussion, but looking at the Bitcoin miners, you get that leveraged exposure to crypto prices. In good times, that&#39;s great. In times of a little bit more uncertainty like right now, these top miners are seeing drops.</p><p>But that being said, you look at Marathon Digital with its three-year return, they&#39;re over 2000%. That is pretty incredible and I think relative to the other ones like Bit Digital, we&#39;re going to touch on a little bit later. Relative to a lot of the other crypto miners it&#39;s got a lot better fundamentals. This would be my top crypto miner to look at it just based on its geographic location in the U.S. and its balance sheet right now.</p><p>There are differences among crypto miners. It is a higher beta one, which is interesting. If the market continues to decline, will Marathon dip harder? That remains to be seen. It has run pretty incredibly over the past three years. This is a sector to watch right now, I think.</p><p><b>Quast:</b> Yes, definitely. Beta doesn&#39;t predict where the price is going to go is a historical indicator. This has been what has historically trended so far. If history continues to repeat itself, it&#39;s what you would expect. The market falls, you&#39;d expect Marathon to fall harder.</p><p>What&#39;s interesting is, if you read the article, Anders, he points out that most of the months with these companies, with these stocks, they are not small moves. It was a 20% or more move up or down, like eight out of 12 months last year. There was a lot of months that it was up by 20% or more, but there was also several months where it was down 20% or more, really big swings.</p><p>For me personally, these bitcoin miners just haven&#39;t been attractive investments to me even though they have several of these. I don&#39;t believe Bit Digital, but definitely, Marathon beating the market by a wide margin over the past three years.</p><p>The reason I don&#39;t really like them is because you have the risk of Bitcoin in the first place and then you bring in a company that is the miner then you add in execution risks on top of it. I don&#39;t really see the point of that. I&#39;m invested in Bitcoin personally and that&#39;s enough risk for me.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Worried About This Crypto Crash? Avoid Crypto Miners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWorried About This Crypto Crash? Avoid Crypto Miners\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-01 08:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/31/worried-about-this-crypto-crash-avoid-crypto-miner/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The question of whether to buy Bitcoin (CRYPTO:BTC) or Bitcoin miners such as Marathon Digital (NASDAQ:MARA), Bit Digital (NASDAQ:BTBT), or CleanSpark (NASDAQ:CLSK) is a good one. Fool.com ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/31/worried-about-this-crypto-crash-avoid-crypto-miner/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MARA":"Marathon Digital Holdings Inc","BTBT":"Bit Digital, Inc.","CLSK":"CleanSpark, Inc.","BK4023":"应用软件"},"source_url":"https://www.fool.com/investing/2022/01/31/worried-about-this-crypto-crash-avoid-crypto-miner/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2207822223","content_text":"The question of whether to buy Bitcoin (CRYPTO:BTC) or Bitcoin miners such as Marathon Digital (NASDAQ:MARA), Bit Digital (NASDAQ:BTBT), or CleanSpark (NASDAQ:CLSK) is a good one. Fool.com contributors Chris MacDonald and Jon Quast discussed the pros and cons of taking this approach on this Jan. 19 episode of \"The Crypto Show\" on Backstage Pass.Jon Quast: We'll go ahead and start talking about that here. This was an article that came out on Saturday, very, very interesting on Bitcoin mining stocks. Specifically, here, I believe he is looking at Marathon Digital symbol, MARA and he is also looking at well, let me just flip ahead Bit Digital, symbol, BTBT, and CleanSpark CLSK. CleanSpark is not just a Bitcoin miner. They do have these other products that are basically designed to make power systems more efficient. Especially, I believe it's off-grid power systems help them be more efficient and they said well, we can apply this and mine Bitcoin more efficiently.But, Anders, very interesting, the look that he had of these companies and their stocks and their beta their relative volatility to the market, finding that, as you pointed out, they're much more volatile than Bitcoin itself.Chris MacDonald: We touched on Bitcoin miners, I know in previous shows, in terms of their leverage exposure to the underlying prices of cryptocurrencies like Bitcoin. These top miners are Bitcoin miners. Generally speaking, when the price of Bitcoin goes up because these miners have high fixed costs and their costs are locked in dollars when the price of Bitcoin goes up, their debt, which is denominated in dollars, goes down relative to Bitcoin and their revenue, which is denominated in Bitcoin, goes up. Their balance sheet looks a heck of a lot better when Bitcoins on an uptrend.Based on which direction Bitcoin is moving, these miners can often move in an amplified way. If you are looking at this slide here, so it's interesting when we look at Marathon with a beta of four that means essentially if the market goes up by 1%, Marathon could go up by 4% on average and vice versa.Bitcoin like I said, with the beta of zero, you don't know which direction it's necessarily going to go. It's kind of agnostic to the markets, which is more of what we would expect. It is a lower correlation asset. Some of these other cryptocurrencies do have higher betas.That goes back to our previous discussion, but looking at the Bitcoin miners, you get that leveraged exposure to crypto prices. In good times, that's great. In times of a little bit more uncertainty like right now, these top miners are seeing drops.But that being said, you look at Marathon Digital with its three-year return, they're over 2000%. That is pretty incredible and I think relative to the other ones like Bit Digital, we're going to touch on a little bit later. Relative to a lot of the other crypto miners it's got a lot better fundamentals. This would be my top crypto miner to look at it just based on its geographic location in the U.S. and its balance sheet right now.There are differences among crypto miners. It is a higher beta one, which is interesting. If the market continues to decline, will Marathon dip harder? That remains to be seen. It has run pretty incredibly over the past three years. This is a sector to watch right now, I think.Quast: Yes, definitely. Beta doesn't predict where the price is going to go is a historical indicator. This has been what has historically trended so far. If history continues to repeat itself, it's what you would expect. The market falls, you'd expect Marathon to fall harder.What's interesting is, if you read the article, Anders, he points out that most of the months with these companies, with these stocks, they are not small moves. It was a 20% or more move up or down, like eight out of 12 months last year. There was a lot of months that it was up by 20% or more, but there was also several months where it was down 20% or more, really big swings.For me personally, these bitcoin miners just haven't been attractive investments to me even though they have several of these. I don't believe Bit Digital, but definitely, Marathon beating the market by a wide margin over the past three years.The reason I don't really like them is because you have the risk of Bitcoin in the first place and then you bring in a company that is the miner then you add in execution risks on top of it. I don't really see the point of that. I'm invested in Bitcoin personally and that's enough risk for me.","news_type":1},"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639734246,"gmtCreate":1643440161012,"gmtModify":1643440161356,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/639734246","repostId":"1109955708","repostType":4,"repost":{"id":"1109955708","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643380234,"share":"https://www.laohu8.com/m/news/1109955708?lang=&edition=full","pubTime":"2022-01-28 22:30","market":"us","language":"zh","title":"开盘：新能源汽车股普跌，苹果高开逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109955708","media":"老虎资讯综合","summary":"1月28日，道琼斯指数开盘上涨20.91点，涨幅0.06%，报34181.69点；标普500指数开盘上涨11.72点，涨幅0.27%，报4338.22点；纳斯达克综合指数开盘上涨84.1点，涨幅0.6","content":"<html><head></head><body><p>1月28日，道琼斯指数开盘上涨20.91点，涨幅0.06%，报34181.69点；标普500指数开盘上涨11.72点，涨幅0.27%，报4338.22点；纳斯达克综合指数开盘上涨84.1点，涨幅0.63%，报13436.8点。</p><p>新能源汽车股普跌，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>跌逾3%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>汽车跌超2%。</p><p><a href=\"https://laohu8.com/S/AAPL\">苹果</a>涨逾4%，公司第一财季营收1239.45亿美元，创有史以来最高的单季度营收。</p><p><a href=\"https://laohu8.com/S/V\">Visa</a>涨7.27%，Q1净营收71亿美元，同比增长24%。</p><p><a href=\"https://laohu8.com/S/WDC\">西部数据</a>跌6.17%，Q2净利润同比增长810%，但警告称供应链问题及疫情将影响近期业绩。</p><p><a href=\"https://laohu8.com/S/CVX\">雪佛龙</a>跌3.59%，Q4同比扭亏为盈，但不及市场预期。</p><p><a href=\"https://laohu8.com/S/CAT\">卡特彼勒</a>跌3.4%，Q4业绩超出市场预期，但预计供应链限制将影响利润率。</p><p><a href=\"https://laohu8.com/S/X\">美国钢铁</a>涨2.64%，Q4销售额同比增长119.5%，预期2022年业绩表现强劲。</p><p><a href=\"https://laohu8.com/S/VFC\">威富集团</a>跌5.35%，Q3业绩不及市场预估，并略微下调全财年的销售指引。</p><p><a href=\"https://laohu8.com/S/WY\">惠好</a>涨1.43%，2021年实现净利润26亿美元，创纪录新高。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>开盘：新能源汽车股普跌，苹果高开逾4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n开盘：新能源汽车股普跌，苹果高开逾4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2022-01-28 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>1月28日，道琼斯指数开盘上涨20.91点，涨幅0.06%，报34181.69点；标普500指数开盘上涨11.72点，涨幅0.27%，报4338.22点；纳斯达克综合指数开盘上涨84.1点，涨幅0.63%，报13436.8点。</p><p>新能源汽车股普跌，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>跌逾3%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>汽车跌超2%。</p><p><a href=\"https://laohu8.com/S/AAPL\">苹果</a>涨逾4%，公司第一财季营收1239.45亿美元，创有史以来最高的单季度营收。</p><p><a href=\"https://laohu8.com/S/V\">Visa</a>涨7.27%，Q1净营收71亿美元，同比增长24%。</p><p><a href=\"https://laohu8.com/S/WDC\">西部数据</a>跌6.17%，Q2净利润同比增长810%，但警告称供应链问题及疫情将影响近期业绩。</p><p><a href=\"https://laohu8.com/S/CVX\">雪佛龙</a>跌3.59%，Q4同比扭亏为盈，但不及市场预期。</p><p><a href=\"https://laohu8.com/S/CAT\">卡特彼勒</a>跌3.4%，Q4业绩超出市场预期，但预计供应链限制将影响利润率。</p><p><a href=\"https://laohu8.com/S/X\">美国钢铁</a>涨2.64%，Q4销售额同比增长119.5%，预期2022年业绩表现强劲。</p><p><a href=\"https://laohu8.com/S/VFC\">威富集团</a>跌5.35%，Q3业绩不及市场预估，并略微下调全财年的销售指引。</p><p><a href=\"https://laohu8.com/S/WY\">惠好</a>涨1.43%，2021年实现净利润26亿美元，创纪录新高。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109955708","content_text":"1月28日，道琼斯指数开盘上涨20.91点，涨幅0.06%，报34181.69点；标普500指数开盘上涨11.72点，涨幅0.27%，报4338.22点；纳斯达克综合指数开盘上涨84.1点，涨幅0.63%，报13436.8点。新能源汽车股普跌，小鹏汽车跌逾3%，蔚来汽车跌超2%。苹果涨逾4%，公司第一财季营收1239.45亿美元，创有史以来最高的单季度营收。Visa涨7.27%，Q1净营收71亿美元，同比增长24%。西部数据跌6.17%，Q2净利润同比增长810%，但警告称供应链问题及疫情将影响近期业绩。雪佛龙跌3.59%，Q4同比扭亏为盈，但不及市场预期。卡特彼勒跌3.4%，Q4业绩超出市场预期，但预计供应链限制将影响利润率。美国钢铁涨2.64%，Q4销售额同比增长119.5%，预期2022年业绩表现强劲。威富集团跌5.35%，Q3业绩不及市场预估，并略微下调全财年的销售指引。惠好涨1.43%，2021年实现净利润26亿美元，创纪录新高。","news_type":1},"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639561895,"gmtCreate":1643353977079,"gmtModify":1643353977370,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OAJ.SI\">$FORTRESS MINERALS LIMITED(OAJ.SI)$</a>&nbsp;cup and handle formation, prepare to loaddd","listText":"<a href=\"https://laohu8.com/S/OAJ.SI\">$FORTRESS MINERALS LIMITED(OAJ.SI)$</a>&nbsp;cup and handle formation, prepare to loaddd","text":"$FORTRESS MINERALS LIMITED(OAJ.SI)$ cup and handle formation, prepare to loaddd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/639561895","isVote":1,"tweetType":1,"viewCount":433,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639675624,"gmtCreate":1643293107046,"gmtModify":1643293107305,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639675624","repostId":"1193693552","repostType":2,"repost":{"id":"1193693552","pubTimestamp":1643201953,"share":"https://www.laohu8.com/m/news/1193693552?lang=&edition=full","pubTime":"2022-01-26 20:59","market":"us","language":"en","title":"10 Biggest Price Target Changes For Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693552","media":"Benzinga","summary":"Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to ","content":"<html><head></head><body><ul><li>Keybanc boosted <b>McDonald&#39;s Corporation</b> price target from $275 to $285. McDonald&#39;s shares rose 1% to $253.07 in pre-market trading.</li><li>SVB Leerink raised <b>UnitedHealth Group Incorporated</b> price target from $480 to $550. UnitedHealth shares rose 0.5% to $459.15 in pre-market trading.</li><li>Goldman Sachs lowered <b>Nielsen Holdings plc</b> price target from $23 to $17. Nielsen shares fell 3.8% to $18.65 in pre-market trading.</li><li>JP Morgan cut the price target for <b>Verizon Communications Inc.</b> from $62 to $56. Verizon shares fell 0.5% to $52.63 in pre-market trading.</li><li>RBC Capital reduced the price target on <b>Gatos Silver, Inc.</b> from $17 to $4. Gatos Silver shares fell 46% to $5.50 in pre-market trading.</li></ul><ul><li>Barclays boosted <b>J.B. Hunt Transport Services, Inc.</b> price target from $220 to $235. J.B. Hunt Transport shares rose 1.1% to $198.00 in pre-market trading.</li><li>JP Morgan cut the price target on <b>Avis Budget Group, Inc.</b> from $225 to $205. Avis Budget shares gained 3% to $174.60 in pre-market trading.</li><li>B of A Securities raised the price target for <b>American Express Company</b> from $191 to $204. American Express shares rose 1.6% to $175.90 in pre-market trading.</li><li>Raymond James boosted<b>Johnson &amp; Johnson</b> price target from $178 to $185. Johnson &amp; Johnson shares rose 0.1% to $167.80 in pre-market trading.</li><li>Stephens &amp; Co. lowered the price target on <b>Capital One Financial Corporation</b> from $210 to $205. Capital One Financial shares rose 0.6% to $153.11 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-26 20:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to $253.07 in pre-market trading.SVB Leerink raised UnitedHealth Group Incorporated price target from $...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXP":"美国运通","JBHT":"JB Hunt运输服务","MCD":"麦当劳","VZ":"威瑞森","JNJ":"强生","GATO":"Gatos Silver, Inc.","COF":"第一资本","NLSN":"尼尔森","CAR":"安飞士","UNH":"联合健康"},"source_url":"https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193693552","content_text":"Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to $253.07 in pre-market trading.SVB Leerink raised UnitedHealth Group Incorporated price target from $480 to $550. UnitedHealth shares rose 0.5% to $459.15 in pre-market trading.Goldman Sachs lowered Nielsen Holdings plc price target from $23 to $17. Nielsen shares fell 3.8% to $18.65 in pre-market trading.JP Morgan cut the price target for Verizon Communications Inc. from $62 to $56. Verizon shares fell 0.5% to $52.63 in pre-market trading.RBC Capital reduced the price target on Gatos Silver, Inc. from $17 to $4. Gatos Silver shares fell 46% to $5.50 in pre-market trading.Barclays boosted J.B. Hunt Transport Services, Inc. price target from $220 to $235. J.B. Hunt Transport shares rose 1.1% to $198.00 in pre-market trading.JP Morgan cut the price target on Avis Budget Group, Inc. from $225 to $205. Avis Budget shares gained 3% to $174.60 in pre-market trading.B of A Securities raised the price target for American Express Company from $191 to $204. American Express shares rose 1.6% to $175.90 in pre-market trading.Raymond James boostedJohnson & Johnson price target from $178 to $185. Johnson & Johnson shares rose 0.1% to $167.80 in pre-market trading.Stephens & Co. lowered the price target on Capital One Financial Corporation from $210 to $205. Capital One Financial shares rose 0.6% to $153.11 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639168757,"gmtCreate":1643206944309,"gmtModify":1643206945479,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/639168757","repostId":"1193693552","repostType":4,"repost":{"id":"1193693552","pubTimestamp":1643201953,"share":"https://www.laohu8.com/m/news/1193693552?lang=&edition=full","pubTime":"2022-01-26 20:59","market":"us","language":"en","title":"10 Biggest Price Target Changes For Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693552","media":"Benzinga","summary":"Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to ","content":"<html><head></head><body><ul><li>Keybanc boosted <b>McDonald&#39;s Corporation</b> price target from $275 to $285. McDonald&#39;s shares rose 1% to $253.07 in pre-market trading.</li><li>SVB Leerink raised <b>UnitedHealth Group Incorporated</b> price target from $480 to $550. UnitedHealth shares rose 0.5% to $459.15 in pre-market trading.</li><li>Goldman Sachs lowered <b>Nielsen Holdings plc</b> price target from $23 to $17. Nielsen shares fell 3.8% to $18.65 in pre-market trading.</li><li>JP Morgan cut the price target for <b>Verizon Communications Inc.</b> from $62 to $56. Verizon shares fell 0.5% to $52.63 in pre-market trading.</li><li>RBC Capital reduced the price target on <b>Gatos Silver, Inc.</b> from $17 to $4. Gatos Silver shares fell 46% to $5.50 in pre-market trading.</li></ul><ul><li>Barclays boosted <b>J.B. Hunt Transport Services, Inc.</b> price target from $220 to $235. J.B. Hunt Transport shares rose 1.1% to $198.00 in pre-market trading.</li><li>JP Morgan cut the price target on <b>Avis Budget Group, Inc.</b> from $225 to $205. Avis Budget shares gained 3% to $174.60 in pre-market trading.</li><li>B of A Securities raised the price target for <b>American Express Company</b> from $191 to $204. American Express shares rose 1.6% to $175.90 in pre-market trading.</li><li>Raymond James boosted<b>Johnson &amp; Johnson</b> price target from $178 to $185. Johnson &amp; Johnson shares rose 0.1% to $167.80 in pre-market trading.</li><li>Stephens &amp; Co. lowered the price target on <b>Capital One Financial Corporation</b> from $210 to $205. Capital One Financial shares rose 0.6% to $153.11 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-26 20:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to $253.07 in pre-market trading.SVB Leerink raised UnitedHealth Group Incorporated price target from $...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXP":"美国运通","JBHT":"JB Hunt运输服务","MCD":"麦当劳","VZ":"威瑞森","JNJ":"强生","GATO":"Gatos Silver, Inc.","COF":"第一资本","NLSN":"尼尔森","CAR":"安飞士","UNH":"联合健康"},"source_url":"https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193693552","content_text":"Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to $253.07 in pre-market trading.SVB Leerink raised UnitedHealth Group Incorporated price target from $480 to $550. UnitedHealth shares rose 0.5% to $459.15 in pre-market trading.Goldman Sachs lowered Nielsen Holdings plc price target from $23 to $17. Nielsen shares fell 3.8% to $18.65 in pre-market trading.JP Morgan cut the price target for Verizon Communications Inc. from $62 to $56. Verizon shares fell 0.5% to $52.63 in pre-market trading.RBC Capital reduced the price target on Gatos Silver, Inc. from $17 to $4. Gatos Silver shares fell 46% to $5.50 in pre-market trading.Barclays boosted J.B. Hunt Transport Services, Inc. price target from $220 to $235. J.B. Hunt Transport shares rose 1.1% to $198.00 in pre-market trading.JP Morgan cut the price target on Avis Budget Group, Inc. from $225 to $205. Avis Budget shares gained 3% to $174.60 in pre-market trading.B of A Securities raised the price target for American Express Company from $191 to $204. American Express shares rose 1.6% to $175.90 in pre-market trading.Raymond James boostedJohnson & Johnson price target from $178 to $185. Johnson & Johnson shares rose 0.1% to $167.80 in pre-market trading.Stephens & Co. lowered the price target on Capital One Financial Corporation from $210 to $205. Capital One Financial shares rose 0.6% to $153.11 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639168456,"gmtCreate":1643206938227,"gmtModify":1643206939316,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/639168456","repostId":"1193693552","repostType":4,"repost":{"id":"1193693552","pubTimestamp":1643201953,"share":"https://www.laohu8.com/m/news/1193693552?lang=&edition=full","pubTime":"2022-01-26 20:59","market":"us","language":"en","title":"10 Biggest Price Target Changes For Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693552","media":"Benzinga","summary":"Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to ","content":"<html><head></head><body><ul><li>Keybanc boosted <b>McDonald&#39;s Corporation</b> price target from $275 to $285. McDonald&#39;s shares rose 1% to $253.07 in pre-market trading.</li><li>SVB Leerink raised <b>UnitedHealth Group Incorporated</b> price target from $480 to $550. UnitedHealth shares rose 0.5% to $459.15 in pre-market trading.</li><li>Goldman Sachs lowered <b>Nielsen Holdings plc</b> price target from $23 to $17. Nielsen shares fell 3.8% to $18.65 in pre-market trading.</li><li>JP Morgan cut the price target for <b>Verizon Communications Inc.</b> from $62 to $56. Verizon shares fell 0.5% to $52.63 in pre-market trading.</li><li>RBC Capital reduced the price target on <b>Gatos Silver, Inc.</b> from $17 to $4. Gatos Silver shares fell 46% to $5.50 in pre-market trading.</li></ul><ul><li>Barclays boosted <b>J.B. Hunt Transport Services, Inc.</b> price target from $220 to $235. J.B. Hunt Transport shares rose 1.1% to $198.00 in pre-market trading.</li><li>JP Morgan cut the price target on <b>Avis Budget Group, Inc.</b> from $225 to $205. Avis Budget shares gained 3% to $174.60 in pre-market trading.</li><li>B of A Securities raised the price target for <b>American Express Company</b> from $191 to $204. American Express shares rose 1.6% to $175.90 in pre-market trading.</li><li>Raymond James boosted<b>Johnson &amp; Johnson</b> price target from $178 to $185. Johnson &amp; Johnson shares rose 0.1% to $167.80 in pre-market trading.</li><li>Stephens &amp; Co. lowered the price target on <b>Capital One Financial Corporation</b> from $210 to $205. Capital One Financial shares rose 0.6% to $153.11 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-26 20:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to $253.07 in pre-market trading.SVB Leerink raised UnitedHealth Group Incorporated price target from $...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXP":"美国运通","JBHT":"JB Hunt运输服务","MCD":"麦当劳","VZ":"威瑞森","JNJ":"强生","GATO":"Gatos Silver, Inc.","COF":"第一资本","NLSN":"尼尔森","CAR":"安飞士","UNH":"联合健康"},"source_url":"https://www.benzinga.com/analyst-ratings/price-target/22/01/25230231/10-biggest-price-target-changes-for-wednesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193693552","content_text":"Keybanc boosted McDonald's Corporation price target from $275 to $285. McDonald's shares rose 1% to $253.07 in pre-market trading.SVB Leerink raised UnitedHealth Group Incorporated price target from $480 to $550. UnitedHealth shares rose 0.5% to $459.15 in pre-market trading.Goldman Sachs lowered Nielsen Holdings plc price target from $23 to $17. Nielsen shares fell 3.8% to $18.65 in pre-market trading.JP Morgan cut the price target for Verizon Communications Inc. from $62 to $56. Verizon shares fell 0.5% to $52.63 in pre-market trading.RBC Capital reduced the price target on Gatos Silver, Inc. from $17 to $4. Gatos Silver shares fell 46% to $5.50 in pre-market trading.Barclays boosted J.B. Hunt Transport Services, Inc. price target from $220 to $235. J.B. Hunt Transport shares rose 1.1% to $198.00 in pre-market trading.JP Morgan cut the price target on Avis Budget Group, Inc. from $225 to $205. Avis Budget shares gained 3% to $174.60 in pre-market trading.B of A Securities raised the price target for American Express Company from $191 to $204. American Express shares rose 1.6% to $175.90 in pre-market trading.Raymond James boostedJohnson & Johnson price target from $178 to $185. Johnson & Johnson shares rose 0.1% to $167.80 in pre-market trading.Stephens & Co. lowered the price target on Capital One Financial Corporation from $210 to $205. Capital One Financial shares rose 0.6% to $153.11 in pre-market trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639009525,"gmtCreate":1643071729886,"gmtModify":1643071730158,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ETHE\">$Grayscale Ethereum Trust (ETH)(ETHE)$</a>Why can't I trade this? @ Tiger Brokers","listText":"<a href=\"https://laohu8.com/S/ETHE\">$Grayscale Ethereum Trust (ETH)(ETHE)$</a>Why can't I trade this? @ Tiger Brokers","text":"$Grayscale Ethereum Trust (ETH)(ETHE)$Why can't I trade this? @ Tiger Brokers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639009525","isVote":1,"tweetType":1,"viewCount":640,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630280662,"gmtCreate":1642903197747,"gmtModify":1642903198037,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/630280662","repostId":"1138349004","repostType":4,"repost":{"id":"1138349004","pubTimestamp":1642896014,"share":"https://www.laohu8.com/m/news/1138349004?lang=&edition=full","pubTime":"2022-01-23 08:00","market":"us","language":"en","title":"US IPO Weekly Recap: No IPOs as Postponements and Pricing Delays Abound","url":"https://stock-news.laohu8.com/highlight/detail?id=1138349004","media":"Renaissance Capital","summary":"Challenging conditions in the IPO market continued this past week. The two major deals on the calend","content":"<html><head></head><body><p>Challenging conditions in the IPO market continued this past week. The two major deals on the calendar postponed, and the remaining micro-caps pushed back their debuts by a week. Seven SPACs completed offerings, and three IPOs and four SPACs submitted initial filings.</p><p><b>Four Springs Capital Trust</b>(FSPR) postponed its $252 million IPO, which was set to be the largest deal of the week. The REIT previously attempted to go public in 2017, and had expanded its portfolio since then. Bitcoin miner<b>Rhodium Enterprises</b>(RHDM) postponed its $100 million IPO as Bitcoin prices continue to drop.</p><p>Seven SPACS went public this past week led by Hondius Capital’s<b>HCM Acquisition</b>(HCMAU), which raised $250 million to target the fintech sector.</p><p>While not included below, Japan-based<b>Yoshitsu</b>(TKLF) began trading after initially pricing its IPO earlier this month. The retailer became the latest micro-cap to soar on its debut, gaining 700% on its first day; it finished the week up 638%.</p><p><img src=\"https://static.tigerbbs.com/f5483ea5b543cd470959591e2016fe0a\" tg-width=\"1471\" tg-height=\"712\" referrerpolicy=\"no-referrer\"/></p><p>Three IPOs submitted initial filings. RIA services platform<b>Dynasty Financial Partners</b>(DSTY) filed to raise $100 million, Chinese insurance firm<b>Hengguang Holding</b>(HGIA) filed to raise $20 million, and Chinese micro-cap<b>Erayak Power Solution Group</b>(RAYA) filed to raise $15 million.</p><p>Four SPACs submitted initial filings. Auto-focused<b>Kensington Capital Acquisition IV</b>(KCAC.U), Intrepid Potash’s<b>Intrepid Acquisition I</b>(IACIU), and life sciences and sustainability-focused<b>Valuence Merger I</b>(VMCAU) all filed to raise $200 million.</p><p><img src=\"https://static.tigerbbs.com/241e940f6136f3bf1b4e6cc056743aa2\" tg-width=\"1478\" tg-height=\"713\" referrerpolicy=\"no-referrer\"/></p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: No IPOs as Postponements and Pricing Delays Abound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: No IPOs as Postponements and Pricing Delays Abound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-23 08:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/90388/US-IPO-Weekly-Recap-No-IPOs-as-postponements-and-pricing-delays-abound><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Challenging conditions in the IPO market continued this past week. The two major deals on the calendar postponed, and the remaining micro-caps pushed back their debuts by a week. Seven SPACs completed...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/90388/US-IPO-Weekly-Recap-No-IPOs-as-postponements-and-pricing-delays-abound\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","TKLF":"Yoshitsu Co., Ltd."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/90388/US-IPO-Weekly-Recap-No-IPOs-as-postponements-and-pricing-delays-abound","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138349004","content_text":"Challenging conditions in the IPO market continued this past week. The two major deals on the calendar postponed, and the remaining micro-caps pushed back their debuts by a week. Seven SPACs completed offerings, and three IPOs and four SPACs submitted initial filings.Four Springs Capital Trust(FSPR) postponed its $252 million IPO, which was set to be the largest deal of the week. The REIT previously attempted to go public in 2017, and had expanded its portfolio since then. Bitcoin minerRhodium Enterprises(RHDM) postponed its $100 million IPO as Bitcoin prices continue to drop.Seven SPACS went public this past week led by Hondius Capital’sHCM Acquisition(HCMAU), which raised $250 million to target the fintech sector.While not included below, Japan-basedYoshitsu(TKLF) began trading after initially pricing its IPO earlier this month. The retailer became the latest micro-cap to soar on its debut, gaining 700% on its first day; it finished the week up 638%.Three IPOs submitted initial filings. RIA services platformDynasty Financial Partners(DSTY) filed to raise $100 million, Chinese insurance firmHengguang Holding(HGIA) filed to raise $20 million, and Chinese micro-capErayak Power Solution Group(RAYA) filed to raise $15 million.Four SPACs submitted initial filings. Auto-focusedKensington Capital Acquisition IV(KCAC.U), Intrepid Potash’sIntrepid Acquisition I(IACIU), and life sciences and sustainability-focusedValuence Merger I(VMCAU) all filed to raise $200 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630207913,"gmtCreate":1642864413017,"gmtModify":1642864413360,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/630207913","repostId":"2205441860","repostType":4,"repost":{"id":"2205441860","pubTimestamp":1642808308,"share":"https://www.laohu8.com/m/news/2205441860?lang=&edition=full","pubTime":"2022-01-22 07:38","market":"us","language":"en","title":"Why I Sold These 3 High-Growth Tech Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2205441860","media":"Motley Fool","summary":"I recently sold my shares of Snap, Palantir, and Bumble. Let's explore the reasons I pulled the trigger on the sales.","content":"<html><head></head><body><p>Rising inflation and higher interest rates have crushed many high-growth tech stocks over the past few months. The reasons are simple: Inflation reduces the value of a company&#39;s future revenue and earnings, while higher interest rates boost borrowing costs for unprofitable companies.</p><p>Like many investors, I reduced my exposure to that shift by selling some of my higher-growth tech stocks and rotating toward more conservative investments. Specifically, I took profits from my investments in <b>Snap</b> (NYSE:SNAP) and <b>Palantir</b> (NYSE:PLTR), but I took a net loss on <b>Bumble</b> (NASDAQ:BMBL).</p><p>Investors should do their own due diligence instead of following my example, but let me explain my logic for selling these three high-growth tech stocks.</p><p><img src=\"https://static.tigerbbs.com/869992e71713ee11433514b27cb91bce\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Getty Images.</p><h2>1. Snap</h2><p>Snap was once my favorite social media stock. It generated robust growth in daily active users and revenue, it remained a top app for teen users, and its profitability was gradually improving.</p><p>But over the past year, several red flags appeared. It vastly underestimated the impact of<b> Apple</b>&#39;s privacy update on iOS, set unrealistic growth targets at its investor day last February, and failed to outshine <b>ByteDance</b>&#39;s TikTok with Spotlight&#39;s short videos.</p><p>Snap&#39;s third-quarter numbers and fourth-quarter guidance last October strongly suggested it couldn&#39;t achieve its investor day target for 50% annual revenue growth over the next few years. But Snap didn&#39;t withdraw that guidance -- even after directly being questioned about it during its conference call -- and said it could retool its ads to overcome Apple&#39;s iOS changes.</p><p>Over the past three months, Snap&#39;s insiders still sold 22 times as many shares as they bought -- even as the stock price dropped more than 50%. That lack of confidence indicates its iOS headaches won&#39;t end anytime soon.</p><p>Snap might seem reasonably valued now at 10 times next year&#39;s sales, especially if it meets analysts&#39; estimates for 60% revenue growth in 2021 and 38% growth in 2022. Unfortunately, I think Snap could continue to struggle over the next few quarters and ultimately withdraw its 50% revenue growth guidance. When that happens, the stock will likely plummet to new lows.</p><h2>2. Palantir</h2><p>Palantir, the data analytics firm which serves the U.S. government and large enterprise customers, also has ambitious growth plans. It believes it can generate at least 30% annual revenue growth from 2021 to 2025.</p><p>At first glance, Palantir seems like a solid investment. The U.S. Army reportedly used its Gotham platform to hunt down Osama Bin Laden in 2011. That battle-hardened reputation enables it to promote its enterprise-facing Foundry platform to large companies. Its ability to gather data from disparate sources can help government agencies and companies make better data-driven decisions to streamline their operations.</p><p>But Palantir also has some glaring problems. It&#39;s deeply unprofitable but still trades at 15 times next year&#39;s sales, which leaves it highly exposed to rising inflation and higher interest rates. It&#39;s also constantly diluting its shares with big stock bonuses -- in the first nine months of 2021, its number of weighted-average shares jumped 165% year over year.</p><p>The growth of Gotham is also decelerating as the U.S. government quietly develops in-house alternatives. Enterprise customers could also gravitate toward other analytics services, such as <b>Alteryx</b> or <b>Splunk, </b>instead of its Foundry platform.</p><p>Instead of sticking with this speculative and unprofitable company, it might be smarter for investors to rotate back toward firmly profitable blue-chip tech stocks which will benefit from the same data-mining tailwinds.</p><h2>3. Bumble</h2><p>After defending Bumble for nearly a year, I finally realized that the online dating company&#39;s weaknesses outweighed its strengths. The growth of Bumble&#39;s namesake app, which lets women make the first move, is decelerating. Its secondary app, Badoo, continues to lose paid users.</p><p>Last quarter, Bumble&#39;s total number of paid users across both apps grew 20% year over year to 1.53 million, but that marked a deceleration from its 36% growth in the previous quarter. Meanwhile, <b>Match Group</b>&#39;s (NASDAQ:MTCH) total number of paying users, 64% of whom use Tinder, increased 16% year over year to 16.3 million in its latest quarter. The company actually accelerated from its 15% growth in the previous quarter.</p><p>Bumble also remains unprofitable, and it&#39;s shouldering <i>more than twice</i> as much debt as its total cash and equivalents. At the same time, it&#39;s pursuing scattershot strategies -- including opening a restaurant in New York City, selling branded apparel and products through an online store, and rebooting its BFF feature (for platonic friendships) as a vaguely defined metaverse platform.</p><p>Those plans probably won&#39;t widen Bumble&#39;s moat against Match&#39;s portfolio of over a dozen dating apps. After listening to its latest conference call, it became painfully clear that Bumble overestimated its own brand appeal while underestimating the competition.</p><p>Bumble expects its revenue to grow 31% to 32% this fiscal year, but that&#39;s only a bit faster than Match&#39;s projected revenue growth rate of 25%. Bumble&#39;s stock might seem reasonably valued at six times next year&#39;s sales, but it probably won&#39;t command a higher premium until it stabilizes its user growth and significantly narrows its net losses. Until that happens, Match will probably be the better overall investment.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why I Sold These 3 High-Growth Tech Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy I Sold These 3 High-Growth Tech Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-22 07:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/21/why-i-sold-these-3-high-growth-tech-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising inflation and higher interest rates have crushed many high-growth tech stocks over the past few months. The reasons are simple: Inflation reduces the value of a company's future revenue and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/21/why-i-sold-these-3-high-growth-tech-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4549":"软银资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","BMBL":"Bumble Inc.","BK4023":"应用软件","SNAP":"Snap Inc","BK4515":"5G概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","AAPL":"苹果","PLTR":"Palantir Technologies Inc.","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","MTCH":"Match Group, Inc.","BK4566":"资本集团","BK4508":"社交媒体","BK4527":"明星科技股","BK4501":"段永平概念","BK4543":"AI","BK4559":"巴菲特持仓","BK4077":"互动媒体与服务","BK4550":"红杉资本持仓","BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓","BK4547":"WSB热门概念"},"source_url":"https://www.fool.com/investing/2022/01/21/why-i-sold-these-3-high-growth-tech-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205441860","content_text":"Rising inflation and higher interest rates have crushed many high-growth tech stocks over the past few months. The reasons are simple: Inflation reduces the value of a company's future revenue and earnings, while higher interest rates boost borrowing costs for unprofitable companies.Like many investors, I reduced my exposure to that shift by selling some of my higher-growth tech stocks and rotating toward more conservative investments. Specifically, I took profits from my investments in Snap (NYSE:SNAP) and Palantir (NYSE:PLTR), but I took a net loss on Bumble (NASDAQ:BMBL).Investors should do their own due diligence instead of following my example, but let me explain my logic for selling these three high-growth tech stocks.Image source: Getty Images.1. SnapSnap was once my favorite social media stock. It generated robust growth in daily active users and revenue, it remained a top app for teen users, and its profitability was gradually improving.But over the past year, several red flags appeared. It vastly underestimated the impact of Apple's privacy update on iOS, set unrealistic growth targets at its investor day last February, and failed to outshine ByteDance's TikTok with Spotlight's short videos.Snap's third-quarter numbers and fourth-quarter guidance last October strongly suggested it couldn't achieve its investor day target for 50% annual revenue growth over the next few years. But Snap didn't withdraw that guidance -- even after directly being questioned about it during its conference call -- and said it could retool its ads to overcome Apple's iOS changes.Over the past three months, Snap's insiders still sold 22 times as many shares as they bought -- even as the stock price dropped more than 50%. That lack of confidence indicates its iOS headaches won't end anytime soon.Snap might seem reasonably valued now at 10 times next year's sales, especially if it meets analysts' estimates for 60% revenue growth in 2021 and 38% growth in 2022. Unfortunately, I think Snap could continue to struggle over the next few quarters and ultimately withdraw its 50% revenue growth guidance. When that happens, the stock will likely plummet to new lows.2. PalantirPalantir, the data analytics firm which serves the U.S. government and large enterprise customers, also has ambitious growth plans. It believes it can generate at least 30% annual revenue growth from 2021 to 2025.At first glance, Palantir seems like a solid investment. The U.S. Army reportedly used its Gotham platform to hunt down Osama Bin Laden in 2011. That battle-hardened reputation enables it to promote its enterprise-facing Foundry platform to large companies. Its ability to gather data from disparate sources can help government agencies and companies make better data-driven decisions to streamline their operations.But Palantir also has some glaring problems. It's deeply unprofitable but still trades at 15 times next year's sales, which leaves it highly exposed to rising inflation and higher interest rates. It's also constantly diluting its shares with big stock bonuses -- in the first nine months of 2021, its number of weighted-average shares jumped 165% year over year.The growth of Gotham is also decelerating as the U.S. government quietly develops in-house alternatives. Enterprise customers could also gravitate toward other analytics services, such as Alteryx or Splunk, instead of its Foundry platform.Instead of sticking with this speculative and unprofitable company, it might be smarter for investors to rotate back toward firmly profitable blue-chip tech stocks which will benefit from the same data-mining tailwinds.3. BumbleAfter defending Bumble for nearly a year, I finally realized that the online dating company's weaknesses outweighed its strengths. The growth of Bumble's namesake app, which lets women make the first move, is decelerating. Its secondary app, Badoo, continues to lose paid users.Last quarter, Bumble's total number of paid users across both apps grew 20% year over year to 1.53 million, but that marked a deceleration from its 36% growth in the previous quarter. Meanwhile, Match Group's (NASDAQ:MTCH) total number of paying users, 64% of whom use Tinder, increased 16% year over year to 16.3 million in its latest quarter. The company actually accelerated from its 15% growth in the previous quarter.Bumble also remains unprofitable, and it's shouldering more than twice as much debt as its total cash and equivalents. At the same time, it's pursuing scattershot strategies -- including opening a restaurant in New York City, selling branded apparel and products through an online store, and rebooting its BFF feature (for platonic friendships) as a vaguely defined metaverse platform.Those plans probably won't widen Bumble's moat against Match's portfolio of over a dozen dating apps. After listening to its latest conference call, it became painfully clear that Bumble overestimated its own brand appeal while underestimating the competition.Bumble expects its revenue to grow 31% to 32% this fiscal year, but that's only a bit faster than Match's projected revenue growth rate of 25%. Bumble's stock might seem reasonably valued at six times next year's sales, but it probably won't command a higher premium until it stabilizes its user growth and significantly narrows its net losses. Until that happens, Match will probably be the better overall investment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":319,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630687567,"gmtCreate":1642818252492,"gmtModify":1642818252792,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630687567","repostId":"1190271564","repostType":2,"repost":{"id":"1190271564","pubTimestamp":1642663422,"share":"https://www.laohu8.com/m/news/1190271564?lang=&edition=full","pubTime":"2022-01-20 15:23","market":"us","language":"en","title":"Got $3,000? 5 Buffett Stocks to Buy and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=1190271564","media":"Motley Fool","summary":"These Berkshire Hathaway-backed winners could supercharge your portfolio.","content":"<html><head></head><body><p>Warren Buffett stands atop the pantheon of history&#39;s most successful investors. If you were lucky enough to own a $3,000 stake in <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) when he took control of the company in 1965, that position would now be worth nearly $81 million.</p><p>The Oracle of Omaha&#39;s knack for finding high-quality long-term investment opportunities has led to market-crushing results, and his storied performance means the investing world tends to keep a close eye on his company&#39;s holdings. Let&#39;s take a closer look at five top stocks backed by Berkshire Hathaway that are worth buying and holding for the long term.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a99bd55ae86722cb44e242a3e8fcd151\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: THE MOTLEY FOOL.</span></p><p><b>1. Apple</b></p><p>With <b>Apple</b>&#39;s (NASDAQ:AAPL) share price having surged roughly 32.1% over the last year and the company currently sporting a market capitalization of more than $2.76 trillion, it&#39;s not unreasonable to look at the stock with a bit of a cautious eye. On the other hand, there&#39;s basically never been a bad time for<i>long-term</i>investors to buy the stock in the company&#39;s history.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/807818ed8a5e4c2574220b38b5cf3a64\" tg-width=\"720\" tg-height=\"433\" width=\"100%\" height=\"auto\"/><span>AAPL DATA BY YCHARTS</span></p><p>Apple stands as the largest stock holding in the Berkshire portfolio, by far. Based on the last 13F filing from Buffett&#39;s company, the iPhone-maker accounts for nearly 43% of the investment conglomerate&#39;s stock holdings. That signifies an incredible vote of confidence from the modern era&#39;s most successful investor.</p><p>Between its market-leading mobile hardware and fast-growing software and services ecosystem, Apple&#39;s core businesses continue to look very strong, and it&#39;s likely that the company will also score wins in some exciting new fields. The California-based tech giant is already a leader in the wearable technology space, and it has huge opportunities in augmented reality hardware, autonomous electric vehicles, and other emerging product categories. The recent run-up in valuation means investors may want todollar-cost averageinto Apple stock, but the company looks well-positioned to continue growing over the long term.</p><p><b>2. Verizon</b></p><p>With a multi-billion-dollar investment in the fourth quarter of 2020, Berkshire Hathaway quickly made <b>Verizon Communications</b> (NYSE:VZ) one of its largest stock holdings. Internet communications are at the heart of modern business operations, and the telecom giant&#39;s top-rated service and infrastructure advantages should help it continue to be a category leader.</p><p>Verizon has been spending big to secure spectrum band and build out infrastructure for5G, but it&#39;s still in the early stages of benefiting from the rollout of the next-generation network technology. In addition to offering consumers a major leap forward with upload and download speeds, Verizon&#39;s 5G service will likely also help boost sales and earnings in the enterprise market.</p><p>With shares trading at roughly 10 times this year&#39;s expected earnings and sporting a 4.8% dividend yield, Verizon stock continues to look attractively valued. Investors even have a chance to buy the stock at prices lower than Berkshire got in at.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b30d6f848f83c57969cb29b9d24b3d1b\" tg-width=\"720\" tg-height=\"433\" width=\"100%\" height=\"auto\"/><span>VZ DATA BY YCHARTS.</span></p><p><b>3. Snowflake</b></p><p>As a cloud software-as-a-service stock that trades at lofty price-to-sales multiple,<b>Snowflake</b> (NYSE:SNOW) is one of the more unusual companies in the Berkshire Hathaway portfolio. While the investment conglomerate has gradually been shifting more of its portfolio weight toward the technology sector, it&#39;s still pretty eye-catching to see Buffett get behind a company that trades at roughly 83 times this year&#39;s expected sales.</p><p>It&#39;s clear that the Oracle of Omaha and the investment team at Berkshire see something special in the data warehousing and analytics player. Snowflake&#39;s platform allows data to be gathered and analyzed from otherwise walled-off sources, enabling applications to have quick and easy access to a much wider spectrum of valuable information. The company offers category-leading service in its niche, and with more customers joining its platform and bringing along valuable data, it&#39;s benefiting from a network effect that could produce a powerful long-term moat.</p><p><b>4. Amazon</b></p><p>Perhaps more so than any other company,<b>Amazon</b>(NASDAQ:AMZN) is built to win the future. The company&#39;s core e-commerce and cloud infrastructure businesses look poised for strong growth over the long term as these industries continue to grow, and its core business pillars should provide the foundation for new growth bets that help the company continue to expand.</p><p>With a market cap of more than $1.6 trillion, Amazon is already a massive company, but it still has plenty of room for growth over the long term. The company&#39;s strength in e-commerce and cloud services has helped it rapidly build its position in the digital advertising market, and Amazon&#39;s excellent collection of resources and proven penchant for innovation suggest that it will be able to continue scoring wins in new categories that drive growth and complement its existing businesses.</p><p><b>5. Berkshire Hathaway</b></p><p>If you want to invest like Buffett, why limit yourself to picking just a handful of stocks in the Berkshire portfolio? Particularly when you can buy shares in Berkshire Hathaway directly and get exposure to all of the stocks in the company&#39;s portfolio, its subsidiaries, and its real estate, insurance, and energy businesses. In addition to Apple, Verizon, Amazon, and Snowflake, Berkshire Hathaway also owns substantial stakes in companies including <b>Bank of America</b>,<b>American Express</b>,<b>Coca-Cola</b>, and other industry-leading names.</p><p>Even after buying back more than $20 billion worth of its own stock last year, the investment conglomerate has a massive pool of resources and ended its third quarter with a record $149 billion in cash on the books. Owning Berkshire Hathaway stock means that when Buffett and his team of analysts go shopping with that money, your own portfolio gets exposure to those buys before they&#39;re made known to the public.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $3,000? 5 Buffett Stocks to Buy and Hold Forever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $3,000? 5 Buffett Stocks to Buy and Hold Forever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 15:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/19/got-3000-5-buffett-stocks-to-buy-and-hold-forever/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett stands atop the pantheon of history's most successful investors. If you were lucky enough to own a $3,000 stake in Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) when he took control of ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/19/got-3000-5-buffett-stocks-to-buy-and-hold-forever/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","BRK.A":"伯克希尔","BRK.B":"伯克希尔B","VZ":"威瑞森","SNOW":"Snowflake"},"source_url":"https://www.fool.com/investing/2022/01/19/got-3000-5-buffett-stocks-to-buy-and-hold-forever/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190271564","content_text":"Warren Buffett stands atop the pantheon of history's most successful investors. If you were lucky enough to own a $3,000 stake in Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) when he took control of the company in 1965, that position would now be worth nearly $81 million.The Oracle of Omaha's knack for finding high-quality long-term investment opportunities has led to market-crushing results, and his storied performance means the investing world tends to keep a close eye on his company's holdings. Let's take a closer look at five top stocks backed by Berkshire Hathaway that are worth buying and holding for the long term.IMAGE SOURCE: THE MOTLEY FOOL.1. AppleWith Apple's (NASDAQ:AAPL) share price having surged roughly 32.1% over the last year and the company currently sporting a market capitalization of more than $2.76 trillion, it's not unreasonable to look at the stock with a bit of a cautious eye. On the other hand, there's basically never been a bad time forlong-terminvestors to buy the stock in the company's history.AAPL DATA BY YCHARTSApple stands as the largest stock holding in the Berkshire portfolio, by far. Based on the last 13F filing from Buffett's company, the iPhone-maker accounts for nearly 43% of the investment conglomerate's stock holdings. That signifies an incredible vote of confidence from the modern era's most successful investor.Between its market-leading mobile hardware and fast-growing software and services ecosystem, Apple's core businesses continue to look very strong, and it's likely that the company will also score wins in some exciting new fields. The California-based tech giant is already a leader in the wearable technology space, and it has huge opportunities in augmented reality hardware, autonomous electric vehicles, and other emerging product categories. The recent run-up in valuation means investors may want todollar-cost averageinto Apple stock, but the company looks well-positioned to continue growing over the long term.2. VerizonWith a multi-billion-dollar investment in the fourth quarter of 2020, Berkshire Hathaway quickly made Verizon Communications (NYSE:VZ) one of its largest stock holdings. Internet communications are at the heart of modern business operations, and the telecom giant's top-rated service and infrastructure advantages should help it continue to be a category leader.Verizon has been spending big to secure spectrum band and build out infrastructure for5G, but it's still in the early stages of benefiting from the rollout of the next-generation network technology. In addition to offering consumers a major leap forward with upload and download speeds, Verizon's 5G service will likely also help boost sales and earnings in the enterprise market.With shares trading at roughly 10 times this year's expected earnings and sporting a 4.8% dividend yield, Verizon stock continues to look attractively valued. Investors even have a chance to buy the stock at prices lower than Berkshire got in at.VZ DATA BY YCHARTS.3. SnowflakeAs a cloud software-as-a-service stock that trades at lofty price-to-sales multiple,Snowflake (NYSE:SNOW) is one of the more unusual companies in the Berkshire Hathaway portfolio. While the investment conglomerate has gradually been shifting more of its portfolio weight toward the technology sector, it's still pretty eye-catching to see Buffett get behind a company that trades at roughly 83 times this year's expected sales.It's clear that the Oracle of Omaha and the investment team at Berkshire see something special in the data warehousing and analytics player. Snowflake's platform allows data to be gathered and analyzed from otherwise walled-off sources, enabling applications to have quick and easy access to a much wider spectrum of valuable information. The company offers category-leading service in its niche, and with more customers joining its platform and bringing along valuable data, it's benefiting from a network effect that could produce a powerful long-term moat.4. AmazonPerhaps more so than any other company,Amazon(NASDAQ:AMZN) is built to win the future. The company's core e-commerce and cloud infrastructure businesses look poised for strong growth over the long term as these industries continue to grow, and its core business pillars should provide the foundation for new growth bets that help the company continue to expand.With a market cap of more than $1.6 trillion, Amazon is already a massive company, but it still has plenty of room for growth over the long term. The company's strength in e-commerce and cloud services has helped it rapidly build its position in the digital advertising market, and Amazon's excellent collection of resources and proven penchant for innovation suggest that it will be able to continue scoring wins in new categories that drive growth and complement its existing businesses.5. Berkshire HathawayIf you want to invest like Buffett, why limit yourself to picking just a handful of stocks in the Berkshire portfolio? Particularly when you can buy shares in Berkshire Hathaway directly and get exposure to all of the stocks in the company's portfolio, its subsidiaries, and its real estate, insurance, and energy businesses. In addition to Apple, Verizon, Amazon, and Snowflake, Berkshire Hathaway also owns substantial stakes in companies including Bank of America,American Express,Coca-Cola, and other industry-leading names.Even after buying back more than $20 billion worth of its own stock last year, the investment conglomerate has a massive pool of resources and ended its third quarter with a record $149 billion in cash on the books. Owning Berkshire Hathaway stock means that when Buffett and his team of analysts go shopping with that money, your own portfolio gets exposure to those buys before they're made known to the public.","news_type":1},"isVote":1,"tweetType":1,"viewCount":255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630321785,"gmtCreate":1642717696513,"gmtModify":1642724011418,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/.SPX\">$S&amp;P 500(.SPX)$</a>&nbsp;triple tops. So bearish.&nbsp;","listText":"<a href=\"https://laohu8.com/S/.SPX\">$S&amp;P 500(.SPX)$</a>&nbsp;triple tops. So bearish.&nbsp;","text":"$S&P 500(.SPX)$ triple tops. So bearish.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630321785","isVote":1,"tweetType":1,"viewCount":271,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697709094,"gmtCreate":1642578862568,"gmtModify":1642578883271,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/I07.SI\">$ISDN HOLDINGS LIMITED(I07.SI)$</a>&nbsp;support broken how low will it go","listText":"<a href=\"https://laohu8.com/S/I07.SI\">$ISDN HOLDINGS LIMITED(I07.SI)$</a>&nbsp;support broken how low will it go","text":"$ISDN HOLDINGS LIMITED(I07.SI)$ support broken how low will it go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697709094","isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":850768007,"gmtCreate":1634628955823,"gmtModify":1634628956116,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/T82U.SI\">$SUNTEC REAL ESTATE INV TRUST(T82U.SI)$</a>&nbsp;bought around sep. Will i be entitled to receive the dividend end of this month?&nbsp;","listText":"<a href=\"https://laohu8.com/S/T82U.SI\">$SUNTEC REAL ESTATE INV TRUST(T82U.SI)$</a>&nbsp;bought around sep. Will i be entitled to receive the dividend end of this month?&nbsp;","text":"$SUNTEC REAL ESTATE INV TRUST(T82U.SI)$ bought around sep. Will i be entitled to receive the dividend end of this month?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":1,"link":"https://laohu8.com/post/850768007","isVote":1,"tweetType":1,"viewCount":726,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3566385558470298","authorId":"3566385558470298","name":"Venus_M","avatar":"https://static.tigerbbs.com/525433622d774840840ddaacaf2281d2","crmLevel":2,"crmLevelSwitch":0},"content":"当然了！你在交货前1天保持这么长时间。前D是30号。你购买并持有的最后一天是29日。","text":"当然了！你在交货前1天保持这么长时间。前D是30号。你购买并持有的最后一天是29日。","html":"当然了！你在交货前1天保持这么长时间。前D是30号。你购买并持有的最后一天是29日。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630207913,"gmtCreate":1642864413017,"gmtModify":1642864413360,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/630207913","repostId":"2205441860","repostType":4,"repost":{"id":"2205441860","pubTimestamp":1642808308,"share":"https://www.laohu8.com/m/news/2205441860?lang=&edition=full","pubTime":"2022-01-22 07:38","market":"us","language":"en","title":"Why I Sold These 3 High-Growth Tech Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2205441860","media":"Motley Fool","summary":"I recently sold my shares of Snap, Palantir, and Bumble. Let's explore the reasons I pulled the trigger on the sales.","content":"<html><head></head><body><p>Rising inflation and higher interest rates have crushed many high-growth tech stocks over the past few months. The reasons are simple: Inflation reduces the value of a company&#39;s future revenue and earnings, while higher interest rates boost borrowing costs for unprofitable companies.</p><p>Like many investors, I reduced my exposure to that shift by selling some of my higher-growth tech stocks and rotating toward more conservative investments. Specifically, I took profits from my investments in <b>Snap</b> (NYSE:SNAP) and <b>Palantir</b> (NYSE:PLTR), but I took a net loss on <b>Bumble</b> (NASDAQ:BMBL).</p><p>Investors should do their own due diligence instead of following my example, but let me explain my logic for selling these three high-growth tech stocks.</p><p><img src=\"https://static.tigerbbs.com/869992e71713ee11433514b27cb91bce\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Getty Images.</p><h2>1. Snap</h2><p>Snap was once my favorite social media stock. It generated robust growth in daily active users and revenue, it remained a top app for teen users, and its profitability was gradually improving.</p><p>But over the past year, several red flags appeared. It vastly underestimated the impact of<b> Apple</b>&#39;s privacy update on iOS, set unrealistic growth targets at its investor day last February, and failed to outshine <b>ByteDance</b>&#39;s TikTok with Spotlight&#39;s short videos.</p><p>Snap&#39;s third-quarter numbers and fourth-quarter guidance last October strongly suggested it couldn&#39;t achieve its investor day target for 50% annual revenue growth over the next few years. But Snap didn&#39;t withdraw that guidance -- even after directly being questioned about it during its conference call -- and said it could retool its ads to overcome Apple&#39;s iOS changes.</p><p>Over the past three months, Snap&#39;s insiders still sold 22 times as many shares as they bought -- even as the stock price dropped more than 50%. That lack of confidence indicates its iOS headaches won&#39;t end anytime soon.</p><p>Snap might seem reasonably valued now at 10 times next year&#39;s sales, especially if it meets analysts&#39; estimates for 60% revenue growth in 2021 and 38% growth in 2022. Unfortunately, I think Snap could continue to struggle over the next few quarters and ultimately withdraw its 50% revenue growth guidance. When that happens, the stock will likely plummet to new lows.</p><h2>2. Palantir</h2><p>Palantir, the data analytics firm which serves the U.S. government and large enterprise customers, also has ambitious growth plans. It believes it can generate at least 30% annual revenue growth from 2021 to 2025.</p><p>At first glance, Palantir seems like a solid investment. The U.S. Army reportedly used its Gotham platform to hunt down Osama Bin Laden in 2011. That battle-hardened reputation enables it to promote its enterprise-facing Foundry platform to large companies. Its ability to gather data from disparate sources can help government agencies and companies make better data-driven decisions to streamline their operations.</p><p>But Palantir also has some glaring problems. It&#39;s deeply unprofitable but still trades at 15 times next year&#39;s sales, which leaves it highly exposed to rising inflation and higher interest rates. It&#39;s also constantly diluting its shares with big stock bonuses -- in the first nine months of 2021, its number of weighted-average shares jumped 165% year over year.</p><p>The growth of Gotham is also decelerating as the U.S. government quietly develops in-house alternatives. Enterprise customers could also gravitate toward other analytics services, such as <b>Alteryx</b> or <b>Splunk, </b>instead of its Foundry platform.</p><p>Instead of sticking with this speculative and unprofitable company, it might be smarter for investors to rotate back toward firmly profitable blue-chip tech stocks which will benefit from the same data-mining tailwinds.</p><h2>3. Bumble</h2><p>After defending Bumble for nearly a year, I finally realized that the online dating company&#39;s weaknesses outweighed its strengths. The growth of Bumble&#39;s namesake app, which lets women make the first move, is decelerating. Its secondary app, Badoo, continues to lose paid users.</p><p>Last quarter, Bumble&#39;s total number of paid users across both apps grew 20% year over year to 1.53 million, but that marked a deceleration from its 36% growth in the previous quarter. Meanwhile, <b>Match Group</b>&#39;s (NASDAQ:MTCH) total number of paying users, 64% of whom use Tinder, increased 16% year over year to 16.3 million in its latest quarter. The company actually accelerated from its 15% growth in the previous quarter.</p><p>Bumble also remains unprofitable, and it&#39;s shouldering <i>more than twice</i> as much debt as its total cash and equivalents. At the same time, it&#39;s pursuing scattershot strategies -- including opening a restaurant in New York City, selling branded apparel and products through an online store, and rebooting its BFF feature (for platonic friendships) as a vaguely defined metaverse platform.</p><p>Those plans probably won&#39;t widen Bumble&#39;s moat against Match&#39;s portfolio of over a dozen dating apps. After listening to its latest conference call, it became painfully clear that Bumble overestimated its own brand appeal while underestimating the competition.</p><p>Bumble expects its revenue to grow 31% to 32% this fiscal year, but that&#39;s only a bit faster than Match&#39;s projected revenue growth rate of 25%. Bumble&#39;s stock might seem reasonably valued at six times next year&#39;s sales, but it probably won&#39;t command a higher premium until it stabilizes its user growth and significantly narrows its net losses. Until that happens, Match will probably be the better overall investment.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why I Sold These 3 High-Growth Tech Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy I Sold These 3 High-Growth Tech Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-22 07:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/21/why-i-sold-these-3-high-growth-tech-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising inflation and higher interest rates have crushed many high-growth tech stocks over the past few months. The reasons are simple: Inflation reduces the value of a company's future revenue and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/21/why-i-sold-these-3-high-growth-tech-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4549":"软银资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","BMBL":"Bumble Inc.","BK4023":"应用软件","SNAP":"Snap Inc","BK4515":"5G概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","AAPL":"苹果","PLTR":"Palantir Technologies Inc.","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","MTCH":"Match Group, Inc.","BK4566":"资本集团","BK4508":"社交媒体","BK4527":"明星科技股","BK4501":"段永平概念","BK4543":"AI","BK4559":"巴菲特持仓","BK4077":"互动媒体与服务","BK4550":"红杉资本持仓","BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓","BK4547":"WSB热门概念"},"source_url":"https://www.fool.com/investing/2022/01/21/why-i-sold-these-3-high-growth-tech-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205441860","content_text":"Rising inflation and higher interest rates have crushed many high-growth tech stocks over the past few months. The reasons are simple: Inflation reduces the value of a company's future revenue and earnings, while higher interest rates boost borrowing costs for unprofitable companies.Like many investors, I reduced my exposure to that shift by selling some of my higher-growth tech stocks and rotating toward more conservative investments. Specifically, I took profits from my investments in Snap (NYSE:SNAP) and Palantir (NYSE:PLTR), but I took a net loss on Bumble (NASDAQ:BMBL).Investors should do their own due diligence instead of following my example, but let me explain my logic for selling these three high-growth tech stocks.Image source: Getty Images.1. SnapSnap was once my favorite social media stock. It generated robust growth in daily active users and revenue, it remained a top app for teen users, and its profitability was gradually improving.But over the past year, several red flags appeared. It vastly underestimated the impact of Apple's privacy update on iOS, set unrealistic growth targets at its investor day last February, and failed to outshine ByteDance's TikTok with Spotlight's short videos.Snap's third-quarter numbers and fourth-quarter guidance last October strongly suggested it couldn't achieve its investor day target for 50% annual revenue growth over the next few years. But Snap didn't withdraw that guidance -- even after directly being questioned about it during its conference call -- and said it could retool its ads to overcome Apple's iOS changes.Over the past three months, Snap's insiders still sold 22 times as many shares as they bought -- even as the stock price dropped more than 50%. That lack of confidence indicates its iOS headaches won't end anytime soon.Snap might seem reasonably valued now at 10 times next year's sales, especially if it meets analysts' estimates for 60% revenue growth in 2021 and 38% growth in 2022. Unfortunately, I think Snap could continue to struggle over the next few quarters and ultimately withdraw its 50% revenue growth guidance. When that happens, the stock will likely plummet to new lows.2. PalantirPalantir, the data analytics firm which serves the U.S. government and large enterprise customers, also has ambitious growth plans. It believes it can generate at least 30% annual revenue growth from 2021 to 2025.At first glance, Palantir seems like a solid investment. The U.S. Army reportedly used its Gotham platform to hunt down Osama Bin Laden in 2011. That battle-hardened reputation enables it to promote its enterprise-facing Foundry platform to large companies. Its ability to gather data from disparate sources can help government agencies and companies make better data-driven decisions to streamline their operations.But Palantir also has some glaring problems. It's deeply unprofitable but still trades at 15 times next year's sales, which leaves it highly exposed to rising inflation and higher interest rates. It's also constantly diluting its shares with big stock bonuses -- in the first nine months of 2021, its number of weighted-average shares jumped 165% year over year.The growth of Gotham is also decelerating as the U.S. government quietly develops in-house alternatives. Enterprise customers could also gravitate toward other analytics services, such as Alteryx or Splunk, instead of its Foundry platform.Instead of sticking with this speculative and unprofitable company, it might be smarter for investors to rotate back toward firmly profitable blue-chip tech stocks which will benefit from the same data-mining tailwinds.3. BumbleAfter defending Bumble for nearly a year, I finally realized that the online dating company's weaknesses outweighed its strengths. The growth of Bumble's namesake app, which lets women make the first move, is decelerating. Its secondary app, Badoo, continues to lose paid users.Last quarter, Bumble's total number of paid users across both apps grew 20% year over year to 1.53 million, but that marked a deceleration from its 36% growth in the previous quarter. Meanwhile, Match Group's (NASDAQ:MTCH) total number of paying users, 64% of whom use Tinder, increased 16% year over year to 16.3 million in its latest quarter. The company actually accelerated from its 15% growth in the previous quarter.Bumble also remains unprofitable, and it's shouldering more than twice as much debt as its total cash and equivalents. At the same time, it's pursuing scattershot strategies -- including opening a restaurant in New York City, selling branded apparel and products through an online store, and rebooting its BFF feature (for platonic friendships) as a vaguely defined metaverse platform.Those plans probably won't widen Bumble's moat against Match's portfolio of over a dozen dating apps. After listening to its latest conference call, it became painfully clear that Bumble overestimated its own brand appeal while underestimating the competition.Bumble expects its revenue to grow 31% to 32% this fiscal year, but that's only a bit faster than Match's projected revenue growth rate of 25%. Bumble's stock might seem reasonably valued at six times next year's sales, but it probably won't command a higher premium until it stabilizes its user growth and significantly narrows its net losses. Until that happens, Match will probably be the better overall investment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":319,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698257919,"gmtCreate":1640418675666,"gmtModify":1640418912963,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"U","listText":"U","text":"U","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698257919","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝","ABBV":"艾伯维公司","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852815359,"gmtCreate":1635257027797,"gmtModify":1635257271297,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/852815359","repostId":"1106832376","repostType":4,"repost":{"id":"1106832376","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635256754,"share":"https://www.laohu8.com/m/news/1106832376?lang=&edition=full","pubTime":"2021-10-26 21:59","market":"us","language":"en","title":"Tesla shares rose 5% in morning trading after reaching one trillion dollar market cap.","url":"https://stock-news.laohu8.com/highlight/detail?id=1106832376","media":"Tiger Newspress","summary":"Tesla shares rose 5% in morning trading after reaching one trillion dollar market cap.","content":"<p>Tesla&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;morning&nbsp;trading&nbsp;after&nbsp;reaching&nbsp;one trillion dollar market cap.<img src=\"https://static.tigerbbs.com/c3596a5589cea958cd7f8a961e5859d7\" tg-width=\"882\" tg-height=\"623\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla shares rose 5% in morning trading after reaching one trillion dollar market cap.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla shares rose 5% in morning trading after reaching one trillion dollar market cap.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tesla&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;morning&nbsp;trading&nbsp;after&nbsp;reaching&nbsp;one trillion dollar market cap.<img src=\"https://static.tigerbbs.com/c3596a5589cea958cd7f8a961e5859d7\" tg-width=\"882\" tg-height=\"623\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106832376","content_text":"Tesla shares rose 5% in morning trading after reaching one trillion dollar market cap.","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608141458,"gmtCreate":1638671100573,"gmtModify":1638671100691,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608141458","repostId":"2188578706","repostType":4,"repost":{"id":"2188578706","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638577500,"share":"https://www.laohu8.com/m/news/2188578706?lang=&edition=full","pubTime":"2021-12-04 08:25","market":"us","language":"en","title":"DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'","url":"https://stock-news.laohu8.com/highlight/detail?id=2188578706","media":"Dow Jones","summary":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pande","content":"<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 08:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DOCU":"Docusign","BK4023":"应用软件","BK4528":"SaaS概念"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188578706","content_text":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down\nDocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.\nShares of DocuSign $(DOCU)$ fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"\nThe stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&P 500 index has rallied 21% this year after climbing 16% last year.\nThe company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"\nCiti Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.\n\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.\nRadke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.\nEvercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"\nBut the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"\nWhile he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"\nHe cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.\nDocuSign shares are off roughly 52% from their September closing high of $310.05.","news_type":1},"isVote":1,"tweetType":1,"viewCount":20,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604071397,"gmtCreate":1639290847466,"gmtModify":1639290847720,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I","listText":"I","text":"I","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604071397","repostId":"2190719536","repostType":4,"repost":{"id":"2190719536","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1639276390,"share":"https://www.laohu8.com/m/news/2190719536?lang=&edition=full","pubTime":"2021-12-12 10:33","market":"us","language":"en","title":"To the moon! Cryptocurrency was the most popular Reddit topic this year","url":"https://stock-news.laohu8.com/highlight/detail?id=2190719536","media":"Dow Jones","summary":"Reddit called users like its WallStreetBets community 'catalysts for real-world change' this year\nWh","content":"<p>Reddit called users like its WallStreetBets community 'catalysts for real-world change' this year</p>\n<p>While Reddit hosts more than 430 million monthly active users in over 100,000 communities who discuss everything under the sun, there was <a href=\"https://laohu8.com/S/AONE.U\">one</a> financial subject that cut through the online chatter this year: Cryptocurrency.</p>\n<p>The massive social network dropped its Reddit Recap 2021 this week, which rounds up the most popular posts, topics and conversations on its platform over the past year. And cryptocurrency was hands down the most popular topic on Reddit in 2021, with people mentioning \"crypto\" 6.6 million times. There are also more than 500 cryptocurrency communities on Reddit, and the five most popular ones this year were r/dogecoin, r/superstonk, r/cryptocurrency, r/amcstock, and r/bitcoin.</p>\n<p>The Most Viewed Topics of 2021 on Reddit</p>\n<p>Cryptocurrencies including Dogecoin , Ethereum and Shiba Inu also topped Google's 2021 Year in Search, which the Alphabet-owned <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a> search engine released this week. \"Dogecoin\" and \"Ethereum price\" landed in the top 10 most-Googled news stories of the past year, both in the U.S. and across the globe. And the top two \"Where to buy\" Google searches were \"Where to buy Dogecoin?\" and \"Where to buy Shiba coin?\"</p>\n<p>Read more:Google's 2021 Year in Search: AMC and GME stocks, Dogecoin, stimulus checks and shortages dominated queries</p>\n<p>Whats's more, a recent Rover.com survey found that pet owners are actually naming their dogs \"Doge\" and their cats \"Bitcoin.\"</p>\n<p>And a group of crypto investors named ConstitutionDAO tried making history last month by crowdfunding more than $40 million to bid on a rare copy of the U.S. Constitution. Alas, it lost out to Citadel founder Ken Griffin, who spent $43.2 million on the historic document.</p>\n<p>Reddit notes that the rise of these retail and crypto investors looking to game the system has had real-world impact, such as the GameStop <a href=\"https://laohu8.com/S/GME\">$(GME)$</a> short squeeze in January. Maybe. The year-end Reddit report credits redditors with being \"catalysts for real-world change\" over the past year.</p>\n<p>Want intel on all the news moving markets each day? Sign up for our daily Need to Know newsletter.</p>\n<p>\"From r/wallstreetbets and the crash of the One Simple Wish website, to the Battle of the Joshes, in 2021, the most notable moments on Reddit were when redditors took their comments, comradery, conversations, and more from URL to IRL,\" Reddit staff wrote in a blog post</p>\n<p>Reddit's year-end review notes that users created 366 million posts over the past year, which was a 19% increase year over year. And as of Nov. 9, 2021, Reddit drew more than 2.3 billion total comments and 46 billion upvotes; aka when users show their approval for a post by clicking an \"up\" arrow, which pushes the post toward the top of the site so that more people can see it.</p>\n<p>The three most upvoted Reddit posts of the year came from the retail investors on the WallStreetBets, and the Superstonk page (which describes itself as discussing GameStop stock specifically) saw a 917K% increase in subscribers year over year.</p>\n<p>Those eager to learn more about the sometimes volatile world of meme stocks can check out MarketWatch's MemeMoney column and weekly MemeMarkets videos on YouTube. Or stay up-to-speed with cryptocurrency market news here.</p>\n<p>And amid the Great Resignation, the r/antiwork subreddit has exploded. The number of \"idlers\" (aka members) in this community for \"those who want to end work, are curious about ending work, want to get the most out of a work-free life, want more information on antiwork ideas and want personal help with their own jobs/work-related struggles\" spiked 279% this year.</p>\n<p>This video highlights the \"oddities and commodities\" discussed on Reddit this year, such as meme stocks like AMC <a href=\"https://laohu8.com/S/AMC\">$(AMC)$</a> and GameStop, supply chain issues, the billionaire space race and the breakout Netflix <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a> hit \"Squid Game.\"</p>\n<p>Check out the full Reddit recap here</p>\n<p>-Nicole Lyn Pesce</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>To the moon! Cryptocurrency was the most popular Reddit topic this year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTo the moon! Cryptocurrency was the most popular Reddit topic this year\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-12 10:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Reddit called users like its WallStreetBets community 'catalysts for real-world change' this year</p>\n<p>While Reddit hosts more than 430 million monthly active users in over 100,000 communities who discuss everything under the sun, there was <a href=\"https://laohu8.com/S/AONE.U\">one</a> financial subject that cut through the online chatter this year: Cryptocurrency.</p>\n<p>The massive social network dropped its Reddit Recap 2021 this week, which rounds up the most popular posts, topics and conversations on its platform over the past year. And cryptocurrency was hands down the most popular topic on Reddit in 2021, with people mentioning \"crypto\" 6.6 million times. There are also more than 500 cryptocurrency communities on Reddit, and the five most popular ones this year were r/dogecoin, r/superstonk, r/cryptocurrency, r/amcstock, and r/bitcoin.</p>\n<p>The Most Viewed Topics of 2021 on Reddit</p>\n<p>Cryptocurrencies including Dogecoin , Ethereum and Shiba Inu also topped Google's 2021 Year in Search, which the Alphabet-owned <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a> search engine released this week. \"Dogecoin\" and \"Ethereum price\" landed in the top 10 most-Googled news stories of the past year, both in the U.S. and across the globe. And the top two \"Where to buy\" Google searches were \"Where to buy Dogecoin?\" and \"Where to buy Shiba coin?\"</p>\n<p>Read more:Google's 2021 Year in Search: AMC and GME stocks, Dogecoin, stimulus checks and shortages dominated queries</p>\n<p>Whats's more, a recent Rover.com survey found that pet owners are actually naming their dogs \"Doge\" and their cats \"Bitcoin.\"</p>\n<p>And a group of crypto investors named ConstitutionDAO tried making history last month by crowdfunding more than $40 million to bid on a rare copy of the U.S. Constitution. Alas, it lost out to Citadel founder Ken Griffin, who spent $43.2 million on the historic document.</p>\n<p>Reddit notes that the rise of these retail and crypto investors looking to game the system has had real-world impact, such as the GameStop <a href=\"https://laohu8.com/S/GME\">$(GME)$</a> short squeeze in January. Maybe. The year-end Reddit report credits redditors with being \"catalysts for real-world change\" over the past year.</p>\n<p>Want intel on all the news moving markets each day? Sign up for our daily Need to Know newsletter.</p>\n<p>\"From r/wallstreetbets and the crash of the One Simple Wish website, to the Battle of the Joshes, in 2021, the most notable moments on Reddit were when redditors took their comments, comradery, conversations, and more from URL to IRL,\" Reddit staff wrote in a blog post</p>\n<p>Reddit's year-end review notes that users created 366 million posts over the past year, which was a 19% increase year over year. And as of Nov. 9, 2021, Reddit drew more than 2.3 billion total comments and 46 billion upvotes; aka when users show their approval for a post by clicking an \"up\" arrow, which pushes the post toward the top of the site so that more people can see it.</p>\n<p>The three most upvoted Reddit posts of the year came from the retail investors on the WallStreetBets, and the Superstonk page (which describes itself as discussing GameStop stock specifically) saw a 917K% increase in subscribers year over year.</p>\n<p>Those eager to learn more about the sometimes volatile world of meme stocks can check out MarketWatch's MemeMoney column and weekly MemeMarkets videos on YouTube. Or stay up-to-speed with cryptocurrency market news here.</p>\n<p>And amid the Great Resignation, the r/antiwork subreddit has exploded. The number of \"idlers\" (aka members) in this community for \"those who want to end work, are curious about ending work, want to get the most out of a work-free life, want more information on antiwork ideas and want personal help with their own jobs/work-related struggles\" spiked 279% this year.</p>\n<p>This video highlights the \"oddities and commodities\" discussed on Reddit this year, such as meme stocks like AMC <a href=\"https://laohu8.com/S/AMC\">$(AMC)$</a> and GameStop, supply chain issues, the billionaire space race and the breakout Netflix <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a> hit \"Squid Game.\"</p>\n<p>Check out the full Reddit recap here</p>\n<p>-Nicole Lyn Pesce</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4514":"搜索引擎","BK4532":"文艺复兴科技持仓","BK4108":"电影和娱乐","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","QNETCN":"纳斯达克中美互联网老虎指数","NFLX":"奈飞","BK4566":"资本集团","GOOGL":"谷歌A","BK4524":"宅经济概念","GME":"游戏驿站","BK4077":"互动媒体与服务","BK4527":"明星科技股","BK4538":"云计算","BK4550":"红杉资本持仓","BK4076":"电脑与电子产品零售","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4547":"WSB热门概念","BK4561":"索罗斯持仓","AMC":"AMC院线","BK4548":"巴美列捷福持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190719536","content_text":"Reddit called users like its WallStreetBets community 'catalysts for real-world change' this year\nWhile Reddit hosts more than 430 million monthly active users in over 100,000 communities who discuss everything under the sun, there was one financial subject that cut through the online chatter this year: Cryptocurrency.\nThe massive social network dropped its Reddit Recap 2021 this week, which rounds up the most popular posts, topics and conversations on its platform over the past year. And cryptocurrency was hands down the most popular topic on Reddit in 2021, with people mentioning \"crypto\" 6.6 million times. There are also more than 500 cryptocurrency communities on Reddit, and the five most popular ones this year were r/dogecoin, r/superstonk, r/cryptocurrency, r/amcstock, and r/bitcoin.\nThe Most Viewed Topics of 2021 on Reddit\nCryptocurrencies including Dogecoin , Ethereum and Shiba Inu also topped Google's 2021 Year in Search, which the Alphabet-owned $(GOOGL)$ search engine released this week. \"Dogecoin\" and \"Ethereum price\" landed in the top 10 most-Googled news stories of the past year, both in the U.S. and across the globe. And the top two \"Where to buy\" Google searches were \"Where to buy Dogecoin?\" and \"Where to buy Shiba coin?\"\nRead more:Google's 2021 Year in Search: AMC and GME stocks, Dogecoin, stimulus checks and shortages dominated queries\nWhats's more, a recent Rover.com survey found that pet owners are actually naming their dogs \"Doge\" and their cats \"Bitcoin.\"\nAnd a group of crypto investors named ConstitutionDAO tried making history last month by crowdfunding more than $40 million to bid on a rare copy of the U.S. Constitution. Alas, it lost out to Citadel founder Ken Griffin, who spent $43.2 million on the historic document.\nReddit notes that the rise of these retail and crypto investors looking to game the system has had real-world impact, such as the GameStop $(GME)$ short squeeze in January. Maybe. The year-end Reddit report credits redditors with being \"catalysts for real-world change\" over the past year.\nWant intel on all the news moving markets each day? Sign up for our daily Need to Know newsletter.\n\"From r/wallstreetbets and the crash of the One Simple Wish website, to the Battle of the Joshes, in 2021, the most notable moments on Reddit were when redditors took their comments, comradery, conversations, and more from URL to IRL,\" Reddit staff wrote in a blog post\nReddit's year-end review notes that users created 366 million posts over the past year, which was a 19% increase year over year. And as of Nov. 9, 2021, Reddit drew more than 2.3 billion total comments and 46 billion upvotes; aka when users show their approval for a post by clicking an \"up\" arrow, which pushes the post toward the top of the site so that more people can see it.\nThe three most upvoted Reddit posts of the year came from the retail investors on the WallStreetBets, and the Superstonk page (which describes itself as discussing GameStop stock specifically) saw a 917K% increase in subscribers year over year.\nThose eager to learn more about the sometimes volatile world of meme stocks can check out MarketWatch's MemeMoney column and weekly MemeMarkets videos on YouTube. Or stay up-to-speed with cryptocurrency market news here.\nAnd amid the Great Resignation, the r/antiwork subreddit has exploded. The number of \"idlers\" (aka members) in this community for \"those who want to end work, are curious about ending work, want to get the most out of a work-free life, want more information on antiwork ideas and want personal help with their own jobs/work-related struggles\" spiked 279% this year.\nThis video highlights the \"oddities and commodities\" discussed on Reddit this year, such as meme stocks like AMC $(AMC)$ and GameStop, supply chain issues, the billionaire space race and the breakout Netflix $(NFLX)$ hit \"Squid Game.\"\nCheck out the full Reddit recap here\n-Nicole Lyn Pesce","news_type":1},"isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842217856,"gmtCreate":1636180980002,"gmtModify":1636180980284,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/842217856","repostId":"1173813098","repostType":4,"isVote":1,"tweetType":1,"viewCount":26,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857052917,"gmtCreate":1635497660314,"gmtModify":1635497660594,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/857052917","repostId":"1170828756","repostType":4,"repost":{"id":"1170828756","pubTimestamp":1635496352,"share":"https://www.laohu8.com/m/news/1170828756?lang=&edition=full","pubTime":"2021-10-29 16:32","market":"us","language":"en","title":"Roblox is a better metaverse play than Facebook - Tao Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1170828756","media":"seekingalpha","summary":"Tao Value revealed in a letter to investors that it has opened a position in Roblox(NYSE:RBLX), sayi","content":"<p>Tao Value revealed in a letter to investors that it has opened a position in Roblox(NYSE:RBLX), saying the gaming company has the ability to become \"a new being for human society.\"</p>\n<p>The fund also blasted Facebook(NASDAQ:FB)and its founder Mark Zuckerberg for putting users and shareholders at risk by engaging in \"blatant negligence\" for&nbsp;ignoring internal data&nbsp;that showed that some of its policies had toxic consequences.</p>\n<p>\"Based on records made public thus far, I believe Facebook proved that it did not put its stakeholders' trust and wellbeing as a priority, thus [is] not a good social platform,\" the firm said&nbsp;in a fund letter released this week.</p>\n<p>Earlier on Thursday, Facebook (FB) announced that the company was rebranding as \"Meta\" to better reflect its commitment to the metaverse.&nbsp;In an appearance at the Facebook Connect conference, Zuckerberg&nbsp;outlined the company's strategy, including moves into office, fitness and games.</p>\n<p>Tao Value pointed to RBLX as a better player in the metaverse space, calling it \"a good social platform\" that \"put stakeholders’ trust and security first.\"</p>\n<p>Tao praised the company's management and stressed its potential to branch out from its current core business of games.</p>\n<p>\"Roblox appears to be a great business undervalued to near term profitable visibility, who also has long term optionality,\" the fund said.</p>\n<p>RBLX came public in March through a direct listing, carrying a reference price of $45. The stock rallied to a high of $103.87 by June but quickly came off those levels.</p>\n<p>Since then, shares have seen choppy trading, generally moving sideways. In Thursday's intraday action, the stock dipped less than a percent to $80.27 at about 2:15 PM ET.</p>\n<p>Meanwhile, FB gained steadily through much of the middle of the year to reach a 52-week high of $384.33 in early September.</p>\n<p>However, shares have taken a haircut lately in the wake of its recent scandals. On Thursday, the stock was up 2% to $318.39 at about 2:15 PM ET.</p>\n<p>Comparing the two stocks that Tao pitted against each other, RBLX and FB have traded leadership over the course of 2021. At this point, the stocks are showing comparable gains year-to-date,with both slightly underperforming the broader market:</p>\n<p><img src=\"https://static.tigerbbs.com/067f39be458186c74c8827f81d097ae8\" tg-width=\"1574\" tg-height=\"537\" width=\"100%\" height=\"auto\"></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roblox is a better metaverse play than Facebook - Tao Value</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoblox is a better metaverse play than Facebook - Tao Value\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-29 16:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3760261-roblox-is-better-metaverse-play-than-facebook-tao-value><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tao Value revealed in a letter to investors that it has opened a position in Roblox(NYSE:RBLX), saying the gaming company has the ability to become \"a new being for human society.\"\nThe fund also ...</p>\n\n<a href=\"https://seekingalpha.com/news/3760261-roblox-is-better-metaverse-play-than-facebook-tao-value\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RBLX":"Roblox Corporation"},"source_url":"https://seekingalpha.com/news/3760261-roblox-is-better-metaverse-play-than-facebook-tao-value","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170828756","content_text":"Tao Value revealed in a letter to investors that it has opened a position in Roblox(NYSE:RBLX), saying the gaming company has the ability to become \"a new being for human society.\"\nThe fund also blasted Facebook(NASDAQ:FB)and its founder Mark Zuckerberg for putting users and shareholders at risk by engaging in \"blatant negligence\" for ignoring internal data that showed that some of its policies had toxic consequences.\n\"Based on records made public thus far, I believe Facebook proved that it did not put its stakeholders' trust and wellbeing as a priority, thus [is] not a good social platform,\" the firm said in a fund letter released this week.\nEarlier on Thursday, Facebook (FB) announced that the company was rebranding as \"Meta\" to better reflect its commitment to the metaverse. In an appearance at the Facebook Connect conference, Zuckerberg outlined the company's strategy, including moves into office, fitness and games.\nTao Value pointed to RBLX as a better player in the metaverse space, calling it \"a good social platform\" that \"put stakeholders’ trust and security first.\"\nTao praised the company's management and stressed its potential to branch out from its current core business of games.\n\"Roblox appears to be a great business undervalued to near term profitable visibility, who also has long term optionality,\" the fund said.\nRBLX came public in March through a direct listing, carrying a reference price of $45. The stock rallied to a high of $103.87 by June but quickly came off those levels.\nSince then, shares have seen choppy trading, generally moving sideways. In Thursday's intraday action, the stock dipped less than a percent to $80.27 at about 2:15 PM ET.\nMeanwhile, FB gained steadily through much of the middle of the year to reach a 52-week high of $384.33 in early September.\nHowever, shares have taken a haircut lately in the wake of its recent scandals. On Thursday, the stock was up 2% to $318.39 at about 2:15 PM ET.\nComparing the two stocks that Tao pitted against each other, RBLX and FB have traded leadership over the course of 2021. At this point, the stocks are showing comparable gains year-to-date,with both slightly underperforming the broader market:","news_type":1},"isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856689312,"gmtCreate":1635173282503,"gmtModify":1635173282756,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856689312","repostId":"2178991421","repostType":4,"isVote":1,"tweetType":1,"viewCount":7,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604508241,"gmtCreate":1639408138182,"gmtModify":1639408843294,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604508241","repostId":"1173824820","repostType":4,"repost":{"id":"1173824820","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406936,"share":"https://www.laohu8.com/m/news/1173824820?lang=&edition=full","pubTime":"2021-12-13 22:48","market":"us","language":"en","title":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1173824820","media":"Tiger Newspress","summary":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.On Decem","content":"<p>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.<img src=\"https://static.tigerbbs.com/2541d11930fa271c03180dbe4f2b3f76\" tg-width=\"776\" tg-height=\"557\" width=\"100%\" height=\"auto\">On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.</p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNu Holdings slid over 8% in morning trading,with its market value falling below $50 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.<img src=\"https://static.tigerbbs.com/2541d11930fa271c03180dbe4f2b3f76\" tg-width=\"776\" tg-height=\"557\" width=\"100%\" height=\"auto\">On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.</p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NU":"Nu Holdings Ltd."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173824820","content_text":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.\nThe company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.\nNubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.\nChief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":91,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609637245,"gmtCreate":1638277338452,"gmtModify":1638277338568,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I","listText":"I","text":"I","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609637245","repostId":"1183198352","repostType":4,"repost":{"id":"1183198352","pubTimestamp":1638274451,"share":"https://www.laohu8.com/m/news/1183198352?lang=&edition=full","pubTime":"2021-11-30 20:14","market":"us","language":"en","title":"Apple Stock: Here's Your Chance To Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=1183198352","media":"Seeking Alpha","summary":"Summary\n\nAAPL has returned to strong price support, and I believe it will turn higher from here.\nThe","content":"<p><b>Summary</b></p>\n<ul>\n <li>AAPL has returned to strong price support, and I believe it will turn higher from here.</li>\n <li>The company's fundamentals continue to improve in a variety of ways, and supply chain issues are just noise.</li>\n <li>The stock is a buy and I believe will make new all-time highs in the relatively near future.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eee640d38ca964a8a25d978d1f858293\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>AleksandarNakic/iStock Unreleased via Getty Images</span></p>\n<p>The selloff that took place last Friday was certainly unexpected. A new COVID variant is never a good thing - for a variety of reasons - and the market sold first and asked questions later. The good news is that selling created some great entry points on leading stocks, and in this article, I'll update my views on technology mothership&nbsp;<b>Apple</b>(AAPL), which I believe just hit very strong support, and is now ready for a run to a new all-time high.</p>\n<p>Apple has been a model portfolio stock in my Seeking Alpha Marketplace service,<i>Timely Trader</i>, since the service's inception, and by all evidence, appears poised to maintain its position. The portfolio is re-evaluated every month to ensure our capital is deployed effectively, and Apple continues to make the cut. Below I'll explain why the noise around the supply chain is just that, and why the stock has positioned itself for continued highs into 2022.</p>\n<p><img src=\"https://static.tigerbbs.com/98a005c1e28b33227395e295eb4d3ac6\" tg-width=\"640\" tg-height=\"812\" width=\"100%\" height=\"auto\"></p>\n<p>We'll take a brief look at the chart, because I think this pretty clearly illustrates why Apple is a buy right now. First, the stock made a new all-time high earlier this month on very heavy volume, which is a bullish trait. It means buyers were out in force while the share price was rising, indicating a lot of market participation with the new high. That coincided with a new high in the accumulation/distribution line, which measures whether the stock is finishing nearer to the high or low for the day. A higher A/D line means buyers are active during the day, and is another bullish trait; Apple is exhibiting this as well.</p>\n<p>The stock was overbought during the rally - as measured by the 14-day RSI - but has since pulled back meaningfully during this consolidation. That's completely expected and totally fine, as it means the bulls can now make another run higher. And finally, the PPO is in very bullish territory, and is continuing to move higher, so I see no issues with momentum despite the recent pullback.</p>\n<p>In short, Apple's chart looks great, and with support at ~$157, which was the prior breakout level, as well as the rising 20-day EMA (in red above), I see a lot of reasons to be bullish today.</p>\n<p>Now, let's take a look at the fundamental case for Apple, which I think remains as strong as it has ever been.</p>\n<p><b>Ignore the noise, Apple is still dominant</b></p>\n<p>Apple's&nbsp;Q4 earnings&nbsp;showed a rare revenue miss and profit number that was only in line with expectations, which is quite unusual for this juggernaut. However, as we all know, Apple and others are being heavily impacted by supply chain woes that have absolutely taken over the conversation when it comes to the economy in recent months. Apple, like any other manufacturer, needs its supply chain to be functioning at full speed in order to maximize revenue, but these things are largely out of its control. Apple suffered for that in Q4, but instead of focusing on the report itself, which you can read all about in a variety of places, let's look at how Apple may respond in the fiscal year that just began.</p>\n<p>There is&nbsp;evidence&nbsp;to suggest that Apple's supply chain issues that negatively impacted the fourth quarter, and indeed, October as well, are abating. Keep in mind that Apple's suppliers have massive incentives to keep their components flowing to Apple to make phones and other devices, so there are literally thousands of people across the world working to address Apple's supply chain issues. With the iPhone 13 cycle ramping up, and&nbsp;China&nbsp;showing strong demand for Apple products once again, all looks well.</p>\n<p>Keep in mind also that selling the stock because Apple cannot keep up with demand is a bit counterintuitive. Generally, you want to sell stocks that have too much supply and not enough demand; Apple has the opposite problem, which indicates two things. First, pricing power should remain quite strong given the demand/supply imbalance, and second, when supply does catch up to demand, we'll see higher volumes at strong prices. Why would you sell a stock with these characteristics?</p>\n<p>Now, let's take a look at revenue estimates to see how analysts see Apple moving forward given the supply chain issues are well-known.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4e4ee0e69bc003794d9ef8a801403a88\" tg-width=\"640\" tg-height=\"281\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha</span></p>\n<p>We can see that Apple's estimates continue to move up and to the right, although one could argue the pace of increases has slowed. That's okay, because the important thing is that we continue to see higher and higher revenue estimates for the years to come. I'd also offer that Apple has generally performed quite well against revenue estimates, which is why Q4's revenue miss took people by surprise. I'll reiterate the revenue miss was due to supply chain issues outside of the company's control, and therefore shouldn't be blown out of proportion; it's transitory.</p>\n<p>Now, another key to the bull thesis is that Apple's margins are&nbsp;<i>flying</i>, which we can see below. I've plotted trailing-twelve-months revenue and operating margins to illustrate how operating leverage is working for Apple.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bbaba8826e257af5666c27d29b2f18cf\" tg-width=\"640\" tg-height=\"167\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>Revenue on a TTM basis was actually pretty flat for a couple of years, but in the past handful of quarters, has flown higher. With that, operating margins have moved significantly higher as well, with the September 2020 quarter posting 24% operating margins, while this year's September quarter posting TTM margins of 30%. That's a 25% increase in the amount of profit per dollar of revenue Apple produces, which is enormous to say the least. And as we'll see in just a moment, those gains look set to continue.</p>\n<p>Below we have TTM gross margins and SG&amp;A costs, which are the two main components of operating margins, to illustrate how Apple has achieved its profitability gains.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/af4bc2b49806742ed776ba5e76577543\" tg-width=\"640\" tg-height=\"166\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>SG&amp;A costs have declined from just over 7% of revenue to only 6% of revenue as of the most recent quarter, while gross margins are up from ~38% to ~42% in the same period. That means Apple is gaining on both sides of the equation, showing strong margins through pricing power, and reducing relative costs to produce revenue. This is how Apple has managed to boost profitability so much in the past few quarters, and it all hinges upon higher revenue.</p>\n<p>The bottom line is that so long as revenue is rising, we should see steady or higher gross margins, and lower SG&amp;A costs. These things combine to create higher profitability per dollar of revenue, so we get this supercharged impact on earnings growth where revenue is higher, and the profit per dollar is higher. If you're an Apple bull, you want to keep your eye on revenue because it's driving everything.</p>\n<p>Switching gears, Apple has been a very strong returner of capital in recent years, and that is no different today. The dividend is pretty small and meaningless at this point, but the company's efforts to reduce the float are anything but.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/02926f966d571a5d9af3865b5534bd75\" tg-width=\"640\" tg-height=\"168\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>We can see the share count is<i>36% lower</i>than it was in 2012, which means that on a per-share basis, Apple's earnings are worth 36% more than they otherwise would be. Apple has far more cash than it could ever profitably reinvest in the business, and it produces more and more every year. That means we'll almost certainly see this continue to dwindle, providing a constant tailwind to EPS every year.</p>\n<p>We therefore have ever-rising revenue, rising margins, and a lower share count, all of which support higher EPS. It is no surprise then that Apple's EPS revisions look the way they do.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b562a3b59264989d5077b069db4633ad\" tg-width=\"640\" tg-height=\"286\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha</span></p>\n<p>This is exactly what you want to see, and it's the product of a company that continues to outperform expectations, intelligently return capital to shareholders, and continue to create and market world-class products that consumers cannot get enough of.</p>\n<p><b>Valuation reset creates a buying chance</b></p>\n<p>Now, we all know valuations are stretched in a lot of places for a lot of different stocks, and Apple is no different. We can see below that its forward PE is 28X today, versus a three-year average of 23X. However, it's well off its high of 37X, and I'd argue that given its acceleration of revenue and margins, Apple should be more highly valued than it was in the past three years. The simple fact is that the company's earnings stream has improved greatly, so why shouldn't the valuation?</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e3375c0e3b0081634279d2f828195612\" tg-width=\"640\" tg-height=\"194\" width=\"100%\" height=\"auto\"><span>Source: TIKR.com</span></p>\n<p>Given the company's growth trajectory, and including the fact that we should see some pent-up demand from fiscal 2021 moved into fiscal 2022 due to supply chain issues, I see this valuation as quite enticing. In fact, I think there's a lot more upside potential to 28X earnings than there is downside potential, so when we combine the technical picture with the fundamentals - including this valuation - I cannot see any path other than a bullish one for Apple.</p>\n<p>I'm certainly no Apple perma-bull, but when I objectively evaluate this company's prospects and the outlook for the stock, I can only reach one conclusion: it's a buy on its way to new all-time highs.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: Here's Your Chance To Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: Here's Your Chance To Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 20:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4472312-apple-heres-your-chance><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nAAPL has returned to strong price support, and I believe it will turn higher from here.\nThe company's fundamentals continue to improve in a variety of ways, and supply chain issues are just ...</p>\n\n<a href=\"https://seekingalpha.com/article/4472312-apple-heres-your-chance\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4472312-apple-heres-your-chance","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183198352","content_text":"Summary\n\nAAPL has returned to strong price support, and I believe it will turn higher from here.\nThe company's fundamentals continue to improve in a variety of ways, and supply chain issues are just noise.\nThe stock is a buy and I believe will make new all-time highs in the relatively near future.\n\nAleksandarNakic/iStock Unreleased via Getty Images\nThe selloff that took place last Friday was certainly unexpected. A new COVID variant is never a good thing - for a variety of reasons - and the market sold first and asked questions later. The good news is that selling created some great entry points on leading stocks, and in this article, I'll update my views on technology mothership Apple(AAPL), which I believe just hit very strong support, and is now ready for a run to a new all-time high.\nApple has been a model portfolio stock in my Seeking Alpha Marketplace service,Timely Trader, since the service's inception, and by all evidence, appears poised to maintain its position. The portfolio is re-evaluated every month to ensure our capital is deployed effectively, and Apple continues to make the cut. Below I'll explain why the noise around the supply chain is just that, and why the stock has positioned itself for continued highs into 2022.\n\nWe'll take a brief look at the chart, because I think this pretty clearly illustrates why Apple is a buy right now. First, the stock made a new all-time high earlier this month on very heavy volume, which is a bullish trait. It means buyers were out in force while the share price was rising, indicating a lot of market participation with the new high. That coincided with a new high in the accumulation/distribution line, which measures whether the stock is finishing nearer to the high or low for the day. A higher A/D line means buyers are active during the day, and is another bullish trait; Apple is exhibiting this as well.\nThe stock was overbought during the rally - as measured by the 14-day RSI - but has since pulled back meaningfully during this consolidation. That's completely expected and totally fine, as it means the bulls can now make another run higher. And finally, the PPO is in very bullish territory, and is continuing to move higher, so I see no issues with momentum despite the recent pullback.\nIn short, Apple's chart looks great, and with support at ~$157, which was the prior breakout level, as well as the rising 20-day EMA (in red above), I see a lot of reasons to be bullish today.\nNow, let's take a look at the fundamental case for Apple, which I think remains as strong as it has ever been.\nIgnore the noise, Apple is still dominant\nApple's Q4 earnings showed a rare revenue miss and profit number that was only in line with expectations, which is quite unusual for this juggernaut. However, as we all know, Apple and others are being heavily impacted by supply chain woes that have absolutely taken over the conversation when it comes to the economy in recent months. Apple, like any other manufacturer, needs its supply chain to be functioning at full speed in order to maximize revenue, but these things are largely out of its control. Apple suffered for that in Q4, but instead of focusing on the report itself, which you can read all about in a variety of places, let's look at how Apple may respond in the fiscal year that just began.\nThere is evidence to suggest that Apple's supply chain issues that negatively impacted the fourth quarter, and indeed, October as well, are abating. Keep in mind that Apple's suppliers have massive incentives to keep their components flowing to Apple to make phones and other devices, so there are literally thousands of people across the world working to address Apple's supply chain issues. With the iPhone 13 cycle ramping up, and China showing strong demand for Apple products once again, all looks well.\nKeep in mind also that selling the stock because Apple cannot keep up with demand is a bit counterintuitive. Generally, you want to sell stocks that have too much supply and not enough demand; Apple has the opposite problem, which indicates two things. First, pricing power should remain quite strong given the demand/supply imbalance, and second, when supply does catch up to demand, we'll see higher volumes at strong prices. Why would you sell a stock with these characteristics?\nNow, let's take a look at revenue estimates to see how analysts see Apple moving forward given the supply chain issues are well-known.\nSource: Seeking Alpha\nWe can see that Apple's estimates continue to move up and to the right, although one could argue the pace of increases has slowed. That's okay, because the important thing is that we continue to see higher and higher revenue estimates for the years to come. I'd also offer that Apple has generally performed quite well against revenue estimates, which is why Q4's revenue miss took people by surprise. I'll reiterate the revenue miss was due to supply chain issues outside of the company's control, and therefore shouldn't be blown out of proportion; it's transitory.\nNow, another key to the bull thesis is that Apple's margins are flying, which we can see below. I've plotted trailing-twelve-months revenue and operating margins to illustrate how operating leverage is working for Apple.\nSource: TIKR.com\nRevenue on a TTM basis was actually pretty flat for a couple of years, but in the past handful of quarters, has flown higher. With that, operating margins have moved significantly higher as well, with the September 2020 quarter posting 24% operating margins, while this year's September quarter posting TTM margins of 30%. That's a 25% increase in the amount of profit per dollar of revenue Apple produces, which is enormous to say the least. And as we'll see in just a moment, those gains look set to continue.\nBelow we have TTM gross margins and SG&A costs, which are the two main components of operating margins, to illustrate how Apple has achieved its profitability gains.\nSource: TIKR.com\nSG&A costs have declined from just over 7% of revenue to only 6% of revenue as of the most recent quarter, while gross margins are up from ~38% to ~42% in the same period. That means Apple is gaining on both sides of the equation, showing strong margins through pricing power, and reducing relative costs to produce revenue. This is how Apple has managed to boost profitability so much in the past few quarters, and it all hinges upon higher revenue.\nThe bottom line is that so long as revenue is rising, we should see steady or higher gross margins, and lower SG&A costs. These things combine to create higher profitability per dollar of revenue, so we get this supercharged impact on earnings growth where revenue is higher, and the profit per dollar is higher. If you're an Apple bull, you want to keep your eye on revenue because it's driving everything.\nSwitching gears, Apple has been a very strong returner of capital in recent years, and that is no different today. The dividend is pretty small and meaningless at this point, but the company's efforts to reduce the float are anything but.\nSource: TIKR.com\nWe can see the share count is36% lowerthan it was in 2012, which means that on a per-share basis, Apple's earnings are worth 36% more than they otherwise would be. Apple has far more cash than it could ever profitably reinvest in the business, and it produces more and more every year. That means we'll almost certainly see this continue to dwindle, providing a constant tailwind to EPS every year.\nWe therefore have ever-rising revenue, rising margins, and a lower share count, all of which support higher EPS. It is no surprise then that Apple's EPS revisions look the way they do.\nSource: Seeking Alpha\nThis is exactly what you want to see, and it's the product of a company that continues to outperform expectations, intelligently return capital to shareholders, and continue to create and market world-class products that consumers cannot get enough of.\nValuation reset creates a buying chance\nNow, we all know valuations are stretched in a lot of places for a lot of different stocks, and Apple is no different. We can see below that its forward PE is 28X today, versus a three-year average of 23X. However, it's well off its high of 37X, and I'd argue that given its acceleration of revenue and margins, Apple should be more highly valued than it was in the past three years. The simple fact is that the company's earnings stream has improved greatly, so why shouldn't the valuation?\nSource: TIKR.com\nGiven the company's growth trajectory, and including the fact that we should see some pent-up demand from fiscal 2021 moved into fiscal 2022 due to supply chain issues, I see this valuation as quite enticing. In fact, I think there's a lot more upside potential to 28X earnings than there is downside potential, so when we combine the technical picture with the fundamentals - including this valuation - I cannot see any path other than a bullish one for Apple.\nI'm certainly no Apple perma-bull, but when I objectively evaluate this company's prospects and the outlook for the stock, I can only reach one conclusion: it's a buy on its way to new all-time highs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":17,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877902505,"gmtCreate":1637853297741,"gmtModify":1637853297843,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877902505","repostId":"2186916023","repostType":4,"repost":{"id":"2186916023","pubTimestamp":1637848500,"share":"https://www.laohu8.com/m/news/2186916023?lang=&edition=full","pubTime":"2021-11-25 21:55","market":"us","language":"en","title":"Will Palantir Be a Trillion-Dollar Stock by 2040?","url":"https://stock-news.laohu8.com/highlight/detail?id=2186916023","media":"Motley Fool","summary":"The data-mining firm has a slim chance of eventually joining the 12-zero club.","content":"<p><b>Palantir Technologies</b> (NYSE:PLTR) has been a volatile and polarizing investment since its direct listing last September. The bulls claimed its data-mining platforms would continue to grow as it signed more government and enterprise contracts.</p>\n<p>The bears pointed out that Palantir was too heavily dependent on government clients, its enterprise business faced too many competitors, it was deeply unprofitable, and its stock was too expensive.</p>\n<p>Palantir's stock price has experienced some wild swings over the past year, but it has still more than doubled since its first trade at $10 per share.</p>\n<p>Today, Palantir is valued at $41.3 billion, or 27 times this year's sales. The bears will argue that the high price-to-sales (P/S) ratio will limit its upside, especially as rising interest rates and inflation make many high-growth tech stocks less attractive.</p>\n<p>But let's look beyond the near-term noise and see if Palantir can still generate big multibagger gains, or even become a trillion-dollar stock, over the next two decades.</p>\n<h2>How fast is Palantir growing?</h2>\n<p>Palantir expects to grow its revenue by at least 30% annually between fiscal 2021 and 2025. That forecast implies its revenue will rise from its target of $1.5 billion this year to at least $4.3 billion in 2025.</p>\n<p>The company expects that growth to be driven by its new and expanded contracts with government agencies, as well as the growth of its Foundry platform for large commercial customers. The accelerating growth of its commercial business over the past year, which notably outpaced the growth of its government business last quarter, supports that thesis.</p>\n<h2>Palantir's path toward a trillion-dollar market cap</h2>\n<p>Palantir hasn't provided any longer-term targets beyond 2025. But based on the growth trajectory of other big data companies like <b><a href=\"https://laohu8.com/S/CRM\">Salesforce</a> </b>(NYSE:CRM), its annual revenue increase could potentially decelerate and stabilize at about 20% over the following 10 years.</p>\n<p>If it hits its target for 2025, then continues to grow its revenue at an average rate of 20% over the following 10 years, it could generate nearly $27 billion in revenue in 2035.</p>\n<p>If Palantir's revenue growth then slows down to 15% per year, which would be more comparable to <b>Microsoft</b>'s (NASDAQ:MSFT) current rate, it could generate over $53 billion in revenue in 2040.</p>\n<p>Assuming the company is still valued at over 20 times sales, its market cap could surpass $1 trillion. But most tech giants that grow their revenue 15% to 25% annually aren't valued at more than 20 times sales.</p>\n<p>Microsoft, which is expected to generate 17% sales growth this year, trades at 13 times that estimate. Salesforce, which is expected to generate 24% sales growth this year, trades at just 11 times this year's sales.</p>\n<p>Therefore, Palantir's market cap could potentially hit $1 trillion by 2040, but it seems highly unlikely. Instead, it will likely be closer to $500 billion (which would still be a 12-bagger gain from its current valuation) if its stock is trading at a more reasonable P/S ratio of 10.</p>\n<h2>Look beyond the market caps</h2>\n<p>Instead of focusing on Palantir's path toward joining the 12-zero club, investors should focus on its ability to generate sustainable growth.</p>\n<p>The company has gained a firm foothold with the U.S. government, but it still faces competition from internally developed systems. Immigration and Customs Enforcement (ICE), for example, has been developing its own platform to replace Palantir's Falcon. If other agencies follow ICE's lead, the company's dream of becoming the \"default operating system for data across the U.S. government\" could abruptly end.</p>\n<p>Palantir is making solid progress in the commercial market, but its Foundry platform still faces plenty of indirect competitors like <b>C3.ai</b>, <b>Salesforce</b>'s Tableau, and Glue from <b>Amazon</b> Web Services.</p>\n<p>The company likely believes its reputation as a battle-hardened platform for the U.S. military and government agencies will attract more enterprise customers. But there's no guarantee that this appeal will last for decades or fend off newer, hungrier, and more disruptive players in the data-mining market.</p>\n<h2>Is Palantir's stock still worth buying?</h2>\n<p>I still believe Palantir's stock is a promising long-term investment on the secular growth of the data-mining and analytics market. However, there's a lot of growth already baked into the stock, and its high valuations could limit its near-term and long-term potential. Palantir probably won't hit a trillion-dollar valuation within the next two decades, but it could still outperform the market and generate impressive multibagger gains.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Palantir Be a Trillion-Dollar Stock by 2040?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Palantir Be a Trillion-Dollar Stock by 2040?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/25/will-palantir-be-a-trillion-dollar-stock-by-2040/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies (NYSE:PLTR) has been a volatile and polarizing investment since its direct listing last September. The bulls claimed its data-mining platforms would continue to grow as it signed...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/25/will-palantir-be-a-trillion-dollar-stock-by-2040/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.fool.com/investing/2021/11/25/will-palantir-be-a-trillion-dollar-stock-by-2040/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186916023","content_text":"Palantir Technologies (NYSE:PLTR) has been a volatile and polarizing investment since its direct listing last September. The bulls claimed its data-mining platforms would continue to grow as it signed more government and enterprise contracts.\nThe bears pointed out that Palantir was too heavily dependent on government clients, its enterprise business faced too many competitors, it was deeply unprofitable, and its stock was too expensive.\nPalantir's stock price has experienced some wild swings over the past year, but it has still more than doubled since its first trade at $10 per share.\nToday, Palantir is valued at $41.3 billion, or 27 times this year's sales. The bears will argue that the high price-to-sales (P/S) ratio will limit its upside, especially as rising interest rates and inflation make many high-growth tech stocks less attractive.\nBut let's look beyond the near-term noise and see if Palantir can still generate big multibagger gains, or even become a trillion-dollar stock, over the next two decades.\nHow fast is Palantir growing?\nPalantir expects to grow its revenue by at least 30% annually between fiscal 2021 and 2025. That forecast implies its revenue will rise from its target of $1.5 billion this year to at least $4.3 billion in 2025.\nThe company expects that growth to be driven by its new and expanded contracts with government agencies, as well as the growth of its Foundry platform for large commercial customers. The accelerating growth of its commercial business over the past year, which notably outpaced the growth of its government business last quarter, supports that thesis.\nPalantir's path toward a trillion-dollar market cap\nPalantir hasn't provided any longer-term targets beyond 2025. But based on the growth trajectory of other big data companies like Salesforce (NYSE:CRM), its annual revenue increase could potentially decelerate and stabilize at about 20% over the following 10 years.\nIf it hits its target for 2025, then continues to grow its revenue at an average rate of 20% over the following 10 years, it could generate nearly $27 billion in revenue in 2035.\nIf Palantir's revenue growth then slows down to 15% per year, which would be more comparable to Microsoft's (NASDAQ:MSFT) current rate, it could generate over $53 billion in revenue in 2040.\nAssuming the company is still valued at over 20 times sales, its market cap could surpass $1 trillion. But most tech giants that grow their revenue 15% to 25% annually aren't valued at more than 20 times sales.\nMicrosoft, which is expected to generate 17% sales growth this year, trades at 13 times that estimate. Salesforce, which is expected to generate 24% sales growth this year, trades at just 11 times this year's sales.\nTherefore, Palantir's market cap could potentially hit $1 trillion by 2040, but it seems highly unlikely. Instead, it will likely be closer to $500 billion (which would still be a 12-bagger gain from its current valuation) if its stock is trading at a more reasonable P/S ratio of 10.\nLook beyond the market caps\nInstead of focusing on Palantir's path toward joining the 12-zero club, investors should focus on its ability to generate sustainable growth.\nThe company has gained a firm foothold with the U.S. government, but it still faces competition from internally developed systems. Immigration and Customs Enforcement (ICE), for example, has been developing its own platform to replace Palantir's Falcon. If other agencies follow ICE's lead, the company's dream of becoming the \"default operating system for data across the U.S. government\" could abruptly end.\nPalantir is making solid progress in the commercial market, but its Foundry platform still faces plenty of indirect competitors like C3.ai, Salesforce's Tableau, and Glue from Amazon Web Services.\nThe company likely believes its reputation as a battle-hardened platform for the U.S. military and government agencies will attract more enterprise customers. But there's no guarantee that this appeal will last for decades or fend off newer, hungrier, and more disruptive players in the data-mining market.\nIs Palantir's stock still worth buying?\nI still believe Palantir's stock is a promising long-term investment on the secular growth of the data-mining and analytics market. However, there's a lot of growth already baked into the stock, and its high valuations could limit its near-term and long-term potential. Palantir probably won't hit a trillion-dollar valuation within the next two decades, but it could still outperform the market and generate impressive multibagger gains.","news_type":1},"isVote":1,"tweetType":1,"viewCount":69,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879127871,"gmtCreate":1636693375849,"gmtModify":1636693376149,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I","listText":"I","text":"I","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879127871","repostId":"1104158261","repostType":4,"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850016773,"gmtCreate":1634533977529,"gmtModify":1634533977882,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BS6.SI\">$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$</a>&nbsp;have the feeling going to flyyyyyy soon","listText":"<a href=\"https://laohu8.com/S/BS6.SI\">$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$</a>&nbsp;have the feeling going to flyyyyyy soon","text":"$YANGZIJIANG SHIPBLDG HLDGS LTD(BS6.SI)$ have the feeling going to flyyyyyy soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850016773","isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821582815,"gmtCreate":1633760382821,"gmtModify":1633760383064,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/821582815","repostId":"1167388174","repostType":4,"repost":{"id":"1167388174","pubTimestamp":1633742914,"share":"https://www.laohu8.com/m/news/1167388174?lang=&edition=full","pubTime":"2021-10-09 09:28","market":"us","language":"en","title":"US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167388174","media":"renaissancecap...","summary":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the w","content":"<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.</p>\n<p>Software development platform&nbsp;<b>GitLab</b>(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.</p>\n<p>B2B payments platform&nbsp;<b>AvidXchange</b>(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.</p>\n<p><b>IHS Holding</b>(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.</p>\n<p>Orthopedic medical device company&nbsp;<b>Paragon 28</b>(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.</p>\n<p>Medical diagnostics company&nbsp;<b>Lucid Diagnostics</b>(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.</p>\n<p>ADHD drug developer&nbsp;<b>Cingulate</b>(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.</p>\n<p>Managed health plan provider&nbsp;<b>Marpai</b>(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.</p>\n<p>Dermatological drug spinoff&nbsp;<b>Biofrontera</b>(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.</p>","source":"lsy1625129603274","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 09:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LUCD":"LUCID DIAGNOSTICS INC.","IHS":"IHS Holding Ltd","AVDX":"AvidXchange Holdings, Inc","GTLB":"GitLab, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167388174","content_text":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.\nB2B payments platform AvidXchange(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.\nIHS Holding(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.\nOrthopedic medical device company Paragon 28(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.\nMedical diagnostics company Lucid Diagnostics(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.\nADHD drug developer Cingulate(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.\nManaged health plan provider Marpai(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.\nDermatological drug spinoff Biofrontera(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698843119,"gmtCreate":1640351039097,"gmtModify":1640351039369,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698843119","repostId":"1175608113","repostType":4,"repost":{"id":"1175608113","pubTimestamp":1640342686,"share":"https://www.laohu8.com/m/news/1175608113?lang=&edition=full","pubTime":"2021-12-24 18:44","market":"us","language":"en","title":"Is Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates","url":"https://stock-news.laohu8.com/highlight/detail?id=1175608113","media":"Investors","summary":"Amazon(AMZN) plans to build its first large-format retail stores, making a new foray into physical o","content":"<p><b>Amazon</b>(AMZN) plans to build its first large-format retail stores, making a new foray into physical outlets and stepping up its battle against&nbsp;<b>Walmart</b>(WMT). Is Amazon stock a buy?</p>\n<p>Amazon's 30,000-square-foot stores, which will&nbsp;debut in California and Ohio, are less than one-third the size of Walmart's conventional outlets. They're about one-sixth the size of Walmart Supercenter stores.</p>\n<p>Walmart, the behemoth of brick-and-mortar discount stores, is dueling Amazon, the giant of online shopping, in a battle over the future of retail, e-commerce and grocery shopping.</p>\n<p>Much work remains for either company to win theAmazon vs. Walmart battle. Walmart needs to expand online operations while also managing 11,500 stores across 28 countries, of which 4,743 are in the U.S. It's in the process of redesigning 1,000 stores by the end of 2021. Its goal is to create a more streamlined and faster shopping experience for customers.</p>\n<p>At the same time, Amazon must continue its aggressive rollout of warehouse distribution centers and figure out its strategy for building physical stores.</p>\n<p>Amazon Is Making Critical Investments</p>\n<p>\"The key question from here is when/if does the current investment cycle drive evidence of share gains and margin leverage,\" RBC Capital Markets analyst Brad Erickson said in a note. \"Only time will tell, but in our view AMZN stock is making critical investments as consumers increasingly demand faster shipping which should at least maintain share gains while, importantly, growing gross profit dollars.\"</p>\n<p>Amazon reported&nbsp;third-quarter results&nbsp;on Oct. 28. Adjusted earnings fell 51% from the year-ago period to $6.12 a share. Analysts expected $8.92 a share. Revenue climbed 15% to $110.8 billion, below expectations of $111.6 billion.</p>\n<p>For its fourth quarter, Amazon forecast revenue in the range of $130 billion to $140 billion. That missed analyst estimates for $142 billion. Amazon forecast earnings before interest and taxes, called EBIT, of $1.5 billion, versus estimates of $8.1 billion.</p>\n<p>The company's cloud-computing unit, Amazon Web Services, reported revenue growth of 39% to $11.6 billion. That topped estimates for 35% cloud-computing growth.</p>\n<p>Cowen analyst John Blackledge recently raised his price target on Amazon stock to 4,500, from 4,300. He listed Amazon as one of the \"best ideas\" for 2022, in the mega-cap category.</p>\n<p><b>Amazon Introduces Numerous New Gadgets</b></p>\n<p>On Sept. 28, Amazon introduced aplethora of consumer electronics gadgets, including smart displays and a home robot, at a fall product launch event.</p>\n<p>The Seattle-based e-commerce giant unveiled several devices that leverage its Alexa voice assistant technology. They include theEcho Show 15smart display, which is designed to keep families organized, connected and entertained.</p>\n<p>Another Alexa-enabled device is Amazon's first robot, which is named&nbsp;Astro. The robot will act as a security guard, companion and mobile smart display. It brings together new advancements in artificial intelligence, computer vision, sensor technology, and voice and edge computing, the company said.</p>\n<p>Earlier this month, Amazon moved deeper into the television market with an&nbsp;all-new lineup of devices&nbsp;and its first Amazon-branded 4K smart TVs. The Amazon TV products go on sale in October. Amazon also introduced a 4K version of its Fire TV stick.</p>\n<p><b>Plenty Of Growth Opportunities</b></p>\n<p>Amazon entered 2021 with plenty of big growth opportunities. This included plans to expand its virtual health care program across the U.S. It is also expanding its prescription drug business.</p>\n<p>On March 17, Amazon announced that its telehealth pilot program, called Amazon Care, would expand to all of its U.S. employees and their families as well as other firms this summer. The program first launched at its Seattle headquarters 18 months ago.</p>\n<p>If Amazon can deliver more efficient health care services, the potential is enormous for fueling its growth engine — and by extension Amazon stock. Health care now comprises nearly a fifth of the U.S. economy.</p>\n<p>Amazon said the program enables workers to connect with medical professionals via chat or video conference, and connect patients with medical professionals. In addition, Amazon Care can dispatch a medical professional to a patient's home for additional care.</p>\n<p>Analysts at Jefferies give Amazon a buy rating and price target or 4,000.</p>\n<p>\"We believe low expectations following two consecutive guide-downs better positions AMZN for upside in the core retail business,\" according to a Jefferies report.</p>\n<p>\"We also see attractive growth at AWS and advertising, AMZN's two highest margin businesses, serving to more than offset near-term cost headwinds from labor shortages and supply chain disruption,\" it said.</p>\n<p><b>Tapping The Market For Prescription Drugs</b></p>\n<p>In addition, Amazon is tapping into the $350 billion market for prescription drugs. The company fired a big shot across the bow of drugstores and prescription drug wholesalers late last year when it&nbsp;launched Amazon Pharmacy. The new unit will offer Amazon Prime members discounts of up to 80% on generic drugs and 40% on brand medications.</p>\n<p>On May 26, Amazon announced it is acquiring&nbsp;iconic film studio Metro-Goldwyn-Mayer&nbsp;for $8.45 billion, looking broadly expand its position in streaming video and increase the value of its Prime rewards program. The acquisition is Amazon's largest since buying Whole Foods for $13.7 billion in 2017.</p>\n<p>To get Amazon Prime, users pay an annual or monthly fee for the service and receive multiple perks. This includes free access to Amazon Video and Amazon Music. Amazon has invested billions of dollars in its film and TV operations as well as live sports.</p>\n<p>Another growth vehicle for Amazon in 2021 is advertising.&nbsp;When looking for a product, about half of U.S. adults start their search with Amazon. More searches draw more advertisers.&nbsp;And as Covid-19 has caused more consumers to shop online that will keep Amazon's ad growth humming.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Amazon Stock A Buy Right Now As Epic Battle With Walmart Escalates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 18:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/amazon-stock-buy-now/?src=A00220><strong>Investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon(AMZN) plans to build its first large-format retail stores, making a new foray into physical outlets and stepping up its battle against Walmart(WMT). Is Amazon stock a buy?\nAmazon's 30,000-...</p>\n\n<a href=\"https://www.investors.com/news/technology/amazon-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","WMT":"沃尔玛"},"source_url":"https://www.investors.com/news/technology/amazon-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175608113","content_text":"Amazon(AMZN) plans to build its first large-format retail stores, making a new foray into physical outlets and stepping up its battle against Walmart(WMT). Is Amazon stock a buy?\nAmazon's 30,000-square-foot stores, which will debut in California and Ohio, are less than one-third the size of Walmart's conventional outlets. They're about one-sixth the size of Walmart Supercenter stores.\nWalmart, the behemoth of brick-and-mortar discount stores, is dueling Amazon, the giant of online shopping, in a battle over the future of retail, e-commerce and grocery shopping.\nMuch work remains for either company to win theAmazon vs. Walmart battle. Walmart needs to expand online operations while also managing 11,500 stores across 28 countries, of which 4,743 are in the U.S. It's in the process of redesigning 1,000 stores by the end of 2021. Its goal is to create a more streamlined and faster shopping experience for customers.\nAt the same time, Amazon must continue its aggressive rollout of warehouse distribution centers and figure out its strategy for building physical stores.\nAmazon Is Making Critical Investments\n\"The key question from here is when/if does the current investment cycle drive evidence of share gains and margin leverage,\" RBC Capital Markets analyst Brad Erickson said in a note. \"Only time will tell, but in our view AMZN stock is making critical investments as consumers increasingly demand faster shipping which should at least maintain share gains while, importantly, growing gross profit dollars.\"\nAmazon reported third-quarter results on Oct. 28. Adjusted earnings fell 51% from the year-ago period to $6.12 a share. Analysts expected $8.92 a share. Revenue climbed 15% to $110.8 billion, below expectations of $111.6 billion.\nFor its fourth quarter, Amazon forecast revenue in the range of $130 billion to $140 billion. That missed analyst estimates for $142 billion. Amazon forecast earnings before interest and taxes, called EBIT, of $1.5 billion, versus estimates of $8.1 billion.\nThe company's cloud-computing unit, Amazon Web Services, reported revenue growth of 39% to $11.6 billion. That topped estimates for 35% cloud-computing growth.\nCowen analyst John Blackledge recently raised his price target on Amazon stock to 4,500, from 4,300. He listed Amazon as one of the \"best ideas\" for 2022, in the mega-cap category.\nAmazon Introduces Numerous New Gadgets\nOn Sept. 28, Amazon introduced aplethora of consumer electronics gadgets, including smart displays and a home robot, at a fall product launch event.\nThe Seattle-based e-commerce giant unveiled several devices that leverage its Alexa voice assistant technology. They include theEcho Show 15smart display, which is designed to keep families organized, connected and entertained.\nAnother Alexa-enabled device is Amazon's first robot, which is named Astro. The robot will act as a security guard, companion and mobile smart display. It brings together new advancements in artificial intelligence, computer vision, sensor technology, and voice and edge computing, the company said.\nEarlier this month, Amazon moved deeper into the television market with an all-new lineup of devices and its first Amazon-branded 4K smart TVs. The Amazon TV products go on sale in October. Amazon also introduced a 4K version of its Fire TV stick.\nPlenty Of Growth Opportunities\nAmazon entered 2021 with plenty of big growth opportunities. This included plans to expand its virtual health care program across the U.S. It is also expanding its prescription drug business.\nOn March 17, Amazon announced that its telehealth pilot program, called Amazon Care, would expand to all of its U.S. employees and their families as well as other firms this summer. The program first launched at its Seattle headquarters 18 months ago.\nIf Amazon can deliver more efficient health care services, the potential is enormous for fueling its growth engine — and by extension Amazon stock. Health care now comprises nearly a fifth of the U.S. economy.\nAmazon said the program enables workers to connect with medical professionals via chat or video conference, and connect patients with medical professionals. In addition, Amazon Care can dispatch a medical professional to a patient's home for additional care.\nAnalysts at Jefferies give Amazon a buy rating and price target or 4,000.\n\"We believe low expectations following two consecutive guide-downs better positions AMZN for upside in the core retail business,\" according to a Jefferies report.\n\"We also see attractive growth at AWS and advertising, AMZN's two highest margin businesses, serving to more than offset near-term cost headwinds from labor shortages and supply chain disruption,\" it said.\nTapping The Market For Prescription Drugs\nIn addition, Amazon is tapping into the $350 billion market for prescription drugs. The company fired a big shot across the bow of drugstores and prescription drug wholesalers late last year when it launched Amazon Pharmacy. The new unit will offer Amazon Prime members discounts of up to 80% on generic drugs and 40% on brand medications.\nOn May 26, Amazon announced it is acquiring iconic film studio Metro-Goldwyn-Mayer for $8.45 billion, looking broadly expand its position in streaming video and increase the value of its Prime rewards program. The acquisition is Amazon's largest since buying Whole Foods for $13.7 billion in 2017.\nTo get Amazon Prime, users pay an annual or monthly fee for the service and receive multiple perks. This includes free access to Amazon Video and Amazon Music. Amazon has invested billions of dollars in its film and TV operations as well as live sports.\nAnother growth vehicle for Amazon in 2021 is advertising. When looking for a product, about half of U.S. adults start their search with Amazon. More searches draw more advertisers. And as Covid-19 has caused more consumers to shop online that will keep Amazon's ad growth humming.","news_type":1},"isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693077218,"gmtCreate":1639956234975,"gmtModify":1639956235244,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693077218","repostId":"2192901606","repostType":4,"repost":{"id":"2192901606","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639955078,"share":"https://www.laohu8.com/m/news/2192901606?lang=&edition=full","pubTime":"2021-12-20 07:04","market":"us","language":"en","title":"Biden electric vehicle push hits setback in U.S Senate","url":"https://stock-news.laohu8.com/highlight/detail?id=2192901606","media":"Reuters","summary":"WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax c","content":"<p>WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax credits hit a major roadblock on Sunday when a key Senate Democrat said he would not support a $1.75 trillion domestic investment bill.</p>\n<p>West Virginia's Joe Manchin appeared to deal a fatal blow to President Joe Biden's signature domestic policy bill, known as Build Back Better, which also aims to expand the social safety net and tackle climate change.</p>\n<p>The bill includes increasing the current $7,500 EV tax credit to up to $12,500 for union-made U.S. vehicles as well as creating a credit of up to $4,000 for used vehicles. The bill would also again make General Motors and Tesla Inc</p>\n<p>eligible for tax credits after they hit the 200,000-vehicle cap on the existing $7,500 credit.</p>\n<p>The bill also includes a 30% credit for commercial electric vehicles.</p>\n<p>GM and Ford are both launching electric pickup trucks in 2022 and new tax credits could be crucial to meeting initial sales targets, as well as meeting rising vehicle emissions requirements.</p>\n<p>Biden wants 50% of new U.S. vehicles to be electric or plug-in electric hybrid by 2030. The administration is expected as soon as this week to finalize tougher new vehicle emissions rules through 2026, automakers say.</p>\n<p>Manchin opposes a $4,500 tax credit for union-made vehicles that is part of the $12,500 proposal. He calls the union credit \"wrong\" and \"not American.\"</p>\n<p>The EV tax credits are backed by Biden, many congressional Democrats and the United Auto Workers (UAW) union and would disproportionately benefit Detroit's Big Three automakers - GM, Ford Motor Co&nbsp;and Chrysler parent <a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a> - which assemble their U.S.-made vehicles in union-represented plants.</p>\n<p>Tesla and foreign automakers operating in the United States do not have unions representing assembly workers and many have fought UAW efforts to organize U.S. plants.</p>\n<p>Toyota Motor Corp, which has a plant in West Virginia but whose U.S. employees are not union members, has lobbied against the $4,500 union credit.</p>\n<p>Toyota announced this month it is building a $1.29 billion battery plant in North Carolina, while EV startup Rivian Automotive&nbsp;said on Thursday that it will build a $5 billion plant in Georgia.</p>\n<p>Vehicles would have to be made in the United States starting in 2027 to qualify for any of the $12,500 credit, which includes $500 for U.S. made batteries. It has faced criticism from Canada, Mexico, Japan and the European Union.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden electric vehicle push hits setback in U.S Senate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden electric vehicle push hits setback in U.S Senate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-20 07:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax credits hit a major roadblock on Sunday when a key Senate Democrat said he would not support a $1.75 trillion domestic investment bill.</p>\n<p>West Virginia's Joe Manchin appeared to deal a fatal blow to President Joe Biden's signature domestic policy bill, known as Build Back Better, which also aims to expand the social safety net and tackle climate change.</p>\n<p>The bill includes increasing the current $7,500 EV tax credit to up to $12,500 for union-made U.S. vehicles as well as creating a credit of up to $4,000 for used vehicles. The bill would also again make General Motors and Tesla Inc</p>\n<p>eligible for tax credits after they hit the 200,000-vehicle cap on the existing $7,500 credit.</p>\n<p>The bill also includes a 30% credit for commercial electric vehicles.</p>\n<p>GM and Ford are both launching electric pickup trucks in 2022 and new tax credits could be crucial to meeting initial sales targets, as well as meeting rising vehicle emissions requirements.</p>\n<p>Biden wants 50% of new U.S. vehicles to be electric or plug-in electric hybrid by 2030. The administration is expected as soon as this week to finalize tougher new vehicle emissions rules through 2026, automakers say.</p>\n<p>Manchin opposes a $4,500 tax credit for union-made vehicles that is part of the $12,500 proposal. He calls the union credit \"wrong\" and \"not American.\"</p>\n<p>The EV tax credits are backed by Biden, many congressional Democrats and the United Auto Workers (UAW) union and would disproportionately benefit Detroit's Big Three automakers - GM, Ford Motor Co&nbsp;and Chrysler parent <a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a> - which assemble their U.S.-made vehicles in union-represented plants.</p>\n<p>Tesla and foreign automakers operating in the United States do not have unions representing assembly workers and many have fought UAW efforts to organize U.S. plants.</p>\n<p>Toyota Motor Corp, which has a plant in West Virginia but whose U.S. employees are not union members, has lobbied against the $4,500 union credit.</p>\n<p>Toyota announced this month it is building a $1.29 billion battery plant in North Carolina, while EV startup Rivian Automotive&nbsp;said on Thursday that it will build a $5 billion plant in Georgia.</p>\n<p>Vehicles would have to be made in the United States starting in 2027 to qualify for any of the $12,500 credit, which includes $500 for U.S. made batteries. It has faced criticism from Canada, Mexico, Japan and the European Union.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TM":"丰田汽车","BK4551":"寇图资本持仓","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","GM":"通用汽车","BK4548":"巴美列捷福持仓","TSLA":"特斯拉","BK4550":"红杉资本持仓","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)","RIVN":"Rivian Automotive, Inc.","F":"福特汽车","BK4099":"汽车制造商","03160":"华夏日股对冲"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192901606","content_text":"WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax credits hit a major roadblock on Sunday when a key Senate Democrat said he would not support a $1.75 trillion domestic investment bill.\nWest Virginia's Joe Manchin appeared to deal a fatal blow to President Joe Biden's signature domestic policy bill, known as Build Back Better, which also aims to expand the social safety net and tackle climate change.\nThe bill includes increasing the current $7,500 EV tax credit to up to $12,500 for union-made U.S. vehicles as well as creating a credit of up to $4,000 for used vehicles. The bill would also again make General Motors and Tesla Inc\neligible for tax credits after they hit the 200,000-vehicle cap on the existing $7,500 credit.\nThe bill also includes a 30% credit for commercial electric vehicles.\nGM and Ford are both launching electric pickup trucks in 2022 and new tax credits could be crucial to meeting initial sales targets, as well as meeting rising vehicle emissions requirements.\nBiden wants 50% of new U.S. vehicles to be electric or plug-in electric hybrid by 2030. The administration is expected as soon as this week to finalize tougher new vehicle emissions rules through 2026, automakers say.\nManchin opposes a $4,500 tax credit for union-made vehicles that is part of the $12,500 proposal. He calls the union credit \"wrong\" and \"not American.\"\nThe EV tax credits are backed by Biden, many congressional Democrats and the United Auto Workers (UAW) union and would disproportionately benefit Detroit's Big Three automakers - GM, Ford Motor Co and Chrysler parent Stellantis NV - which assemble their U.S.-made vehicles in union-represented plants.\nTesla and foreign automakers operating in the United States do not have unions representing assembly workers and many have fought UAW efforts to organize U.S. plants.\nToyota Motor Corp, which has a plant in West Virginia but whose U.S. employees are not union members, has lobbied against the $4,500 union credit.\nToyota announced this month it is building a $1.29 billion battery plant in North Carolina, while EV startup Rivian Automotive said on Thursday that it will build a $5 billion plant in Georgia.\nVehicles would have to be made in the United States starting in 2027 to qualify for any of the $12,500 credit, which includes $500 for U.S. made batteries. It has faced criticism from Canada, Mexico, Japan and the European Union.","news_type":1},"isVote":1,"tweetType":1,"viewCount":19,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693060090,"gmtCreate":1639929565902,"gmtModify":1639929566156,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693060090","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&amp;P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&amp;A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p>\n<p>Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&amp;A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p>\n<p>Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p>\n<p><a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p>\n<p>Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p>\n<p>Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p>\n<p>Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p>\n<p>Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 11:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CERN":"美国塞纳","ORCL":"甲骨文","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BK4007":"制药","PFE":"辉瑞","ARNA":"阿里那","BK4534":"瑞士信贷持仓"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals  dominated with a ~83.8% rise after Pfizer  agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner  also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle  for the electronic-medical-records company.\nVaccine developer, Novavax  jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical  posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences  added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":98,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608478292,"gmtCreate":1638784853446,"gmtModify":1638785433084,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608478292","repostId":"2189457105","repostType":4,"repost":{"id":"2189457105","pubTimestamp":1638783010,"share":"https://www.laohu8.com/m/news/2189457105?lang=&edition=full","pubTime":"2021-12-06 17:30","market":"us","language":"en","title":"3 Hot Metaverse Stocks to Buy Before 2021 Is Over","url":"https://stock-news.laohu8.com/highlight/detail?id=2189457105","media":"Motley Fool","summary":"Looking to benefit from the rise of the metaverse? These stocks are top plays.","content":"<p>The metaverse could be one of the biggest emerging product and service trends of 2022, but investors don't have to wait to build an early position in this potentially revolutionary trend. Recent market volatility has led to promising players in the space trading at fresh discounts, and some are worth buying before this year is out.</p>\n<p>With that in mind, a panel of Motley Fool contributors has identified three stocks that are primed to benefit from surging metaverse momentum. Read on to see why they think that these three companies will take your portfolio to the next level.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/09090c7707569356e25602f222e37bdf\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>The social media giant is evolving into a metaverse company</h2>\n<p><b>Parkev Tatevosian:</b>&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> (NASDAQ:FB), the company formerly known as Facebook, is arguably the reason why so many people are talking about the metaverse right now. The name change follows a shift in focus for the social media company that has amassed over 3.5 billion monthly active users across its family of apps (Facebook, Instagram, WhatsApp). The company's apps are free to join. It makes money by showing advertisements to people spending time on its platforms. Since the metaverse is a place where people can interact with each other and the environment virtually, having a large foundation of users is a great start.</p>\n<p>In addition to a strong foundation of users, Meta is generating massive profits from its core social media business -- over $20 billion in operating profit in each of its last four fiscal years. Looking back longer, Meta has grown free cash flow at a compound annual rate of 50% in the last decade.</p>\n<p>It can use those profits and cash to reinvest in the growth of its metaverse. Indeed, founder Mark Zuckerberg outlined ambitious goals when he spoke at the company's most recent conference call on Oct. 25: \"Our goal is to help the metaverse reach a billion people and hundreds of billions of dollars of digital commerce this decade. Strategically, helping to shape the next platform should also reduce our dependence on delivering our services through competitors.\"</p>\n<p>Fortunately for investors, you can buy this company with excellent profits in the near term and massive opportunities in the long term for a bargain price. Meta Platforms is trading at a price-to-free-cash-flow ratio of 25, the lowest the stock has sold for in the last 10 years.</p>\n<h2>This company will help you see (and profit from) the metaverse</h2>\n<p><b>Keith Noonan:&nbsp;</b>Most of the excitement surrounding the metaverse rightfully centers around its potential software applications, but new hardware is going to play a huge role in powering the evolution of virtual worlds. Betting on individual device manufacturers has historically been tough for investors in the tech sector, and even most hardware producers will be relying on software and services to drive profits for their metaverse ventures. However, some components manufacturers stand to see big windfalls from the emergence of virtual reality (VR), augmented reality (AR), and metaverse applications.</p>\n<p><b>Himax Technologies</b> (NASDAQ:HIMX) is a small-cap semiconductor specialist valued at roughly $1.8 billion,&nbsp;and I think it stands out as a great pick-and-shovel play for investors aiming to benefit from the metaverse trend. The company's core business revolves around display drivers -- chips that regulate the colors displayed by pixels on screens. Himax's chips are already used in televisions, mobile devices, and automotive displays, and the business is on track to enjoy powerful tailwinds if metaverses continue to gain traction as places for digital socialization and commerce.</p>\n<p>Himax investors have waited for years for virtual reality and augmented reality glasses to provide the company with a substantial new high-margin revenue source. These product trends were slower to emerge than many investors and analysts predicted, but it looks like the picture is starting to come together.</p>\n<p>Between the company's strong position in the mobile market, fast-growing demand for automotive display chips, and the potential for exploding demand for chips used for AR and VR headsets, Himax has some strong growth catalysts on the horizon. The company produces essential components that will be at the heart of immersive virtual experiences, and its earnings and valuation could soar as the promise of the metaverse increasingly becomes a reality.</p>\n<h2>A company that makes the metaverse possible</h2>\n<p><b>Jason Hall:</b> There are a handful of wonderful companies that are building the framework and technology that the metaverse(s) will exist on. And I agree with my colleagues, who mention two of those here, that they could make for wonderful investments as a result.</p>\n<p>But investors shouldn't sleep on the infrastructure companies that are critical to making virtual reality and the metaverse possible. <b>Crown Castle&nbsp;</b>(NYSE:CCI) is one in particular that I think investors should make part of their metaverse portfolio.</p>\n<p>With 80,000 miles of fiber optic routes, more than 40,000 towers, and over 80,000 small cells, Crown Castle's assets are central to the continued rollout of 5G and the high-speed connections that are necessary to handle the vast amounts of data that the metaverse will require. It's also in the sweet spot of the value chain: Its customers, the telecommunications carriers, make the investments in 5G and other high-speed data tech, paying Crown Castle to house and operate it on that company's vast network.</p>\n<p>And it's a very lucrative business. Since Crown converted to a real estate investment trust, or REIT, and first paid a dividend in 2014, the payout has gone up every year, more than a fourfold increase. Investors have enjoyed 240% in total returns over that period, outperforming the market by a wide margin:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/da6565c002b330b4f7610413941c1018\" tg-width=\"720\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>CCI Dividend data by YCharts</span></p>\n<p>And it think it will continue to beat the market. With a plan to raise the dividend 7% to 8% every year, and growing bandwidth and coverage demands as more people and businesses leverage artificial intelligence, Crown Castle is a great stock to win from the growth of the metaverse.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Hot Metaverse Stocks to Buy Before 2021 Is Over</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Hot Metaverse Stocks to Buy Before 2021 Is Over\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-06 17:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/05/3-hot-metaverse-stocks-to-buy-before-2021-is-over/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The metaverse could be one of the biggest emerging product and service trends of 2022, but investors don't have to wait to build an early position in this potentially revolutionary trend. Recent ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/05/3-hot-metaverse-stocks-to-buy-before-2021-is-over/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","HIMX":"奇景光电","BK4503":"景林资产持仓","CCI":"冠城","VR":"GLOBAL X METAVERSE ETF","BK4548":"巴美列捷福持仓","BK4213":"石油与天然气的勘探与生产","BK4554":"元宇宙及AR概念","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4525":"远程办公概念","AR":"Antero Resources Corp","BK4524":"宅经济概念","BK4508":"社交媒体","BK4077":"互动媒体与服务","BK4527":"明星科技股","BK4526":"热门中概股","BK4550":"红杉资本持仓","BK4141":"半导体产品","BK4084":"特种房地产投资信托"},"source_url":"https://www.fool.com/investing/2021/12/05/3-hot-metaverse-stocks-to-buy-before-2021-is-over/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189457105","content_text":"The metaverse could be one of the biggest emerging product and service trends of 2022, but investors don't have to wait to build an early position in this potentially revolutionary trend. Recent market volatility has led to promising players in the space trading at fresh discounts, and some are worth buying before this year is out.\nWith that in mind, a panel of Motley Fool contributors has identified three stocks that are primed to benefit from surging metaverse momentum. Read on to see why they think that these three companies will take your portfolio to the next level.\nImage source: Getty Images.\nThe social media giant is evolving into a metaverse company\nParkev Tatevosian: Meta Platforms (NASDAQ:FB), the company formerly known as Facebook, is arguably the reason why so many people are talking about the metaverse right now. The name change follows a shift in focus for the social media company that has amassed over 3.5 billion monthly active users across its family of apps (Facebook, Instagram, WhatsApp). The company's apps are free to join. It makes money by showing advertisements to people spending time on its platforms. Since the metaverse is a place where people can interact with each other and the environment virtually, having a large foundation of users is a great start.\nIn addition to a strong foundation of users, Meta is generating massive profits from its core social media business -- over $20 billion in operating profit in each of its last four fiscal years. Looking back longer, Meta has grown free cash flow at a compound annual rate of 50% in the last decade.\nIt can use those profits and cash to reinvest in the growth of its metaverse. Indeed, founder Mark Zuckerberg outlined ambitious goals when he spoke at the company's most recent conference call on Oct. 25: \"Our goal is to help the metaverse reach a billion people and hundreds of billions of dollars of digital commerce this decade. Strategically, helping to shape the next platform should also reduce our dependence on delivering our services through competitors.\"\nFortunately for investors, you can buy this company with excellent profits in the near term and massive opportunities in the long term for a bargain price. Meta Platforms is trading at a price-to-free-cash-flow ratio of 25, the lowest the stock has sold for in the last 10 years.\nThis company will help you see (and profit from) the metaverse\nKeith Noonan: Most of the excitement surrounding the metaverse rightfully centers around its potential software applications, but new hardware is going to play a huge role in powering the evolution of virtual worlds. Betting on individual device manufacturers has historically been tough for investors in the tech sector, and even most hardware producers will be relying on software and services to drive profits for their metaverse ventures. However, some components manufacturers stand to see big windfalls from the emergence of virtual reality (VR), augmented reality (AR), and metaverse applications.\nHimax Technologies (NASDAQ:HIMX) is a small-cap semiconductor specialist valued at roughly $1.8 billion, and I think it stands out as a great pick-and-shovel play for investors aiming to benefit from the metaverse trend. The company's core business revolves around display drivers -- chips that regulate the colors displayed by pixels on screens. Himax's chips are already used in televisions, mobile devices, and automotive displays, and the business is on track to enjoy powerful tailwinds if metaverses continue to gain traction as places for digital socialization and commerce.\nHimax investors have waited for years for virtual reality and augmented reality glasses to provide the company with a substantial new high-margin revenue source. These product trends were slower to emerge than many investors and analysts predicted, but it looks like the picture is starting to come together.\nBetween the company's strong position in the mobile market, fast-growing demand for automotive display chips, and the potential for exploding demand for chips used for AR and VR headsets, Himax has some strong growth catalysts on the horizon. The company produces essential components that will be at the heart of immersive virtual experiences, and its earnings and valuation could soar as the promise of the metaverse increasingly becomes a reality.\nA company that makes the metaverse possible\nJason Hall: There are a handful of wonderful companies that are building the framework and technology that the metaverse(s) will exist on. And I agree with my colleagues, who mention two of those here, that they could make for wonderful investments as a result.\nBut investors shouldn't sleep on the infrastructure companies that are critical to making virtual reality and the metaverse possible. Crown Castle (NYSE:CCI) is one in particular that I think investors should make part of their metaverse portfolio.\nWith 80,000 miles of fiber optic routes, more than 40,000 towers, and over 80,000 small cells, Crown Castle's assets are central to the continued rollout of 5G and the high-speed connections that are necessary to handle the vast amounts of data that the metaverse will require. It's also in the sweet spot of the value chain: Its customers, the telecommunications carriers, make the investments in 5G and other high-speed data tech, paying Crown Castle to house and operate it on that company's vast network.\nAnd it's a very lucrative business. Since Crown converted to a real estate investment trust, or REIT, and first paid a dividend in 2014, the payout has gone up every year, more than a fourfold increase. Investors have enjoyed 240% in total returns over that period, outperforming the market by a wide margin:\nCCI Dividend data by YCharts\nAnd it think it will continue to beat the market. With a plan to raise the dividend 7% to 8% every year, and growing bandwidth and coverage demands as more people and businesses leverage artificial intelligence, Crown Castle is a great stock to win from the growth of the metaverse.","news_type":1},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876551999,"gmtCreate":1637333836829,"gmtModify":1637333837176,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"J","listText":"J","text":"J","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876551999","repostId":"1129693973","repostType":4,"repost":{"id":"1129693973","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637332940,"share":"https://www.laohu8.com/m/news/1129693973?lang=&edition=full","pubTime":"2021-11-19 22:42","market":"us","language":"en","title":"Moderna jumped over 8% while Pfizer and BioNTech SE rose around 2% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1129693973","media":"Tiger Newspress","summary":"Moderna jumped over 8% while Pfizer and BioNTech SE rose around 2% in morning trading.Pfizer(PFE.US)","content":"<p>Moderna jumped over&nbsp;8% while Pfizer and BioNTech SE rose around 2% in morning trading.<img src=\"https://static.tigerbbs.com/1788750b32795d8eb3fbb1f2b7eb08a3\" tg-width=\"773\" tg-height=\"565\" referrerpolicy=\"no-referrer\">Pfizer(PFE.US) plans to apply to the European Union for authorization of its COVID-19 drug Paxlovid today.In addition, the report pointed out that German Health Minister Jens Spahn planned to purchase Paxlovid.</p>\n<p>The report quoted a spokesman for the German Ministry of Health as saying: \"The Ministry of Health is in contact with Pfizer on the possible purchase of COVID-19 drug Paxlovid.\"</p>\n<p>Moreover，Moderna, Inc.&nbsp;today announced that the&nbsp;U.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p>\n<p>“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna jumped over 8% while Pfizer and BioNTech SE rose around 2% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna jumped over 8% while Pfizer and BioNTech SE rose around 2% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna jumped over&nbsp;8% while Pfizer and BioNTech SE rose around 2% in morning trading.<img src=\"https://static.tigerbbs.com/1788750b32795d8eb3fbb1f2b7eb08a3\" tg-width=\"773\" tg-height=\"565\" referrerpolicy=\"no-referrer\">Pfizer(PFE.US) plans to apply to the European Union for authorization of its COVID-19 drug Paxlovid today.In addition, the report pointed out that German Health Minister Jens Spahn planned to purchase Paxlovid.</p>\n<p>The report quoted a spokesman for the German Ministry of Health as saying: \"The Ministry of Health is in contact with Pfizer on the possible purchase of COVID-19 drug Paxlovid.\"</p>\n<p>Moreover，Moderna, Inc.&nbsp;today announced that the&nbsp;U.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p>\n<p>“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129693973","content_text":"Moderna jumped over 8% while Pfizer and BioNTech SE rose around 2% in morning trading.Pfizer(PFE.US) plans to apply to the European Union for authorization of its COVID-19 drug Paxlovid today.In addition, the report pointed out that German Health Minister Jens Spahn planned to purchase Paxlovid.\nThe report quoted a spokesman for the German Ministry of Health as saying: \"The Ministry of Health is in contact with Pfizer on the possible purchase of COVID-19 drug Paxlovid.\"\nMoreover，Moderna, Inc. today announced that the U.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.\n“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}